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ABSTRACT 
LIGAND-RECEPTOR INTERACTIONS FOR SUPRAMOLECULAR DISASSEMBLY WITH 
APPLICATIONS IN SCREENING AND DRUG DELIVERY 
MAY 2014 
 
DIEGO F. AMADO TORRES, B.S., UNIVERSIDAD INDUSTRIAL DE SANTANDER 
 
M.S., UNIVERSIDAD INDUSTRIAL DE SANTANDER 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Sankaran Thayumanavan 
 
Proteins have the capacity to bind specific sets of compounds known as ligands, 
these are small molecules with a recurrent theme in their molecular design that is a 
characteristic exploited here to (i) identify particular affinities of small molecules for 
proteins with the aim of using them as ligands, inhibitors, or targeting moieties in more 
complex systems by means of a methodology that screens small molecules based on 
protein affinity; (ii) decorate a self-assembling supramolecular system at different 
positions, making it responsive to a complementary protein with the aim of exploring 
differences in disassembly and sensitivity of the release of encapsulated guest 
molecules, depending on the initial location of the ligand upon binding to a specific 
protein; (iii) decorate self-assembling and crosslinkable dendrons aiming to introduce a 
system incorporating multiple ligands, sequentially responsive to a reducing 
environment, and to specific proteins.  
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CHAPTER 1 
 
INTRODUCTION 
1.1 Protein Binding: from Self-assemblies to Ligands 
Synthetic amphiphilic macromolecules that can spontaneously self-assemble in 
solution possess the capability of mimicking features of naturally occurring architectures 
such as cell membranes and endosomes, and macromolecules, such as proteins, RNA, 
and DNA.1 As a result, such systems are of great importance in supramolecular 
chemistry. Synthetic supramolecular systems often utilize the same kind of interactions 
that nature uses in its own designs, namely hydrophobic interactions, van der Walls 
forces, hydrogen bonds, electrostatic interactions, - interactions, and metal-ligand 
binding interactions.2 All of these non-covalent interactions are involved in the specific 
binding of ligands to proteins, which led to their inclusion by synthetic chemists in 
artificial systems in an attempt to emulate designs that evolution has refined over 
millions of years.3 Many of those artificial tailored systems include self-assembling 
molecules and macromolecules as scaffolds for nanostructures such as micelles, 
vesicles, lamellae, and aggregates along with less frequent nanostructures in other 
shapes.4 The main characteristics sought in self-assembling systems are often beneficial 
in encapsulation of guest molecules for drug delivery purposes and sensing applications. 
Artificial self-assembling supramolecular systems are formed by a variety of 
molecules, including small molecule surfactants, block copolymers, random copolymers, 
and dendrons.5,6 The self-assembling capabilities of these molecules and 
 2 
macromolecules in an aqueous environment is complemented by the encapsulation 
properties, usually of small molecules upon mixing them with the corresponding self-
assembling motifs, i.e. small hydrophilic molecules trapped in the aqueous interior of 
vesicles, or hydrophobic molecules occupying hydrophobic pockets in a micelle, 
lamellae, or aggregate. As in naturally occurring proteins, which suffer conformational 
changes when bound to specific molecules, man-made self-assembling systems have 
been functionalized with particular features to induce conformational changes upon 
stimulation.3,5 A supramolecular system incorporating responsive features becomes 
more complex and interesting when a stimulus triggers either disassembly or a 
morphological transformation of the system.7 Such disturbances in assembly and 
morphology are usually followed by release of encapsulated small molecules, which are 
often a pharmacophore or a reporter chromophore. Nevertheless, disassembly and 
morphology changes are sought to be reversible in many cases, as a more accurate 
emulation of protein features.  
The proteins’ capacity for binding to specific sets of compounds known as 
ligands, small molecules with a recurrent theme in their molecular design, is a 
characteristic exploited and described in this thesis for a system based on 
supramolecular analytical chemistry. It is desirable to identify particular affinities of 
small molecules for proteins, so they can be used as ligands, inhibitors, or targeting 
moieties in more complex systems.8 With that in mind, a methodology that screens 
small molecules based on protein affinity would be useful to identify hits that are 
synthetically more accessible, cheaper, and easier to modify than other known ligands. 
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Previously, the same protein-ligand binding capacity has been used to give 
specificity to self-assembling nanostructures, including soft and hard nanoparticles, 
towards a target protein.3,5 However, the importance of the ligand location on a 
nanoassembly has been disregarded, and nothing is known about how it affects either 
disassembly or the further release of encapsulated guest molecules. 
Since this thesis is about the protein-ligand binding event and its influence on (i) 
discrimination of small molecules affinity in a screening assay, (ii) disassembly of 
dendrimeric aggregates and (iii) release efficiency, in this chapter, we will discuss some 
relevant aspects about determination of binding affinity and dendron responsiveness to 
diverse stimuli, what has been shown previously from our lab. 
1.2 Protein-Ligand Binding Affinities, Importance and Discrimination 
Protein-ligand interactions are known for their specificity and biological 
relevance, which is due to the myriad of physiological functions triggered upon a 
protein-ligand binding event.9 Mimicking the details and advantages of receptors’ 
binders has been an important task for pharmacological science; this problem has been 
approached by designing ligand-like small molecules with the purpose of either 
enhancing or reducing a physiological response after interaction with a specific 
protein.10 Discriminating protein-affinity of a new molecule when comparing it to a 
different molecule with already known binding affinity, i.e. how well the new molecule 
inhibits the action of a target protein by blocking its binding site, is a matter of great 
importance in the fields of drug discovery and bioresponsive materials. 
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Discriminating methods for rapid screening of small molecules is a crucial 
requirement in drug discovery and development. Even though there has been significant 
advancement in diversity-oriented organic synthesis to obtain a large library of small 
molecules, developing screening techniques with greater efficacy is still a challenging 
task for the pharmaceutical industry.11 Most of the current methods require either 
radio-labeling of the ligand molecule or labeling the receptor itself.12 Although there are 
a number of non-labeling methods, they involve expensive instrumentation and 
excessive time consumption. An efficient approach to address these issues would 
involve the development of versatile screening methods, utilizing simple analytical tools, 
thereby improving their broader applicability without compromising the speed of test.11 
In the past several decades, great efforts in medicinal chemistry and the advent 
of combinatorial chemistry have generated the possibility of synthesizing large libraries 
of organic molecules to target a number of diseases. However, only limited efforts have 
been made in finding new techniques for screening these huge numbers of molecular 
compounds.13 
For the screening of large numbers of molecules, the pharmaceutical industry 
requires simple and robust methods that could be easily transferred to automated drug 
screening. While high throughput screening (HTS) is currently available for such 
endeavors, 14 these techniques require special instrumentation with highly complicated 
methodologies and expertise. Thus, it is pertinent to develop novel and more 
straightforward methods than the existing ones, using simple instrumentation 
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techniques to make the screening process and the identification of “hits” economical 
and time-saving. 
The identification of “hit” molecules is important during the early stages of drug 
discovery. The following stages involve the transformation of the hit into a “lead” 
molecule, and then the optimization of those “lead” molecules. However, quantitatively 
assessing the binding strength of molecule-receptor interactions at an early stage plays 
a vital role in expediting the drug discovery process. Some of the most used methods for 
this purpose are described in the following sections.  
1.2.1 X-Ray Crystallography 
An increase in the speed and power of protein crystallography has had a 
significant impact on screening of small molecules through defining drug binding modes 
more rapidly and with greater certainty, which has significant importance on lead 
discovery. 
In an X-ray approach to screening,15 protein crystals are exposed to either single 
molecules or molecule cocktails in a solvated environment. Since protein crystals 
contain extensive channels filled with solvent accounting for approximately 50% of the 
three-dimensional structure volume of the protein, ligand small molecules will generally 
diffuse rapidly into the crystals and interact as if they were in solution, as long as the 
crystal packing does not occlude the binding site. Once the initial protein crystals have 
been characterized, the small molecules can be visualized by collecting sets of X-ray data 
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on each soaked crystal under identical conditions. The aid of automatic procedures 
enables the rapid analysis of the protein–ligand complex solutions.16  
However, the protein fragments are used at much higher concentrations than in 
conventional HTS approaches, assuming that the crystal is adequate for the study. 
Figure 1.1 shows a known binding site in a soaked protein crystal and illustrates how 
different small molecules are identified according to their fit within the protein.17 
Although this method has several disadvantages including the required high 
concentrations and proper crystallization, high-throughput crystallography is now a 
viable screening method in the recognition of molecular fragments that bind protein 
targets and precise definition of the protein binding sites. 18 It can subsequently be used 
as a rapid technique to guide lead optimization. 
 
Figure 1.1. Fragment based approach to lead discovery; a) schematic representation 
of an active site with three pockets; b) two fragments binding two of the pockets; c) a 
scaffold linking three fragments binding the pockets; e) the real binding site defined 
by van der Waals surface; f) a fragment defined by X-ray crystallography.15 
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1.2.2 NMR Based Strategies 
Several NMR based strategies have been developed with a particularly useful set 
for drug discovery.19 These include traditional chemical-shift mapping, ligand-based 
techniques that monitor changes in nuclear ligand spin relaxation properties upon 
binding, and diffusion measurements. However, some of these approaches are better 
suited to validate hits coming from HTS campaigns while others are better suited to 
guide hit optimization to lead compounds, mostly due to the high concentration of 
protein needed for the screening of large libraries of compounds.  
One of the most often utilized for hit identification and validation by NMR is 
called chemical-shift mapping.20 This approach exploits the differences in chemical shift 
between free and bound target protein, in two-dimensional correlation spectra upon 
titration with a ligand or a mixture of ligands. This is a ligand-binding assay that can 
provide meaningful information on the binding site; it has advantages over other 
screening techniques, as compounds bound to the target protein can be found and 
characterized without need for an assay. When the structure of the target has been 
determined by NMR, it could be possible to derive ligand-protein distances. However, 
for target proteins over 30-40 kDa at least one amino acid needs to be labeled to reduce 
the spectral complexity. 
The ligand-based techniques use a smaller amount of protein than the previous 
approach, and are based on the observation of perturbations induced by a 
substoichiometric amount of target protein on the NMR spectra of the ligand.21 
Saturation transfer difference (STD) is one of these techniques in which a simple 1H 
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NMR is recorded for a ligand in the presence of a small amount of target i.e. 
ligand:protein 100:1, with and without selective irradiations of the protein resonances 
in regions that are not occupied by resonances of the small molecule ligand. This 
technique also exploits the relaxation differences between bound and free state of a 
ligand nuclei, even if the binding is transient in the presence of a substoichiometric 
amount of protein. This approach however, is less informative than chemical-shift 
mapping and is typically used for screening and validation. 
Another interesting strategy uses both X-ray crystallography and NMR based 
methods for hit screening and validation along with in silico docking of compounds to 
predict those that should bind to a target protein. This is a very important aid used in 
the fragment-based drug design (FBDD) strategy, which combine the information 
acquired from either X-ray crystallography or NMR with computational simulations that 
help to save time and resources. FBDD is now an alternative to conventional HTS.15,19  
1.2.3 Mass Spectrometry 
Mass spectrometry (MS) plays a role in nearly every step of the drug 
development process. However, it was not until recently that MS has emerged as an 
effective technique for identifying lead compounds based on the characterization of 
ligand-protein target interactions. One of the main advantages of this strategy is the 
small quantities of ligand and target protein required, and the capacity to study them 
without labeling them.22 
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A MS approach stands apart in the identification of hits and lead compounds 
when is combined with electrospray ionization (ESI). ESI-MS reduces considerable 
constraints on the purity of both targets and ligands due to differentiations in molecular 
mass, allowing for detection of non-covalent complexes, which makes it useful in 
compound screening and structure-activity relationship (SAR) optimization.23 
A different method that can measure binding of small molecules to protein 
targets either directly or indirectly is affinity selection mass spectrometry (AS-MS). All 
varieties of AS-MS include a step of affinity selection, where the protein is equilibrated 
with at least one potential ligand; during this stage the protein forms a complex with 
any compound capable of binding. In the next step the resulting receptor-ligand 
complexes are separated from unbound components. In a final step, ligands are 
identified by MS or MS-MS.24 
AS-MS methods measure the binding event directly or indirectly. The direct 
methods separate protein-ligand complexes from unbound components within the mass 
spectrometer. Then, the mass of the non-covalent or covalent protein-ligand complex is 
measured in the gas phase. Indirect methods use a separation technique, usually 
chromatography, to isolate the protein-ligand complex formed from unbound 
components before MS. Both direct and indirect methods have been applied in 
screening of libraries of compounds, compound mixtures, and unpurified natural 
products extracts.  
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1.2.4 Microcalorimetry 
Currently, isothermal scanning calorimetry, also known as isothermal titration 
calorimetry (ITC), permits direct determination of enthalpy values and gives complete 
thermodynamic profiles for binding events. The instruments for ITC most commonly use 
a power compensation design in which the temperature difference between a sample 
cell and a reference cell is monitored. While both cells are maintained at a constant 
temperature, a titration system delivers a reactant to the sample cell where any heat of 
reactant binding results in an imbalance between the reference and sample cells, which 
is compensated for by modulating the power applied to cell heaters.25 
Figure 1.2 shows an example of ITC data of a ligand binding to a protein. The top 
panel shows the primary titration data, or raw data, in which power is displayed as a 
function of time. The programmed titration delivery steps are evident by the series of 
peaks that return to baseline. The area of each peak is the heat of reaction for each 
reactant addition and the magnitude decreases as the receptor binding site becomes 
saturated. The bottom panel shows the primary ITC data transformed into a binding 
isotherm displaying the characteristic sigmoidal shape. This binding isotherm is fit into a 
particular binding model to get the binding constant, binding enthalpy, and the 
stoichiometry of the binding event. 
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However, ITC is a laborious and time 
consuming method. Even an experienced 
investigator can usually complete only a few 
experiments per day, which relegates 
calorimetry to the pharmaceutical industry for 
use as a secondary screening method for 
validation of other assays. High throughput 
calorimeters are still a work in progress with 
less than promising early results. Perhaps the 
most impressive results come from a hybrid 
technology between calorimetry and 
fluorimetry. ThermoFluor measures the 
fluorescence of dyes that sense protein 
unfolding; it is used to conduct miniaturized thermal shift assays in drug discovery.26  
1.2.5 Fluorescence Based techniques 
Fluorescence techniques can be easily implemented as a HTS.14 There are a 
number of methods involving fluorescence as screening techniques; although most of 
these methods are robust, many require specialized and costly instrumentation as well 
as the required knowledge to keep them working well.11,27 The most popular methods 
involve fluorescence-based displacement assays. Among them, fluorescence correlation 
spectroscopy (FCS) based assays are worth mention; these assays utilize the difference 
 
Figure 1.2. ITC data for a binding 
event. The top panel shows the raw 
titration data; the bottom panel 
shows the binding isotherm 
constructed from the raw data. 
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in the diffusion time of bound and unbound ligands, and yet they require special 
instrumentation and expertise to correlate the data. Assays based on FRET partners are 
also of importance; although these assays require simpler fluorescent instruments the 
required labeling of the protein itself reduces their versatility. 
Fluorescence-polarization activity-based protein profiling (fluopol-ABPP) 
technology, an interesting technique that has recently been developed, is compatible 
with HTS (Figure 1.3).28 Fluorescence polarization, a measure of the apparent size of a 
fluorophore, is widely used to study molecular interactions. When excited with plane-
polarized light, a fluorophore emits light parallel to the plane of excitation, unless it 
rotates in the excited state. The speed of molecular rotation and resulting extent of 
depolarization are inversely proportional to molecular volume. Typically, small 
fluorophores of less than 10 kDa rotate quickly and emit depolarized light that is 
registered as a low fluorescence polarization signal when free in solution, but, when 
they are bound to a protein, they rotate more slowly and emit highly polarized light that 
is registered as a high fluorescence polarization signal.29 The reaction between an 
activity-based probe and an enzyme results in a time-dependent increase in 
fluorescence polarization signal, enabling real time monitoring of enzymatic activity in a 
homogeneous assay format. 
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As a pictoric representation of this technique’s concept, in Figure 1.3, a protein is 
placed into a 384 well plate, followed by the addition of a different test compound into 
each well. The figure represents an inhibitor (a) and an inactive compound (b). A 
fluorescent ABPP probe is then introduced to each well and the plate incubated for 
some time. The reaction of the probe with unbound protein (but not with bound 
protein) will greatly increase the apparent mass of the probe, resulting in the 
maintenance of a strong fluorescence polarization signal. 
1.3 Dendrimers, Mono-Dispersed Polymers 
It was mentioned before that amphiphilic molecules are primarily interesting 
due to the self-assembling characteristics they exhibit, both in solution as micelles or 
vesicles and in aggregates. The driving force for the formation of these amphiphile 
assemblies is to maintain a favorable hydrophilic–lipophilic balance (HLB) between the 
hydrophilic and the lipophilic components. In solution, these molecules self-assemble 
only when they are above certain concentration, which is known as critical aggregation 
 
Figure 1.3. Pictorial representation of a fluopol-ABPP assay. a) An inhibitor mixed with 
a protein shows low fluorescence polarization, b) an inactive compound shows high 
fluorescence polarization.27 
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concentration (CAC).30 Amphiphilic macromolecules exhibit CACs substantially lower 
than smaller surfactants. While small surfactants have CACs in the millimolar range, 
assemblies formed by macromolecules such as dendrimers, amphiphilic homopolymers, 
amphiphilic random copolymes or amphiphilic block copolymers have CACs lingering in 
the micro and nanomolar range.31,32,33 In a way, amphiphilic macromolecules could be 
seen as macro-surfactants. Although polymers form more stable self-assembling 
structures with lower CACs than the small molecule surfactants, the inherent 
polydispersity associated with their synthesis makes a challenge of the synthetic 
reproducibility, which could be a drawback for this kind of polymeric system in drug 
delivery, sensing, and in general in the study of nanoassemblies’ surface properties.34 In 
that sense, dendrimers have the advantage of synthetic reproducibility, monodispersity, 
and controlled molecular weight. 
1.3.1 Structural Characteristics of Dendrimers 
Among amphiphilic macromolecules, dendrimers are interesting due to their 
uniform structures, controlled functionalization, and defined molecular weight. 
Multivalency is another important feature that is provided by the highly branched 
dendrimer structures,35 which mean a high number of terminal functional groups are 
available for functionalization. 
In fact, branching is the primary characteristics of dendrimers. For this reason, 
the macromolecules were initially called “arborols” by Newkome,36 and later on 
“dendrimers” by Tomalia, which became the term accepted in the literature.37 The 
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words dendrimer, and dendron, come from the Greek word δένδρον (read dendron), 
which means “tree”, and refers to the branched structures of the molecules. Usually, a 
dendrimer or a dendron contains a monomer or a single group called the core or the 
focal point. Typically, a dendrimer is symmetric around the core but a dendron branches 
out from the focal point in one hemisphere direction. The branches’ terminal groups are 
called the periphery in either case, as it can be seen from the cartoon depicting the 
backbone of dendrons in Figure 1.4. 
Amphiphilic dendrimers are formed using hydrophilic and hydrophobic 
components. As mentioned before, the non-covalent forces drive dendrimers to self-
assemble above their CAC, when dispersed in aqueous media. Hydrophilic components, 
that often incorporate structures of carboxylates, phosphates or quaternary ammonium 
groups, render these dendrimers water soluble. However, the non-specific interactions 
of these charged species with biomolecules i.e. non-specific binding, often limit their 
use in biological applications. To address that issue, non-ionic and well known 
biocompatible hydrophilic molecules, such as poly(ethylene glycols), have been used as 
 
Figure 1.4. Cartoon representation for the focal point, middle layer, and periphery of a dendron 
generation 1 (G1), and a dendron generation 2 (G2). 
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the hydrophilic part.38 On the other hand, hydrophobic components dictate parameters 
such as stability and loading capacity. 
There are also amphiphilic dendrimers that do not form assemblies. Instead, 
Fréchet-type dendrimers form unimolecular micelles in solution by displaying a 
hydrophilic periphery and a hydrophobic polyether core.39 Newkome,40 and Meijer41 
have reported on similar kinds of dendrimers. 
Dendrimers, as a type of monodispersed macromolecules, are synthesized in a 
controlled fashion. The appearance of dendrimers in specialized literature increased 
considerably in the last two decades, as well as their applications on a variety of fields. 
In our lab, a unique kind of biaryl amphiphilic self-assembling dendrons has been 
developed incorporating a range of different functionalities, with the goal of imparting 
the macromolecules with responsiveness towards different stimuli.  
1.3.2 Divergent and Convergent Methods for Dendrimer Synthesis 
Usually, a self-assembly is formed by amphiphilic macromolecules such as 
synthetic polymers, which show broad molecular weight distributions after synthesis; 
unlike natural amphiphilic polymers i.e. proteins, which are monodispersed despite their 
complexity. Thus, polymers are polydispersed regardless of the advances in 
polymerization techniques achieved during the last three decades.42 One way to access 
macromolecules with defined molecular weights is through iterative synthesis. Although 
this method is more tedious, time consuming and less efficient than step-by-step and 
radical polymerizations, it allows for successive and controlled attachment of 
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monomers. With this type of synthesis, it is possible to control the exact molecular 
weight and location of ligands and various functionalities into the macromolecule. 
Dendrimer synthesis involves either divergent43,44 or convergent covalent 
attachment strategies,45 which generally require molecular scaffolds and synthetic 
pathways as outlined in Figure 1.5. Simply stated, the divergent strategy involves the 
controlled and iterative assembly of AB2 type monomers, where the co-reactive nature 
of A and B allows for a controlled covalent attachment of the monomers. This might be 
visualized as a molecular tree growing from the stem towards the branches, and ending 
when it has reached the periphery of the branches or tree canopy. The convergent 
strategy also involves the controlled, iterative assembly of AB2 type monomers, where 
the B and A components are co-reactive; in this case protection and deprotection 
 
Figure 1.5. Illustration representing divergent (top) and convergent (bottom) syntheses 
of dendrons. 
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protocols are used to build the dendrons, generation by generation. In essence, the 
molecular tree starts to grow from the periphery of the branches or tree canopy 
towards the inner branches, until reaching the stem (focal point), to produce a 
molecular tree, as shown in Figure 1.5. In general, dendrimers produced by the 
divergent strategy suffer an increase of reactive functionalities as the generation 
increases, which leads to a higher number of defects at higher generations. Dendrimers 
synthesized by the convergent strategy are nearly free of defects due to a fewer number 
of reactive functionalities that remain constant as the generation increases. However, 
steric hindrance produced by the growing bulky groups leads to reaction problems at 
higher generations. 
An example of a single product generated using the convergent approach is 
shown in Figure 1.6.46 Briefly, a polyphenylazomethine-based dendrimer, which consist 
of a -conjugated backbone synthesized up to the 4th generation (G4) using the 
 
Figure 1.6. G4 dendrimer and its monodispersed MS obtained from a convergent 
approach. 
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convergent method, led to a single macromolecular structure, as it was observed by 
MALDI-TOF-MS. The product was monodispersed and showed a consistent molecular 
weight (m/z 5451.26 [M + H]+). Figure 1.7 shows an example of how the divergent 
approach affects the purity of the products by introducing defects that lead to 
byproducts of diverse molecular weights.47 Briefly, a poly(propylene imine) dendrimer 
synthesized via a divergent approach accumulated statistical defects as soon as the first 
synthetic step, which led to imperfections in the G1, G2, G3, and final products (Figure 
1.7. with m/z 740.6, 1622.0, 3384.0, 6909.7 for increasing generations of this 
dendrimer). 
1.3.3 Biomimetic Characteristics of Dendrimers 
The synthesis of dendrons and dendrimers provides a precise and tunable 
strategy for the controlled construction of macromolecules. Formed by reproducible 
monomers, dendrimers are often compared to proteins due to their size and three-
dimensional structure, characteristics imparted by the forming monomers. Each 
 
Figure 1.7. Main G4 dendrimer and polydispersed MS for its synthetic 
divergent approach including G2, G3, and higher generations. 
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architectural component bears a specific function that will define specific properties in 
the nanostructures, generation by generation. Dendrimers’ monodispersity and three-
dimensional architecture resemble the homogeneity of the naturally occurring proteins, 
and closely mimic the globular shape and scale of the bio-macromolecules. These 
characteristics grant dendrimers and dendrons the epithet of artificial proteins.48,49 
The groups that are primarily exposed to the solvent and nanoenvironment 
surrounding them lie at the surface of the nanostructure. These functionalities might 
consist of either reactive or unreactive terminal groups that impart important properties 
to the macromolecule such as solubility, charge surface, accessibility to the interior from 
the outside and to the outside from the interior, surface functionalization, and 
specificity towards a target or stimulus. Within the interior of the nanostructure lie the 
group functionalities that are less exposed to the solvent; these functionalities define 
the type of interior based on the groups’ composition and branching, the hydrophobic 
properties of the macromolecules, and also the host-guest properties. The spherical 3D 
nanostructure generates a nanoenvironment at the inner layers of the dendrimer that 
allows for encapsulation of small molecules kindred to that nanoenvironment. The core, 
or focal point, provides information about the kind of monomer forming the dendrimer; 
the size, shape, and directionality are expressed by the connectivity of the core towards 
the outer layers.4 
Such architectural components form the overall set of physicochemical 
properties namely size, shape, flexibility, and reactivity of the dendrimers. In particular, 
the encapsulation property of dendritic globular nanostructures and the possibility of 
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altering that property, as a response to an external stimulus, resemble protein’s 
characteristics, in which the active site is buried in hydrophobic pockets. Figure 1.8 
shows a Fréchet type globular dendrimer which forms a unimolecular micelle, making it 
a system free of CAC. Such structure bears a hydrophilic periphery that might be formed 
by carboxylic acid functionalities (red beats in the figure) and a hydrophobic interior (red 
waving lines in the figure).50 Due to its globular shape and by means of the hydrophilic 
periphery of the macromolecule, the whole structure is water soluble regardless of its 
hydrophobic interior. Figure 1.8 clearly shows the voids in between hydrophobic 
branches (green), which, though unrealistic, are a pictoric representation of where the 
encapsulated hydrophobic molecules might remain trapped in a dendrimer 
(hydrophobic interior). 
Amphiphilic dendrimers, such as the one represented in Figure 1.8, should adopt 
a globular shape in aqueous solution,4,48 displaying a hydrophobic core and hydrophobic 
inner layers (green color) that could be used as pockets to encapsulate small 
 
Figure 1.8. Globular amphiphilic dendrimer with hydrophilic periphery and 
hydrophobic inner layers.50 
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hydrophobic molecules in between the branches of the unimolecular micelle inner 
layers. Encapsulation, one of the main characteristics of amphiphilic dendrons and 
dendrimers, will be discussed in the next section. 
1.3.4 Encapsulation of Molecules within the Dendritic Architecture 
Due to the interstitial space between branches in the dendritic architecture, the 
possibility of encapsulating hydrophobic small molecules has been explored thoroughly. 
In amphiphilic dendrimers, water solubility is given by the hydrophilic groups at the 
periphery, which wrap the hydrophobic inner layers screening them from the solvent. As 
a result, the dendritic structure is water soluble regardless of its encapsulated 
hydrophobicity. This phenomenon offers the possibility of using dendrimers and 
dendrons to interact with poorly soluble or non-water soluble molecules, such as 
drugs.51 The nature of guest non-covalent encapsulation could be simply physical 
entrapment or, could involve interactions with the dendritic structure depending on the 
branching functionalities.39 
Encapsulation of hydrophobic small molecules in the hydrophobic interior of 
dendrimers prevents them from precipitating out of an aqueous media. Given a 
hydrophobic drug molecule, encapsulation would enhance its bioavailability and 
circulation time in a biological system, improve its transit across biological barriers, and 
slow drug metabolism. Given the right functionalization, a dendrimer could act as a 
nanocarrier, taking the drug to specific types of cells i.e. active targeting rather than 
passive targeting through enhanced permeation and retention effect (EPR).34,51 Thus, a 
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dendrimer with optimized characteristics would enhance drug bioavailability to diseased 
cells, and would reduce the risk of the drug reaching healthy cells, preventing the side 
effects of chemotherapies.52 
One of the first dendritic systems forming a unimolecular micelle, able to 
encapsulate guest molecules was described by Hawker and Fréchet.39 The 
macromolecule was a dendritic polyether synthesized by a convergent protocol and 
based on the electron rich 3,5-dihydroxybenzyl alcohol unit as the primary building 
 
Figure 1.9. Unimolecular dendritic micelle for encapsulation of hydrophobic guests. 
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block. The final structure displayed carboxylate groups as terminal functionalities to 
asses a hydrophilic periphery. Such a system had the capability of encapsulating 
hydrophobic molecules like pyrene, anthracene, 1,4-diaminoanthraquinone, and 
2,3,6,7-tetranitrofluorenone. The sequestration of these small molecules was tracked by 
UV-VIS spectroscopy once they were solubilized by the dendrimer, which is shown in 
Figure 1.9. For the encapsulated hydrophobic small molecules, the dendrimer showed a 
high solubilizing power, which is also known as encapsulation efficiency. The reason for 
this phenomenon was not only due to physical entrapment, but also to the formation of 
stabilizing - interactions between the dendritic aromatic rings forming the 
hydrophobic branches and the aromatic small molecules. 
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However, hydrophobic components in dendrimers could potentially cause 
precipitation of the entire system due to lack of solubility. Poly(ethylene glycol) (PEG) 
has been conjugated to dendrimers and dendrons with the purpose of increasing the 
hydrophilicity of the system and, in general, to translate the PEG properties to the 
dendrimers. That is, PEG is usually conjugated to the surface of a dendrimer or a 
 
Figure 1.10. G2 dendritic unimolecular micelle funtionalized with PEG. 
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dendron to provide a biocompatible hydrophilic shell, diminish non-specific interactions 
of the macromolecule in a biological media, and increase the circulation time of the 
conjugated system.53 
An example of a dendritic molecule capable of forming a unimolecular micelle 
with a hydrophobic core surrounded by a hydrophilic shell is shown in Figure 1.10. 
Briefly, the macromolecule was prepared by coupling a hydrophobic dendrimer with 
PEG. The monomer used to build the dendritic core was 4,4-bis(4’-
hydroxyphenyl)pentanol, which provided flexibility and, consequently, contributed to 
the cavity size or container capacity of the dendritic architecture.53  
The G2 micelle shown in Figure 1.10 contains a hydrophobic alkyl-aryl core 
surrounded by a hydrophilic PEG shell. Such micelles were able to encapsulate 
hydrophobic small molecules like pyrene and indomethacin. In general, it was found 
that the encapsulation capacity for a unimolecular micelle depends on the generation 
and the PEG chain length that is grafted to the dendritic hydrophobic core.53 
Encapsulation of small molecules within a dendrimer becomes interesting and 
important from the pharmaceutical and sensing points of view, as long as there is a way 
of triggering or controlling their release. For that, it is necessary to design dendritic 
structures incorporating sensitive functionalities to render stimuli-responsive host-guest 
systems. The next section refers to a particular class of stimuli-responsive dendrons that 
self-assemble into aggregates able to encapsulate small hydrophobic molecules, rather 
than forming unimolecular micelles. 
 27 
1.4 Stimuli-Responsive Supramolecular Aggregates formed by Biaryl Amphiphilic 
Dendrons 
Biaryl amphiphilic dendrons present a particular design in which hydrophilic and 
hydrophobic moieties are displayed toward opposite directions in every layer of the 
dendron. Unlike Fréchet type dendrimers, biaryl amphiphilic dendrons do not form 
unimolecular micelles; instead these macromolecules self-assemble in water into 
aggregates of sizes around 100 nanometers containing hydrophobic pockets. Such 
pockets are product of the dendrons hydrophobic moieties collapsing towards the 
interior of the aggregate, and the PEG chains being exposed towards the aqueous 
solvent, shielding the nanoassembly from water. Surprisingly, when the same dendrons 
are in a non-polar media, such as toluene, the self-assembly process evolves towards an 
inverse micelle-like aggregate in which the hydrophobic moieties are exposed to the 
solvent and the hydrophilic branches collapse towards the interior of the aggregate, as 
shown in Figure 1.11.54,55 
Although, by definition, this type of nanoassembly has a CAC, which could be 
taken as a disadvantage when comparing them to dendritic unimolecular micelles; the 
 
Figure 1.11. Pictoric representation of biaryl amphiphilic dendrons forming a micelle-
like assembly in water (right) and an inverse micelle-like assembly in a non-polar 
solvent (left). 
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capability of these dendrons to self-assemble presents an opportunity to control the 
disassembly and, if no cleavage of covalent bonds is involved, to make the disassembly 
event reversible.56 Furthermore, adding the non-covalent encapsulation of guest 
molecules, disassembly is the key to produce release of a structurally unaffected guest 
molecule, since the guest is not covalently conjugated to the dendron. It has been 
observed that disassembly could be triggered by diverse stimuli, depending on which 
responsive unit has been incorporated into the molecular structure of the dendron. 
1.4.1 Temperature Sensitive Dendrimeric Supramolecular Aggregates 
This section refers to amphiphilic dendrons that undergo temperature-
dependent solubility changes once the lower critical solubility temperature (LCST), or 
“cloud point”, is reached. There are many reports on temperature-sensitive hard and 
soft nanoparticles.57,58,59,60 Such thermoresponsive materials could be utilized as drug 
delivery vehicles for biomedical applications in thermotherapy (hyperthermia), which 
involves exposure of the diseased cells or tissues to high temperature in order to 
damage them. This therapy involves the use of clinically approved radiofrequency 
ablation as a local heating system. LCST behavior has been observed and thoroughly 
studied in poly(N-isopropylacrylamide) polymers (PNIPAM) and PEG based 
macromolecules. It has been determined that the LCST depends greatly on the balance 
between hydrophilicity and hydrophobicity of the system.61  
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Temperature-sensitive dendrimers could be prepared by conjugating them to 
thermoresponsive polymers, either at the periphery or at the focal point. There are 
amphiphilic dendrimers that showed the particularity of aggregating in micelle-like 
assemblies with thermosensitive properties (Figure 1.12.b), i.e. LCST behavior.62 Such 
dendrimers were formed using a hydrophobic oligo(p-phenylene vinylene) core and a 
hydrophilic periphery consisting of oligoethylene glycol. The temperature sensitivity was 
found to be dependent on the oligoethylene glycol moieties and on the dendrimer 
generation. Dendrimers with a backbone that displays hydrophobicity and hydrophilicity 
adequately balanced also act as temperature sensitive dendrimers. In fact, the first 
report on a thermoresponsive dendrimer including temperature sensitive functionalities 
as part of the backbone used oligoethylene glycol as a building block (Figure 1.12.a).63 
 
Figure 1.12. Temperature sensitive dendrimers. a) G2 dendrimer incorporating 
balanced hydrophilic and hydrophobic moieties in the backbone; b) G3 dendrimer 
that forms micelle-like aggregates rather than unimolecular micelles. 
a) b)
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The concept of having hydrophilic and hydrophobic units in each building block is 
applied in biaryl amphiphilic dendrons, in which oligoethylene glycol acts as a 
hydrophilic moiety being present in every repeating unit of the molecular design along 
with hydrophobic decyl fragments. This confers the dendrons, and their assemblies, 
responsiveness toward changes in temperature in such a way that these systems exhibit 
a macroscopic transition, or LCST, in which the assembly separates from the aqueous 
phase at higher temperatures (42 oC for G1, 32 oC for G2, and 31 oC for G3). At these 
temperatures the size of the supramolecular assemblies changes due to a decrease in 
 
Figure 1.13. Structure of temperature sensitive G1, G2, and G3 dendrons. 
G1
G2
G3
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the hydration of the oligoethylene glycol branches.64 Figure 1.13 shows the structure of 
G1, G2, and G3 biaryl amphiphilic dendrons. 
It was not until recently that a sub-LCST transition was found in the assemblies 
formed by the biaryl G1 dendron; although this transition was not observed for the 
assemblies formed by either G2 or G3 dendrons.64 Therefore this transition, which 
occurs well below the LCST, was found to be dependent on the dendron generation. At 
this sub-LCST, the size of the dendron supramolecular assembly changes significantly in 
response to temperature variations due to an enhanced hydration of the oligoethylene 
glycol branches. A larger energetic penalty for reorganization could be the reason for a 
lack of sub-LCST transition in higher than G1 generation dendrons. 
1.4.2 Photosensitive Dendrimeric Supramolecular Aggregates 
Photoresponsive materials have found application in biomedical sciences, where 
they have been developed for photodynamic therapy in the treatments of superficial 
tumors and age related muscular degeneration. This technique involves the 
photochemical generation of a reactive single oxygen species (1O2) directly on the 
diseased site to cause oxidative damage of cells. Although dendritic nanoparticles 
encapsulating or conjugated to photosensitizers have been developed, photodegradable 
dendrimers constitute a more interesting class of light-sensitive systems.34,61 The latter 
are called self-immolative dendrimers; after a photochemical reaction at the dendrimer 
core, the entire molecule is broken down into low molecular weight fragments, 
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ultimately resulting in the release of non-covalently encapsulated molecules or 
covalently conjugated peripheral groups, as depicted in Figure 1.14.50,65 
In our lab, a class of photoresponsive biaryl amphiphilic dendrons was developed 
by incorporating a photosensitive linker in the hydrophobic face of the design.66 While 
PEG was used as the hydrophilic face, an o-nitrobenzylesther moiety was incorporated 
as a linker in the hydrophobic chains in such a way that after photocleavage, a residual 
 
Figure 1.14. Self-immolative photoresponsive dendron. 
 
Figure 1.15. Photosensitive biaryl amphiphilic dendron 
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carboxylic acid functionality remains as part of the dendron backbone, terminating the 
amphiphilicity of the system and causing disassembly, as depicted in Figure 1.15. If small 
guest molecules are encapsulated in the hydrophobic core of the assembly, release can 
be observed after photocleavage due to a change of the core’s hydrophobicity into 
hydrophilicity, resulting in disassembly. 
The same kind of previously mentioned micelle-like aggregates can be stabilized 
through photochemical crosslinking, if the photosensitive moieties incorporated at the 
hydrophobic face of the dendrons react with each other in a dimerization process after 
photo-stimulus. Since photodimerization of coumarin is well known, a coumarin 
derivative was used as terminal functional groups in the hydrophobic branches of the 
dendron. As expected, after photo-stimulation at 365 nm the aggregate stage in solution 
was locked.67 Since photodimerization of coumarin is reversible, the crosslinked micelle-
like nanoassembly can be decrosslinked simply by using a 250 nm wavelength light, as it 
was inferred and it is shown in Figure 1.16. 
The crosslinking of dendritic aggregates increases the encapsulation stability of 
the system, since the equilibrium between monomeric stage and micelle-like aggregate 
 
Figure 1.16. Crosslink of dendrons in the aggregate stage 
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stage is shifted then towards the aggregate stage, preventing the inherent leakage due 
to the equilibrium. 
1.4.3 Protein-Sensitive Dendrimeric Supramolecular Aggregates 
Bioresponsive materials are of great importance due to their potential to 
respond to pathologically relevant stimuli.30,34,61,68 Among the known bio-stimuli, some 
have greater relevance than others for they are directly related to diseases. Examples 
are imbalances in protein concentrations or enzymatic activities,69,70,71 which are known 
as primary imbalances of the human organism. Then, a system that disassembles and 
releases cargo in presence of proteins presents advantages in comparison to either 
thermoresponsive or photoresponsive systems. 
The capability of a system to distinguish a target protein among a mixture by 
molecular recognition is of great importance. Such specificity, capability of 
encapsulation, nanometer size, and ability to prevent non-specific interactions are 
characteristics that have been described for biaryl amphiphilic dendrons. Particularly, 
the ability to respond to specific proteins can be embedded in these dendrons by 
incorporating specific protein substrates.72 Using this concept, a dendritic aggregate was 
 
Figure 1.17. Enzymatic cleavage of hydrophobic moieties of a dendron. Change in HLB 
based on covalent modifications. 
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made responsive to an esterase, as shown in Figure 1.17. 
In Figure 1.17 an esterase cleaves the ester functionalities linking the 
hydrophobic chains to the backbone of the dendron. As a result, the hydrophobic 
terminal groups of the dendron are transformed into carboxylic acid functionalities. 
Hence, by means of an enzymatic hydrolysis, the dendron loses its amphiphilicity and 
HLB, which results in the aggregate disassembly.72 Although disturbing the dendron’s 
HLB by breaking covalent bonds and increasing its hydrophilicity is a successful 
approach, there are many non-enzymatic proteins that could be used as a target for 
drug delivery. For such targets, non-covalent interactions remain as an option to disrupt 
the HLB and trigger disassembly. 
By tethering a ligand specific to the target protein, a dendron and its assembly 
acquire specificity towards that protein. After the binding event, the enhanced 
hydrophilicity of the protein disturbs the HLB of the dendritic aggregate, triggering 
disassembly, and, as depicted in Figure 1.18, the release of guest molecules.73 
 
Figure 1.18. Protein-aggregate binding through non-covalent interactions change the 
HLB of the dendron and the aggregate, triggering disassembly and release. 
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1.5 Summary 
The importance of ligand-protein interactions has been reviewed along with 
some of the most relevant methods for the screening of small molecules in the quest of 
the pharmaceutical industry for hits and lead molecules. Among the different screening 
methods, probably the most versatile and accessible are those based on fluorescence. 
Most important, although tethering with at least one fluorophore is required in most 
cases, fluorimetry based methods are rapidly adaptable as a HTS technique, which 
presents advantages for screening high numbers of compounds in less time. 
Some interesting characteristics of classical amphiphilic dendrimers, which form 
unimolecular micelles, have been discussed in this chapter along with the recently 
developed biaryl amphiphilic dendrons, which self-assemble to form nanometer size 
aggregates able to non-covalently encapsulate hydrophobic small molecules. Unlike 
unimolecular micelles, aggregates formed by biaryl amphiphilic dendrons are not rigid, 
covalently bound nanostructures; on the contrary, when the biaryl dendrons are in 
water, they form micelle-like aggregates but when they are in a non-polar solvent, they 
form inverse micelle-like aggregates.  
This chapter also explored the disassembly capability of the aggregates 
depending on the responsive features installed in the dendrons and when stimuli are 
applied. Once disassembly is triggered, the release of guest molecules is observed. We 
discussed relevant stimuli, such as proteins, which could cause disruption in the 
system’s HLB without breaking any covalent bond. For that method, the installation of a 
ligand, specific to the target protein is necessary. In the upcoming chapters of this 
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manuscript, we will discuss how the location of the ligand might affect disassembly of 
the dendritic nanoaggregates and the release of encapsulated guest molecules. From 
there, mechanisms to explain our results will be proposed.  
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CHAPTER 2 
 
SUPRAMOLECULAR DISPLACEMENT AND ACTIVATION OF A SILENT FLUORESCENCE 
PROBE FOR LABEL FREE LIGAND SCREENING 
2.1 Introduction 
The ability of a small molecule to tightly bind to a target protein receptor is 
arguably the most important criterion in drug development. For this purpose, the 
development of reliable methods for rapidly screening small molecules against specific 
proteins is essential. Current methods for small molecule screening include X-ray 
crystallography,1 NMR,2 mass spectrometry,3,4,5 microcalorimetry,6 and fluorescence 
based techniques,7,8,9 as mentioned in detail in the previous chapter. These techniques 
are generally complementary to each other. While ITC gives the most valuable 
thermodynamic information, such as precise binding affinities, the difficulty of adapting 
it as a HTS technique makes it a more valuable method for validation those promising 
molecule candidates found using other techniques more easily adaptable to HTS, such 
as fluorescence and MS. On the other hand, techniques such as X-ray crystallography 
give valuable information about the binding site and ligand interactions but again, it is 
often only use as a validation method and less often for screening due to the amount of 
target protein required and the need for adequate crystals for the measurements.10 
NMR is used as a validation method but also for screening, although the analysis of the 
acquired data requires great expertise. An extra inconvenience of NMR screening 
methods is the limitation in size for the target proteins, since samples larger than 30 kDa 
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require labeling of at least one amino acid close to the binding site in order to facilitate 
the interpretation of the data. 
Among the different techniques, fluorescence stands apart as the premier tool 
due to its simplicity and speed in analysis along with the easy adaptability of it as a HTS 
method.11 However, most fluorescence-based approaches require labeling the target, 
drug candidate, or analyte with dyes.12,13 Tagging adds another step of planning and 
design to the screening process. To skip the labeling step, here we present a new label-
free, fluorescence-based supramolecular platform to rapidly discriminate binding 
affinities of analytes against a target protein. 
2.2 Approach and Molecular Design 
The general scheme depicting the approach is shown in Figure 2.1. It is based on 
the observation that when a small molecule binds to a protein, nearby proteins, 
including enzymes, cannot bind to the small molecule, or at least not until it is dislodged 
from the initial protein. 
 
Figure 2.1. Label-free ligand screening. a) Probe characteristics; b) schematic illustration 
of the strategy. 
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In the strategy illustrated in Figure 2.1a, the probe is designed using a known 
ligand that is complementary to the protein and is connected to a pro-fluorophore 
through a linker.14 The key features of the molecular design are: (i) the linker is cleavable 
by an enzyme; (ii) enzymatic cleavage of the linker converts the non-fluorescent 
precursor to a water-soluble fluorophore; (iii) when the probe is bound to the target 
protein, the linker is sterically inaccessible for the enzyme, as depicted in Figure 2.1b. By 
designing a probe molecule that satisfies these requirements we envisaged the 
possibility of using this system to screen small molecule binders for the target protein. 
For this, the analyte small molecule with comparable or better binding affinity than the 
probe molecule would be able to displace it from the protein, depending on its relative 
concentration. This displacement would expose the enzyme-active linker,15 the cleavage 
of which should result in the formation of the fluorophore. The concentration-
dependence of the fluorescence generation can then be used to evaluate the ability of 
the ligand candidates to bind the target protein. 
To test this design hypothesis, we chose human carbonic anhydrase I (hCA1) as 
the target protein, an interesting and well characterized protein that has been 
 
Figure 2.2. Probe structure. Benzenesulfonamide as the ligand, an ester group as the 
cleavable linker, and umbelliferone as the reporter or fluorophore. 
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implicated in a variety of pathophysiological processes.16,17 The molecular structure of 
our probe is shown in Figure 2.2. Arylsulfonamide is a ligand for hCA1,18,19,20,21 while the 
coumarin derivative, umbelliferone is an excellent fluorophore. The ligand and the 
fluorophore are linked through an aliphatic chain bearing an ester bond. Coumarin is 
attached to the ester through an acetal moiety, where the cleavage of the ester using 
porcine liver esterase (PLE) would release the fluorophore, umbelliferone. 
Since the binding pocket in hCA1 is a 15 Å deep cleft,21 the linker length of the 
probe was designed to be modifiable in order to have two probes with different linker 
lengths as this would impact the enzyme’s accessibility to the ester moiety. In this way, 
we are making the linker length a critical component of our molecular design. As it will 
be shown in the synthesis of the probe, the attachment of the ligand is performed as a 
final step to allow for the use of a variety of ligands, depending on the chosen protein to 
target. This, along with the variations in the linker length renders the design modular. 
The analytes to use, as represented in Figure 2.1b, must be a set of molecules with 
diverse affinities for hCA1, ranging from excellent ligands with nanomolar affinity to 
Chart 2.1. Structure of the analyte molecules used in the assay and their literature-reported 
binding affinities.9 
 
 
Comp. 1 2 3 4 5 6 7 
KD(M) 9x10
-9 1.15x10-6 1.67x10-6 3.4x10-6 90x10-6 N/A N/A 
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ligands with middle and low affinity. These molecules are ethoxzolamide 1, 
acetazolamide 2, p-toluenesulfonamide 3, 4-carboxybenzensulfonamide 4, and 4-
aminobenzenesulfonamide 5, which are shown in Chart 2.1. In this set, we have also 
included analyte molecules that have not been reported as ligands for hCA1 and that 
are unlikely to have any affinity for the protein, these molecules are p-iodoaniline 6 and 
p-nitrophenol 7. The molecules used as ligands and their binding constants (KD) are 
shown in Chart 2.1. Analyte 8 was synthesized as a probe analogue; lacking the esterase 
substrate it will not be cleaved by PLE and, hence, will show no increase in fluorescence. 
This analogue should have similar binding affinity as the probe. 
2.3 Results and Discussion 
2.3.1 Synthetic Strategy 
In order to have a modular design and a working probe for the conditions of our 
experiments, certain characteristics must be fulfilled. The most important of those 
requirements is that the reporter must be silent, if we are to track the binding of the 
analytes to the target protein; this means that the fluorescence of the fluorophore 
should be very low when it is linked to the benzenesulfonamide moiety. Also, it should 
be water soluble after enzymatic cleavage of the linker. For that purpose, 4-
methylumbelliferone, a coumarin modified with a methyl group in position 4 and with a 
hydroxyl group in position 7 is an ideal molecule, for when it is O-alkylated at the 
position 7 its fluorescence decreases considerably and when it is not alkylated its 
solubility in water is better than an unmodified coumarin. 
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It was observed that when an ester bond is directly formed at the position 7 of 4-
methylumbelliferone, it is rapidly hydrolyzed in a buffer solution at pH 7.4. However, 
when an acetal moiety is placed between the ester bond and the aromatic 
umbelliferone the ester functionality remains stable during the timeframe of our 
experiments. Also, by introducing a short spacer, as is the acetal, we prevent possible 
hindrance from the 4-methylumbelliferone system on the PLE action over the ester 
group. 
The acetal and ester groups are formed in a two-step one-pot reaction between 
4-methylumbelliferone 11, dibromomethane, and an alkyl carboxylic acid 9 in refluxing 
acetone aided by the catalyst 18-crown-6, as shown in Scheme 2.1. The carboxylic acid is 
the molecule that dictates the final length of the linker. As seen in Figure 2.2 for the two 
  
Scheme 2.1. Synthesis of the probes, (a) and ester group cleavage by an esterase or a 
nucleophile (b). 
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probes with n = 4 and n = 8, the carboxylic acids used were 6-bromohexanoic acid 9a 
and 10-bromodecanoic acid 9b, respectively. To prevent nucleophilic attacks on the 
terminal carbon attached to the bromine, an planning on having a terminal primary 
amine the halogen was substituted by an azide 10a,b before esterification by reacting 
with sodium azide in N,N-dimethylformamide (DMF). Once the 4-methylumbelliferone 
has been O-substituted in the 7 position 12a,b, the terminal azide is reduced to a 
primary amine 13a,b through a Staudinger reduction in tetrahydrofuran (THF).  
This reduction is a critical step when n = 4, since the newly formed amine can act 
as a nucleophile and attack the carbonyl ester via an intramolecular cyclization to form a 
7 membered -caprolactam, while recovering the 4-methylumbelliferone and releasing 
the formaldehyde byproduct (Scheme 2.1b). The yield for this step was low. Finally, the 
last step of the synthesis is the coupling of the ligand. Since the previously mentioned 
scaffold 13a,b holds a primary amine, it is convenient that the ligand moiety has a 
carboxylic acid functional group 14, in that way, the two fragments are tethered via 
amide coupling in DMF using 1,1’-carbonyldiimidazole (CDI) as the coupling agent. 
 
Scheme 2.2. Synthesis of analyte 8. 
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The synthesis of the analyte 8 is faster and less troublesome to accomplish than 
the synthesis of the probes, since 8 lacks the ester and acetal functionalities that are 
prone to hydrolysis. So, as it is shown in Scheme 2.2, the analyte was synthesized 
starting from the O-alkylation of 4-methylumbelliferone 11 with the commercially 
available N-Boc protected 6-bromohexylamine 15, refluxing in acetone, using K2CO3 as 
the base and 18-crown-6 as a catalyst to get 16. Then, the primary amine is deprotected 
using trifluoroacetic acid in dichloromethane getting the molecule 17. Then, once again 
the terminal amine can be attached to the ligand 14 through amide coupling using CDI 
as the coupling agent to get the analyte 8.22 
2.3.2 Supramolecular Displacement23  
2.3.2.1 Hindering Enzymatic Action on the Probe 
To first test our hypothesis, we chose the Probe A where the linker length is n=4 
and exposed it to different concentrations of hCA1, as shown in Figure 2.3a. First, the 
probe itself does not hydrolyze in the buffer without the enzyme (green line). Secondly, 
while 5 µM concentration of Probe A with 50 nM PLE generated significant fluorescence 
within a few seconds (red line), this combination did not generate meaningful 
fluorescence in the presence of 20 µM hCA1 (blue line). At smaller concentrations of 
hCA1, such as 15 µM, there was intermediate fluorescence (purple line) in presence of 
PLE. Thirdly, we were surprised to find that the presence of hCA1 at a lower 
concentration (10 µM), enhanced the enzymatic cleavage of the probe (black line). This 
could be because the protein concentration is not enough to hinder enzymatic action on 
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the ester moiety of Probe A during the binding equilibrium but helps in improving the 
probe’s solubility, making it more available for the PLE. 
When we tested 5 µM of Probe B, the probe itself also does not hydrolyze in the 
buffer without the enzyme (green line) and is stable in the sole presence of 20 µM hCA1 
(orange line). Exposing Probe B to 50 nM PLE generated significant fluorescence within a 
few seconds (red line), similar to Probe A. However, under these conditions, a higher 
fluorescence in the presence of 20 µM hCA1 (blue line) is generated, unlike Probe A. 
This is due to the longer distance between the ligand moiety and the enzyme cleavable 
bond in Probe B, which makes it more difficult for hCA1 to hinder the action of PLE. 
Once again, the presence of hCA1 helped to improve the solubility of the probe and 
enhance enzymatic cleavage of the probe, as seen in Figure 2.3b. This could be because 
the protein does not sufficiently mask the ester moiety upon binding. 
As shown in Scheme 2.1, both probes have a hydrophobic component that, to 
some extent, could compromise their water solubility, especially for Probe B where n = 
 
Figure 2.3. Hindering enzymatic action on the probe. a) Probe A (5 µM) is exposed to 
different concentrations of hCA1 and PLE 50 nM; b) Probe B (5 µM) is exposed to 
hCA1 20 µM and PLE 50 nM. 
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8. Then, hCA1 acts as a solubilizing agent for the probes, when it is at lower 
concentrations. 
2.3.2.2 Pre-incubation Time 
It is important for a HTS technique to be expedited in each of its steps. For this 
label-free supramolecular displacement assay to fulfill that requirement, the time for 
the binding event equilibration must be reasonable. Given the right concentration of 
hCA1 needed to efficiently hinder enzymatic action on the substrate, 20 µM in our 
experiments, the pre-incubation time with the probe was tested up to 18 hours. 
As seen in Figure 2.4, the pre-incubation timeframe for Probe A-hCA1 was 
reduced to 15 minutes, after which PLE (50 nm) was added to the system. These 
experiments were accomplished without losing the steric masking provided to the probe 
by hCA1, since the difference in fluorescence intensity between just Probe A and PLE is 
meaningful. 
 
Figure 2.4. Effective hCA1-Probe A pre-incubation time. 
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2.3.2.3 Competitive Displacement 
With the identification of a combination of Probe A and the optimal relative 
Probe A:protein concentrations, along with their effective pre-incubation time, we were 
interested in testing the possibility of competitive displacement of the probe from the 
hCA1 binding pocket as an assay for the relative affinity of an analyte molecule. The 
analyte molecules used for this purpose were mentioned previously and are shown in 
Chart 2.1, along with their corresponding binding constants. Briefly, ligands 1-5 are 
known to be good inhibitors for hCA1, while molecules 6 and 7 are randomly chosen 
and are presumably not good ligands for hCA1. Analyte 8 should have a similar binding 
affinity as the probe. 
When different amounts of these molecules were introduced into a solution 
containing a mixture of the Probe A:hCA1 (5:20 µM) and 50 nM PLE, the system showed 
an increase in fluorescence as a response to increasing concentrations of molecules 1-5. 
However, the response of the system to molecules 6 and 7 did not exhibit any 
 
Figure 2.5. Displacement-mediated activity profiles generated by a) the analytes 1, 2, 
4-7; and (b) 1, 3, 4, 8 with the slopes of the curve corresponding to the effective probe 
displacement by the analytes 
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appreciable change in fluorescence with concentration. The fluorescence profiles for the 
set of molecules are shown in Figure 2.5a. 
Three key features are evident from these plots: (i) analytes with strong to 
moderate binding affinities can displace Probe A and the displacement profile can be 
traced by the fluorescence evolution; (ii) since the relative concentration of Probe A vs. 
hCA1 dictates that there are some free proteins in the system, the fluorescence 
response remains flat in the initial part of the plot, which indicates that the ligands are 
first binding to the excess free proteins;24 (iii) the slope of the fluorescence change 
correlates with the analyte binding affinities, thus providing an opportunity to assess the 
relative binding affinities of the analyte molecules tested (Figure 2.5b). When there are 
no probe molecules remaining to be enzymatically hydrolyzed, the fluorescence stops 
increasing and the displacement profile reaches a final plateau. 
The experiment is complete once the concentration of analyte has reached 100 
µM, which is achieved in less than 45 minutes. During that time, Probe A must remain 
stable in the buffer media and PLE must be unable to hydrolyze the substrate. If so, the 
 
Figure 2.6. Control experiments. a) Probe A at 5 µM, hCA1 at 20 µM, PLE at 50 nM; 
b) enzymatic activity of PLE (50 nM) on Probe A (5 µM) in presence of the analytes 1-
8 (40 µM). 
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increase in intensity accounts for the analyte binding affinity to the target protein and 
displacement of the probe. Figure 2.6a shows a control experiment with the highest 
fluorescence intensity of the reporter reached by enzymatic cleavage of Probe A (blue 
curve), and the probe in the buffer media (green line). The low fluorescence of the 
combination of PLE exposed to the pre-incubated probe:hCA1 (red line), accounts for 
the hCA1 esterase activity,25 which is much lower compared to the PLE activity on the 
probe. The conditions of this control experiment and the displacement assays are 
identical. 
It is also important to note that the PLE activity is not inhibited by any of the 
analytes to which the enzyme is exposed in solution. To confirm this, 5 µM of the probe 
was exposed to 50 nM PLE in absence and presence of 40 µM of each analyte. As it is 
shown in Figure 2.6b, PLE activity is not inhibited to any extent by any of the analytes 1-
8. 
2.3.3 Correlation between Binding Affinity and Displacement 
The analyte molecules 1-5 were chosen for this approach mainly because they 
 
Figure 2.7. Correlation between binding constants and fluorescence profiles. Fitting 
equation: Log Slope = 0.2254 (-Log KD) + 5.5209; R
2 = 0.9217 
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have been reported as effective inhibitors for hCA1. It is clear that the trend in the 
slopes obtained in our assays correlates well with the literature-reported KD values. 
Since the displacement rate of the probe is directly related to the affinity of the analyte 
for the binding pocket of the protein, which is reflected in the slopes of the fluorescence 
profiles, in Figure 2.5 we provide an example of the type of qualitative comparison that 
could be obtained with this method.  
Molecules 3 and 4 have an identical functional group, benzene sulfonamide 
(Chart 2.1); however, while 3 has a methyl group in para- position to the sulfonamide, 4 
has a carboxylic acid functional group, which provides different hydrophilic properties. 
This difference can be attributed to the higher affinity of 3, which is more hydrophobic 
than 4. Molecule 8 has a carboxamide functional group at the para- position that could 
be comparable to the carboxylic acid in 4, but this molecule is more hydrophobic than 3. 
To test whether the hydrophobicity indeed influences the binding affinity, we tested the 
relative binding affinity of 8 (Section 2.3.5). Our results suggest that 8 is indeed better 
than 3, but as seen in Figure 2.5b, it is not as good of an inhibitor as 1.  
From Figure 2.5, and based on the analysis above, the displacement assay 
Table 2.1. Logarithmic correlation between binding constants and slopes from Figure 
2.5a. 
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described here is useful to qualitatively discriminate binding affinities of small molecules 
for a target protein. Therefore, it is possible to evaluate the predictive capability of the 
assay developed here. Figure 2.7 shows a correlation between the literature-reported KD 
values and the slopes obtained from the linear regime of the plot in Figure 2.5a, where 
there is significant fluorescence change. In Figure 2.7 we provide a numeric correlation 
that could be used for predictive purposes as a calibration curve. In fact, using the 
equation from the calibration curve (Log Slope = 0.2254 (-Log KD) + 5.5209), and the 
slope displayed in Figure 2.5b (1.20 x 10-7), the numeric value obtained for the binding 
constant of analyte 8 is 1.22 x 10-7 M, which represents a better binding constant than 
analyte 3 but not as good as analyte 1, as was inferred qualitatively above. Table 2.1 
shows the numeric values. 
The reproducibility of the slopes obtained for the analytes and the experiment, 
in general, is an advantage for the assay, if it is to be adapted as a HTS method. 
It has been reported that the coumaryl moiety could contribute to the binding 
affinity of a ligand.26 However, this could happen only if the sulfonamide ligand moiety is 
connected to the coumaryl through a short linker (two or three carbons) in such a way 
that when the ligand is completely bound to the binding pocket of the hCA1, the 
coumaryl is buried into the binding site, since it can interact only with the amino acid 
fragments buried deep in the binding cleft and not with the fragments close to the rim. 
Although the coumaryl moiety could be contributing to the improved affinity of 8, and 
consequently the affinity of the probe, this is not likely. 
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2.3.4 Adaptability as a HTS Method 
The approach outlined here works well in providing an evaluation of relative 
affinities, but does not provide direct quantitative binding affinity measurements. 
However, the possibility of getting approximate binding constants through a calibration 
curve has been introduced as an option. Therefore, for such an approach to be useful, it 
is necessary that we can adapt this strategy for the rapid screening of analytes. For this 
purpose, we further tested the versatility of our approach in a 96-wells plate reader set-
up. In such a setting, the volume of the components needed to generate a data point 
would be low and the screening can be done in a highly parallel fashion. The data 
generated from this experiment are shown in Figure 2.8 (compare with Figure 2.5a). The 
results indeed are consistent and reliably reproducible. As it is observed from Table 2.1, 
data for analyte 3 were incorporated from a similar experiment held at a different time 
and yet, its binding constant value remains between the values of analytes 2 and 3. This 
is an example of the methodology’s precision. 
 
Figure 2.8. Probe A displacement-mediated activity profiles generated by the analytes 1, 
3, 4, 6, 7 with 96-well plate reader. 
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2.3.5 Inhibitory Concentrations 
As it was mentioned before, during the analysis of Figure 2.5, our results suggest 
that analyte 8 is indeed better than analyte 3, but is not as good as 1. However, our 
attempts to independently obtain KD values for 8 through isothermal titration 
calorimetry (ITC) were unsuccessful due to precipitation issues in the concentration 
regimes needed for the experiment. Although ITC is the best validation method 
available, an alternative to compare the binding constants of Probe A, Probe B, and 
analyte 8 is to evaluate affinities through a comparative binding assay e.g. inhibitory 
concentration, or IC50.
27 It is possible to get such values via an hCA1 inhibition assay 
using 4-nitrophenyl acetate (NPA) as the substrate.28 
In an hCA1 inhibitory assay, it is the esterase activity of the protein that is 
evaluated. Since the active site is the same binding pocket targeted by the probes and 
analytes, a molecule that binds at that site could be potentially used as an inhibitor for 
hCA1. In the presence of hCA1, the ester bond in NPA is cleaved (Figure 2.9a); this event 
can be tracked by UV-Vis spectroscopy through observing the maximum absorbance of 
the p-nitrophenol (λabs = 348 nm), which is formed in situ. So, hCA1 must be pre-
incubated with the inhibitors and then exposed to the substrate, NPA. Figure 2.9 shows 
the inhibition profiles for Probe A, Probe B, and analyte 8. 
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The IC50 is found based on the normalized maximum absorbance of the p-
nitrophenol at a determined time of enzymatic action, in the presence of an inhibitor at 
different concentrations. Indeed, we found the IC50 of 8 to be in the low micromolar 
region (0.10 μM), close to the IC50 of Probe A (0.04 μM), although it was clearly a better 
hCA1 inhibitor than Probe B (1.37 μM). Figure 2.10 illustrates the plots of concentration 
of inhibitor against the percentage of hCA1 activity. 
 
Figure 2.9. Inhibition of hCA1 (2 µM) activity on NPA (2 mM). a) Enzymatic cleavage of 
NPA; b) analyte 8 as inhibitor; c) Probe A as inhibitor; d) Probe B as inhibitor. 
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The analogues with shorter linkers than Probe B show a better IC50. Although, for 
the analogue 8 and the Probe A the coumaryl moiety might be contributing to improve 
the affinity for hCA1, it could be that the less rigid nature of Probe B is diminishing its 
affinity for the target. The IC50 values were measured in a Varian UV-Vis 
spectrophotometer CARY 100, following the procedures described in literature. 
2.4 Summary 
In summary, we have introduced a new approach to screen the binding of small 
molecules to proteins using a supramolecular displacement approach. Following are the 
noteworthy features of our approach: (i) a protein-specific ligand is attached to a 
fluorophore via an enzyme cleavable linker, which is chosen such that the cleavage 
results in the generation of a water-soluble, high quantum yield fluorophore, 
 
Figure 2.10. IC50 of a) Probe A, b) analyte 8, c) Probe B. 
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umbelliferone; (ii) the linker length is chosen such that the enzyme-cleavable functional 
group is sterically masked from the enzyme, when bound to the protein; (iii) molecules 
with different binding affinities for the protein show different probe displacement 
profiles to expose the enzyme cleavable functionality and thus exhibit affinity-
dependent fluorescence response; (iv) this approach can be rendered high throughput, 
as this is easily translated to a multi-well plate reader based fluorescence measurement; 
(v) a limitation of the approach is that one initial molecule with a reasonable binding 
affinity for the target protein must be known to successfully design the fluorescent 
probe and execute further ligand optimization. We envision that the design principles 
outlined here have the potential to be broadly adapted for rapid screening of small 
molecules against a protein target. 
2.5 Experimental Section 
2.5.1 Synthetic Procedures and Characterization of Compounds 
All reagents and solvents were purchased from commercial sources and were 
used as received. 1H-NMR spectra were recorded on a 400 MHz Bruker spectrometer 
using residual proton resonance of the solvent as the internal standard. 13C-NMR 
spectra were recorded on a 100 MHz Bruker spectrometer. Fluorescence spectra were 
recorded using a JASCO FP-6500 spectrofluorimeter. FAB-MS spectra were measured on 
a JEOL JMS700. IR spectra were measured on a Bruker Alpha-P FT-IR. 
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2.5.1.1 General Synthesis of Azidoalkanoic Acids 10a,b 
To a solution of bromo alkanoic acid 9a,b (1 equivalent) in DMF (15 mL) was 
added NaN3 (3.0 equivalents). This reaction mixture was heated at 80 
oC for 18 hours, 
stirring under argon atmosphere. After cooling to room temperature, most of the 
solvent was evaporated under vacuum. The crude material was mixed with water (50 
mL) and extracted with ethyl acetate (3 x 50 mL). The organic layers were collected on 
Na2SO4. After filtration, the solvent was evaporated under vacuum to yield a yellowish 
oil that was used for the next step without further purification. 
2.5.1.2 General Synthesis of Azidoalkanoic-Coupled 4-Methylumbelliferone 12a,b 
In a two-necked round bottom flask, 4-methylumbelliferone 11 (1.2 equivalents) 
and dibromomethane (2.4 equivalents) were mixed and stirred in acetone (50 mL), with 
K2CO3 (2.2 equivalents) and 18-crown-6 (0.2 equivalents) under argon atmosphere at 
reflux for 1 hour. Then, the azidoalkanoic acid 10a,b was added (1 equivalent) with extra 
dibromomethane (1.2 equivalents). The reaction mixture was refluxed for 18 hours. 
Then, the reaction crude was filtered and washed with acetone. The filtrates were 
collected and the solvent was evaporated. The crude was then poured into water and 
extracted with ethyl acetate (5 x 100 mL). The organic layers were dried over anhydrous 
Na2SO4, filtered, and concentrated in vacuo. The product was obtained after purification 
using Combiflash chromatography. 
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2.5.1.3 General Amide Coupling Reaction to get Probes a,b and Analyte 8 
A mixture of 4-carboxybenzenesulfonamide (1.5 equivalents) and 
carbonyldiimidazole (CDI) (1.8 equivalents) in anhydrous DMF was stirred for 20 minutes 
under argon atmosphere. Then, the resultant solution was added to a solution of 4-
methylcoumarin-7-oxymethyl aminoalkanoate (1 equivalent) in anhydrous DMF stirring 
under argon atmosphere at 50oC. After 12 hours, the reaction was cooled to room 
temperature and the solvent was vacuum evaporated. Then, the crude was mixed with 
aqueous solution of sodium bicarbonate to be extracted with ethyl acetate with 1% 
methanol. The organic layers were dried over anhydrous Na2SO4, filtered and 
concentrated. The remaining crude solid was washed with acetone to obtain the 
product as the insoluble solid. 
2.5.1.4 Synthesis of 4-Methylcoumarin-7-oxymethyl 6-Azidohexanoate 12a (DA-2-65) 
 
According to the general procedure described above for coupling of 
umbelliferone with azidoalkanoic acids, the reaction of 4-methylumbelliferone 11 (4.71 
g, 27.0 mmol), dibromomethane (13.94 g, 80.0 mmol), 6-azidohexanoic acid 10a (3.50 g, 
22.3 mmol), K2CO3 (6.77 g, 50.0 mmol), and 18-crown-6 (1.18 g, 4.5 mmol) in acetone, 
yielded 1.98 g of a white solid 12a (35% yield). 1H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 
8.7 Hz, 1H, b), 7.03 (d, J = 2.1 Hz, 1H, d), 6.99 (dd, J = 8.7, 2.3 Hz, 1H, c), 6.22 (s, 1H, a), 
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5.84 (s, 2H, e), 3.25 (t, J = 6.8 Hz, 2H, j), 2.44 (s, 3H, k), 2.42 (t, J = 7.5 Hz, 2H, f), 1.69 (tt, J 
= 7.4 Hz, 2H, i), 1.65-1.52 (m, 2H, g), 1.47-1.36 (m, 2H, h). 13C NMR (100 MHz, CDCl3) δ 
172.2, 161.1, 159.6, 155.2, 152.4, 125.9, 115.3, 113.3, 113.1, 103.5, 84.8, 51.3, 34.0, 
28.6, 26.2, 24.3, 18.8. FAB-MS m/z calculated for C17H19N3O5 + H
+: 346.3; found: 346.2. 
2.5.1.5 Synthesis of 4-Methylcoumarin-7-oxymethyl 10-Azidodecanoate 12b 
 
According to the general procedure described above for coupling of 
umbelliferone with azidoalkanoic acids, the reaction of 4-methylumbelliferone 11 (2.97 
g, 16.9 mmol), dibromomethane (8.76 g, 50.4 mmol), 10-azidodecanoic acid 10b (3 g, 
14.1 mmol), K2CO3 (4.29 g, 31.0 mmol), and 18-crown-6 (0.74 g, 2.8 mmol) in acetone, 
yielded 1.85 g of a white solid 12b (33% yield). 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 
8.6 Hz, 1H, b), 6.99 (d, J = 2.3 Hz, 1H, d), 6.95 (dd, J = 8.6, 2.4 Hz, 1H, c), 6.16 (s, 1H, a), 
5.80 (s, 2H, e), 3.22 (t, J = 8.8 Hz, 2H, p), 2.39 (s, 3H, k), 2.38-2.32 (m, 2H, f), 1.65-1.54 
(m, 4H, g-h), 1.45-1.15 (m, 10H, i-n). 13C NMR (100 MHz, CDCl3) δ 171.4, 160.4, 154.0, 
153.1, 152.1, 125.4, 118.1, 114.3, 110.3, 51.3, 34.1, 28.7 (5C), 26.4, 24.5, 18.6. IR-FT (cm-
1) 2917.2, 2849.1, 2085.0, 1707.6, 1262.1, 1128.1, 960.0, 842.5, 448.6. 
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2.5.1.6 Synthesis of 4-Methylcoumarin-7-oxymethyl 6-Aminohexanoate 13a (DA-2-
121) 
 
The 4-methylcoumarin-7-oxymethyl 6-azidohexanoate 12a (2.0 g, 5.8 mmol) was 
dissolved in anhydrous THF and then, triphenyl phosphine (1.82 g, 7.0 mmol) was 
added. The reaction was stirred under argon atmosphere for 5 hours at room 
temperature. Afterwards, water (1 mL) was added to the reaction and the temperature 
was increased to 50oC. After 5 hours, the reaction mixture was poured into water and 
extracted three times with dichloromethane. The organic layers were dried over 
anhydrous Na2SO4, filtered, and the solvent was evaporated. The product was purified 
by silica flash column on Combiflash to obtain 240 mg (15% yield) of a white solid 13a. 
1H NMR (400 MHz, CDCl3) δ 7.53 (d, J = 8.7 Hz, 1H, b), 6.99 (d, J = 2.5 Hz, 1H, d), 6.96 (dd, 
J = 8.5, 2.5 Hz, 1H, c), 6.18 (s, 1H, a), 5.99 (bs, 2H, q), 5.80 (s, 2H, e), 2.49-2.44 (m, 2H, j), 
2.40 (s, 3H, k), 2.39-2.33 (m, 2H, f), 1.79-1.72 (m, 2H, g), 1.72-1.59 (m, 4H, h-i). 13C NMR 
(100 MHz, CDCl3) δ 172.7, 162.1, 159.7, 155.0, 153.6, 126.0, 115.4, 113.1, 111.0, 103.5, 
84.9, 43.2, 36.6, 34.1, 29.9, 23.4, 18.7. FAB-MS m/z calculated for C17H21NO5 + H
+: 320.3; 
found: 320.1. 
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2.5.1.7 Synthesis of 4-Methylcoumarin-7-oxymethyl 10-Aminodecanoate 13b (DA-2-
50) 
 
The 4-methylcoumarin-7-oxymethyl 10-azidodecanoate 12b (0.70 g, 1.75 mmol) 
was dissolved in ethanol (15 mL) and then, zinc (0.15 g, 2.27 mmol) was added to the 
mixture.29 An aqueous solution (5 mL) of ammonium chloride (0.22 g, 4.01 mmol) was 
added to the reaction mixture and then, it was refluxed for 30 minutes. The reaction 
was stopped and the ethanol was evaporated in vacuo. More water was added to the 
remaining mass and then extracted with ethyl acetate (3 x 20 mL). The organic layers 
were dried over anhydrous Na2SO4, filtered, concentrated, and purified by column 
chromatography. The product was recovered as 0.16 g of a white solid 13b (25% yield). 
1H NMR (400 MHz, MeOD) δ 7.75 (d, J = 8.8 Hz, 1H, b), 7.09 (dd, J = 8.8, 2.5 Hz, 1H, c), 
7.05 (d, J = 2.4 Hz, 1H, d), 6.24 (s, 1H, a), 5.89 (s, 2H, e), 2.90 (t, J = 7.8 Hz, 2H, p), 2.47 (s, 
3H, k), 2.39 (t, J = 7.2 Hz, 2H, f), 1.64-1.58 (m, 4H, g,n), 1.40-1.27 (m, 10H, i-m), 1.24 (s, 
2H). 13C NMR (100 MHz, MeOD) δ 175.3, 160.5, 159.0, 156.0, 154.1, 131.2, 115.1, 114.4, 
109.1, 101.1, 85.6, 42.3, 35.3, 34.4, 30.1, 30.0, 29.9, 27.0, 19.6. FT-IR (cm-1) 2917.2, 
2849.1, 1724.1, 1614.8, 1262.1, 1128.1, 960.0, 842.5, 448.6. FAB-MS m/z calculated for 
C21H29NO5 + H+: 375.5; found: 375.2. 
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2.5.1.8 Synthesis of 4-Methylcoumarin-7-oxymethyl 6-(4-
Sulfamoylbenzamido)hexanoate, Probe A 
 
According to the general procedure described above for the reaction of 4-
methylcoumarin-7-oxymethyl 6-aminohexanoate 13a (0.16 g, 0.50 mmol) with 4-
carboxybenzenesulfonamide 14 (0.15 g, 0.75 mmol) and CDI (0.15 g, 0.90 mmol) in DMF, 
0.10 g of a white solid were obtained as the product Probe A (40%). 1H NMR (400 MHz, 
DMSO-d6) δ 8.58 (t, J = 5.4 Hz, 1H, q), 7.96 (d, J = 8.5 Hz, 2H, x), 7.88 (d, J = 8.3 Hz, 2H, 
y), 7.73 (d, J = 8.8 Hz, 1H, b), 7.47 (s, 2H, z), 7.12 (d, J = 2.4 Hz, 1H, d), 7.06 (dd, J = 8.7, 
2.5 Hz, 1H, c), 6.27 (s, 1H, a) 5.89 (s, 2H, e), 3.19 (dd, J = 13.0, 6.6 Hz, 2H, j), 2.40 (s, 3H, 
k), 2.39 (t, J = 8.0 Hz, 2H, f), 1.61-1.51 (m, 2H, g), 1.52-1.42 (m, 2H, i), 1.32-1.21 (m, 2H, 
h). 13C NMR (100 MHz, DMSO-d6) δ 172.5, 165.7, 160.4, 159.6, 154.9, 153.9, 146.6, 
138.1, 128.2, 127.4, 126.2, 115.1, 113.5, 112.6, 103.6, 85.0, 33.7, 29.2, 26.3, 24.5, 18.7. 
FAB-MS m/z calculated for C24H26N2O8S + H
+: 503.5; found: 503.2. 
2.5.1.9 Synthesis of 4-Methylcoumarin-7-oxymethyl 10-(4-
Sulfamoylbenzamido)decanoate, Probe B (DA-2-70) 
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According to the general procedure described above for the reaction of 4-
methylcoumarin-7-oxymethyl 10-aminodecanoate 13b (0.16 g, 0.43 mmol) with 4-
carboxybenzenesulfonamide 14 (0.13 g, 0.65 mmol) and CDI (0.13 g, 0.78 mmol) in DMF, 
0.09 g of a white solid were obtained as the product Probe B (38%). 1H NMR (400 MHz, 
DMSO-d6) δ 8.60 (t, J = 5.0 Hz, 1H, q), 7.97 (d, J = 8.5 Hz, 2H, x), 7.88 (d, J = 8.2 Hz, 2H, 
y), 7.74 (d, J = 8.7 Hz, 1H, b), 7.47 (s, 2H, z), 7.11 (d, J = 2.4 Hz, 1H, d), 7.07 (dd, J = 8.7, 
2.5 Hz, 1H, c), 6.28 (d, J = 1.1 Hz, 1H, a), 5.89 (s, 2H, e), 3.23 (td, J = 8.0, 4.0 Hz, 2H, p), 
2.40 (s, 3H, k), 2.36 (t, J = 7.1 Hz, 2H, f), 1.51-1.44 (m, 4H, g,n), 1.28-1.09 (m, 10H, h-m). 
13C NMR (100 MHz, DMSO-d6) δ 171.9, 165.0, 160.1, 158.9, 154.5, 153.4, 146.4, 137.5, 
127.8, 126.81, 125.6, 114.8, 112.9, 112.2, 103.1, 84.3, 33.3, 28.6, 28.2, 26.6, 24.2, 18.1, 
7.5. FAB-MS m/z calculated for C28H34N2O8S + H
+: 559.6; found: 559.3. 
2.5.1.10 Synthesis of tert-butyl (6-((4-Methylcoumarin-7-yl)oxy)hexyl)carbamate 16 
(DA-2-52) 
 
The compound 16 was obtained from the O-alkylation of 4-methylumbelliferone 
11 with the commercially available N-Boc protected 6-bromohexylamine 15 using K2CO3 
(2 equivalents) as the base, and 18-crown-6 (0.2 equivalents) as the catalyst, refluxing in 
acetone for 13 hours (43% yield). C21H29NO5, 
1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 8.8 
Hz, 1H, b), 6.84 (dd, J = 8.8, 2.5 Hz, 1H, c), 6.79 (d, J = 2.4 Hz, 1H, d), 6.12 (sd, J = 1.1 Hz, 
1H, a), 4.53 (bs, 1H, q), 4.00 (t, J = 6.4 Hz, 2H, e), 3.13 (dd, J = 12.2, 6.0 Hz, 2H, j), 2.39 (s, 
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3H, k), 1.90-1.74 (m, 2H, f), 1.59-1.33 (m, 15H, g-i, w). FAB-MS m/z calculated for 
C21H29NO5 + H+: 375.5; found: 375.2. 
2.5.1.11 Synthesis of the Analyte 8 (DA-2-64) 
 
After deprotection of the amine functionality in 16 with trifluoroacetic acid in 
dichloromethane at room temperature, the mixture was concentrated in vacuo and the 
remaining dry oil 17 was dissolved in anhydrous DMF and coupled with 4-
carboxybezenesulfonamide 14 in presence of CDI following the procedure for the 
general synthesis of the probes (n=4, n=8). The product 8 was obtained as a white solid 
(7%). 1H NMR (400 MHz, MeOD) δ 7.96 (d, J = 8.0 Hz, 2H, x), 7.95 (d, J = 8.0 Hz, 2H, y), 
7.66 (d, J = 8.8 Hz, 1H, b), 6.93 (dd, J = 8.8, 2.4 Hz, 1H, c), 6.89 (d, J = 2.4 Hz, 1H, d), 6.16 
(d, J = 1.1 Hz, 1H, a), 4.09 (t, J = 6.3 Hz, 2H, e), 3.42 (t, 2H, j), 2.45 (s, 3H, k), 1.92-1.79 (m, 
2H, f), 1.74-1.64 (m, 2H, i), 1.64-1.54 (m, 2H, g), 1.54-1.44 (m, 2H, h). 13C NMR (100 MHz, 
DMSO-d6) δ 165.1, 162.0, 160.4, 154.9, 153.5, 146.2, 137.7, 128.0, 126.5, 125.7, 113.1, 
112.5, 111.1, 101.3, 68.4, 29.1, 28.5, 26.3, 25.3, 18.3. FAB-MS m/z calculated for 
C23H26N2O6S + H
+: 459.5; found: 459.2. 
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2.5.2. Protocols for Screening Experiments 
2.5.2.1 Protocol for Screening of Analytes 
A stock solution of the Probe (1.0 x 10-2 M) was prepared in DMSO and then 5 µL 
of this stock was dissolved in 10 mL of HEPES buffer (50 mM, pH 7.4). 1 mL of this 
solution was transferred to a cuvette. A solution of hCA1 (5.0 x 10-4 M) was prepared 
and 40 µL of it were mixed with the 1 mL Probe solution in the cuvette, leaving the final 
solution to stir gently for the pre-incubation time (15 min - 5 h). The concentrations of 
Probe and hCA1 in the cuvette are 5 and 20 µM respectively. 
A solution of the esterase (PLE, 5.0 x 10-5 M) was prepared and 1 µL of this 
solution was transferred to the cuvette with the pre-incubated Probe and hCA1. A 
fluorescence spectrum at this time showed no increase in the intensity before and after 
exposure to the esterase. The concentration of PLE in the cuvette was 50 nM. 
Stock solutions of the analytes (1 x 10-2 M) were prepared in DMSO. For a given 
analyte, 100 µL of its stock were diluted to 1 mL with the buffer and mixed well. Then, 5 
µL of this analyte solution were transferred to the cuvette with the solution of Probe, 
hCA1, and PLE. After two minutes, 5 µL more of the analyte solution are added. The 
same volume of the analyte solution is added every two minutes until the end of the 
experiment. The evolution of the experiment was tracked by fluorimetry during 35 to 50 
minutes, depending on the affinity of the analyte for the target protein. The increasing 
concentration of the analyte in the cuvette generates a fluorescence profile with time 
(sigmoidal shape), depending on the affinity of the analyte for the target protein. 
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2.5.2.2 Protocol for Screening of Analytes in a 96 Well Plate Reader 
The protocol for the plate reader experiments follows the same principles 
applied in the cuvette based assay. From a stock solution of the Probe (1.0 x 10-2 M) in 
DMSO 5.0 µL were dissolved in 10 mL of HEPES buffer (50 mM, pH 7.4). To a different 
vial 6.0 mL of the Probe solution 5.0 µM were transferred and hCA1 was added until 
reaching the concentration of 20 µM. This solution was left stirring gently to pre-
incubate (15 min to 1 h). 
Solutions of 2.0 x 10-3 M of the analytes were prepared. 400 µL of the previous 
analyte solutions were diluted to 2.0 mL with buffer solution. A PLE solution (10 mL, 5 
µM) was also prepared. 
The wells in the plate are set with 200 µL of the pre-incubating solution. 2 µL of 
the PLE solution were added to the wells plate and their fluorescence were recorded. 
Then, 1 µL of the analyte solutions were added every two minutes and the evolution of 
the experiment was followed by fluorimetry. 
2.5.2.3 Criteria Used for Calculating the Slope 
Once the displacement-mediated activity profiles were generated, the data 
involved in the linear increment in fluorescence were selected to analyze the difference 
in binding affinity. Out of this selected data, only the data points with a higher value 
than the inflection point were selected to calculate the slope of the curve, trying to 
avoid any incidence of the excess hCA1 binding. 
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2.5.2.4 Finding Optimal Pre-incubation Time 
A solution of Probe A (5 µM) in buffer (HEPES 50 mM, pH 7.4) was pre-incubated 
with hCA1 (20 µM) for different times (15 min, 1 h, and 5 h). Then, the solutions were 
exposed to PLE (50 nM) and the fluorescence spectra were registered. The evolution of 
the emission intensities with time were plotted in order to find the minimal time that is 
required for the pre-incubation of probe with hCA1 (Figure 2.4). 
2.5.2.5 Enzymatic activity of PLE in Presence of the Analytes 1-8 
To a cuvette, with 1 mL solution of Probe (5 µM) and analyte (1-8) (40 µM) were 
added 1 µL of PLE (50 µM) and the evolution of fluorescence (λexc: 365 nm, λem: 445 nm) 
was measured every minute for 7 minutes and after 20 to 50 minutes. The enzymatic 
activity of the PLE was not affected by any of the analytes as is shown in Figure 2.6b. A 
curve from a control experiment just exposing Probe A to PLE in the same 
concentrations as before is also shown. 
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CHAPTER 3 
 
PROTEIN-TRIGGERED SUPRAMOLECULAR DISASSEMBLY OF DENDRITIC AGGREGATES 
BASED ON LIGAND LOCATION 
3.1 Introduction 
Host systems that can spontaneously self-assemble and stably encapsulate guest 
molecules under one set of conditions, but disassemble and release the guest molecules 
when external conditions change, have been of great interest in supramolecular 
chemistry due to implications in a variety of biomedical applications.1,2,3,4 While earlier 
studies have primarily focused on properties observed initially, i.e. self-assembly and 
binding, there has been a recent surge in interest in the latter features i.e. disassembly 
and release in response to an environmental change.  
The responsiveness of the assemblies has primarily focused on physical or 
chemical changes. For example, there has been a significant interest in systems that 
disassemble in response to chemical stimuli such as pH5,6 or redox7,8 variations, as well 
as physical stimuli such as light,9,10 temperature,11,12,13 or a magnetic field.14,15 While 
systems incorporating features sensitive to light and magnetic field have been designed 
to respond to external triggers for biological applications, pH- and redox- responsive 
systems have been designed to respond to the inherent imbalances observed in certain 
diseased tissues. The anomalous pH or redox conditions in disease locations can be 
considered to be secondary imbalances, as the primary imbalances in biology are the 
result of aberrant protein concentrations or enzymatic activity.16,17,18 Therefore, there is 
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a growing interest in rendering supramolecular systems that respond to these primary 
factors in biology.19,20,21,22,23,24,25,26 
Protein-responsive systems can be broadly classified into two categories, viz. 
covalent modification of the hosts to disable their capacity to hold the guest molecules 
and non-covalent modification of the host assemblies to produce the same effect.27,28,29 
The former is often achieved by an enzyme-driven chemical reaction that modulates the 
host characteristics of the molecule; in the latter case, this is achieved due to a non-
covalent binding interaction. While there have been several systems designed to be 
degradable or covalently modified by enzymes,30 supramolecular assemblies that lose 
their host capacities due to non-covalent binding with proteins have been limited. 
Among the systems that undergo binding induced disassembly, polyelectrolyte 
assemblies that can non-covalently bind a complementarily charged surface to cause a 
disassembly have attracted some attention.31,32,33,34 Although non-specific in its 
interaction, the simplicity of these systems has proven useful in applications such as 
specific separations of peptides.35,36 It has also been clear that for a binding induced 
approach to be useful in applications such as delivery and sensing, where specificity is 
critical, strategies that use specific ligand-protein interactions are needed.37,38,39 Since 
dendritic macromolecules can be produced in high molecular weights, but with a great 
degree of control, these scaffolds have certain unique advantages for this strategy.40,41 
For example, the critical aggregate concentrations of the dendrimer-based amphiphilic 
assemblies are low, an advantage that polymeric systems have over small molecule-
based amphiphilic assemblies. Similarly, the control over functional group placements in 
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dendritic architectures captures the advantage that small molecules have over their 
polymeric counterparts.42 
The features mentioned above allow for structure-property relationship studies 
that unravel the factors that underlie the binding induced supramolecular disassembly 
process. In this chapter, we take advantage of this unique feature by incorporating 
specific locations within facially amphiphilic dendrons and interrogating the efficiency of 
supramolecular disassembly and molecular release in response to a specific protein 
binding event. We use both experiments and some of the molecular dynamics (MD) 
simulations developed by our collaborators to gain insights into the ligand-protein 
recognition based disassembly event.43 
3.2 Approach and Molecular Design 
Facially amphiphilic dendrons, containing a biaryl-based internal repeat unit and 
an aryl peripheral unit, both consist of hydrophilic and hydrophobic functional groups as 
side chains in each of these repeat units.44,45 The amphiphilic functional groups are 
placed at opposite faces of the biaryl backbone of the dendron such that these 
molecules are endowed with the capability to form micelle-like assemblies in aqueous 
phase and form inverse micelle-like assemblies in apolar solvents.46,47 In preliminary 
findings from our lab, it has been shown that placing a ligand moiety at the hydrophilic 
face of the dendron can provide binding-induced disassembly of the micelle-like 
structure in the aqueous phase.37 In that work, the ligand moiety was placed at the focal 
point of the dendron, as this structure is synthetically most easily accessible. However, 
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the release efficiency of guests following to protein binding was relatively low reaching 
43% for G1 and G2. In order to fully realize the potential of this process, it is critical that 
we understand the effect of the functional group placement, hence taking advantage of 
one of the most critical advantages of dendritic architectures in this supramolecular 
process. Thus, in this chapter, we investigate the effect of the placement of a protein-
specific ligand moiety at specific positions of a dendron upon the accessibility of the 
complementary protein to the supramolecular assembly, and hence the effects on the 
concomitant guest release response as it has been represented in Figure 3.1. 
The CAC of even the first generation of this kind of dendrons is substantially 
lower than the corresponding amphiphilic small molecule (µM compared to mM). 
Within each generation of dendrons however, the CAC gain has been relatively small, if 
 
Figure 3.1. G2 and G1 dendrons molecular design. Schematic of self-assembly 
sequestering hydrophobic small molecules, and releasing them upon protein binding. 
Nomenclature of the design in the bottom right part. 
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any, especially when one accounts for the difference in molecular weights. Therefore, 
here we focus on the G1 and G2 dendrons, which provide sufficient variations in the 
functional group placement. We targeted five different dendrons within these two 
generations, where the ligand placement is the key difference as it can be appreciated 
from the structures in Figure 3.1. Pentaethyleneglycol monomethylether (PEG) was 
chosen as the hydrophilic moiety not only for its ability to provide the macromolecules 
and the nanoassembly with the requisite solubility in the aqueous phase, but also for its 
propensity to present a charge neutral surface on the assembly that exhibits minimal 
non-specific interactions.48 Decyl moieties were incorporated as the hydrophobic 
components of the amphiphile. Biotin was chosen as the ligand, because of its well-
established high affinity towards avidin.49,50  
 
Figure 3.2. Possibilities to target a single position in each layer of a dendron. 
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As it is shown in Figure 3.2, a ligand can be incorporated on a G1 dendron either 
at the focal point or at the periphery. On a G2 dendron, a ligand can be incorporated on 
three different layers: (i) the focal point; (ii) the middle layer; and (iii) the periphery. To 
install a single ligand at a specific place, one of the PEG units was replaced by the ligand, 
attaching it to the dendron backbone via a hydrophilic linker. This placement allows the 
ligand to be exposed to the aqueous solution on the hydrophilic face of the assembly.  
Note from Figure 3.2 that the focal point is synthetically the easiest place to 
attach a single functional group, since the focal point is a single and unique position in a 
dendron. However, to install a single functional group at the periphery, it is necessary to 
distinguish one of the peripheral monomers from otherwise identical positions within 
the dendron.  
The G1 dendron has two such identical positions in the periphery, while the G2 
dendron has four such locations. Similarly, the middle layer of the G2 dendron contains 
two similar positions that need to be distinguished for specifically placing a ligand 
moiety. Accordingly, the degree of difficulty in placing a unique functional group in the 
dendron increases as we move from the focal point to the periphery and as we increase 
the generation. To achieve these selective functionalization, we and others have 
developed a variety of synthetic strategies that afford multi-functionalized dendrons 
and dendrimers.42,51,52,53 
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3.3 Results and Discussion 
3.3.1 Synthetic Strategy 
In all our syntheses, we initially targeted dendrons containing an acetylene 
moiety, which will be used as the handle to “click” the biotin moiety in the last steps of 
the syntheses. Overall, we made the syntheses of the dendrons modular in order to 
assemble the targeted dendrons in a small number of steps. Accordingly, we first 
synthesized the biaryl protected AB2 monomer 7 (Scheme 3.1), the propargyl-
functionalized periphery unit 12, and the non-functionalized amphiphilic periphery unit 
13 (Scheme 3.2) following the previously reported procedures. 
Scheme 3.1 shows the synthesis of the protected AB2 monomer 7. First, from 
commercially available 3,5-dimethoxybromobenzene 1 involving (i) deprotection of the 
phenolic hydroxyl groups from the methyl substituents, (ii) treatment of the phenolic 
 
Scheme 3.1. Synthesis of protected AB2 monomer 7. 
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hydroxyls with MOM-Cl to introduce a protecting group easier to handle in 3 and, (iii) 
conversion of the bromo functionality to a stannane 5. The bottom aryl ring 6 was 
obtained from 4-bromo-3,5-dihydroxybromobenzoic acid 2. This involves, first, 
esterification of the acid followed by mono-O-alkylation of a phenolic hydroxyl by 
means of treatment with n-bromodecane in the presence of potassium carbonate and 
18-crown-6 to get 4. Secondly, protection of the remaining hydroxyl by means of an O-
acetylation to get 6. The stille coupling between the aryl stannane 5 and the 
arylbromide 6, followed by deprotection of the acetyl-protected hydroxyl and the 
reduction of the ester moiety, was accomplished in one step to generate the benzyl 
alcohol and biaryl AB2 monomer 7. 
Scheme 3.2 shows the synthesis of periphery containing an alkyne moiety 10. 
First, mono O-alkylating 3,5-dihydroxybenzyl alcohol 8 using n-bromodecane in the 
presence of potassium carbonate and 18-crown-6 to get 9. The mono alkylated 
compound 9 could be further treated with propargyl bromide using the same conditions 
of O-alkylation than before to yield the propargyl bearing periphery 10. Compound 9 
could also be treated with PEG-Ts in the same conditions to get amphiphilic periphery 
11. The resultant hydroxymethyl compounds 10 and 11 were converted to the 
corresponding bromides 12 and 13 respectively, using phosphorus tribromide. 
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Scheme 3.2. Synthesis of periphery bearing either propargyl or PEG. 
 
Scheme 3.3. Synthesis of biotin azide 18. 
 
Scheme 3.4. AB2 monomer. 
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In order to attach the biotin ligand to the dendrons through click chemistry, not 
only the installation of a propargyl unit on the dendrons structure is imperative, but also 
the functionalization of the ligand with a pendant azide. Scheme 3.3 shows such biotin-
azide preparation. Briefly, it involves the amine-protection of 2-(2-aminoethoxy)ethanol 
14 to get 15, which is followed by mesylation of the alcohol moiety and then, treatment 
with sodium azide to obtain the azide-compound 16. Next, the amine functionality of 16 
was de-protected upon acidic treatment to get the amino-azide 17, which is coupled 
with biotin as a final step to the biotin azide 18. 
To achieve the targeted dendrons G1 and G2 (see Figure 3.1 for structures), it is 
imperative to deprotect and further functionalize the AB2 molecule 7. In Scheme 3.4 the 
functionalization of 7 is accomplished in two different ways, (i) using propargyl bromide 
and (ii) using PEG-Ts in the conditions for alkylation described above. 
3.3.1.1 Synthesis of Final G1 Dendrons 
To achieve G1-P, the biaryl monomer 20 was first mono-alkylated with a 
periphery unit 12 to get the propargyl-functionalized scaffold 21 (Scheme 3.5) in 25% 
yield. The low isolated yield was because of the statistical distribution mono- and di-
substituted products obtained in this reaction. It is worth to mention that although the 
di-substituted product has no further use in our synthetic design, the initially attempted 
mono-substitution of monomer 20 with periphery 13 generated also a di-substituted 
byproduct, which could have been used for the synthesis of G2 dendrons. However, the 
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isolation of such mono-alkylated product from the di-alkylated byproduct could not be 
accomplished due to their similar polarities and close retardation factors (Rf).  
Molecule 21 was then treated with the amphiphilic peripheral monomer 13 
under similar alkylation conditions to achieve the G1 dendron 22 containing the reactive 
propargyl moiety at its periphery. The G1 dendron 22 was then treated with the azide 
modified biotin 18 under click chemistry conditions54,55,56,57 in presence of copper(II) 
sulfate and sodium ascorbate to obtain the final G1 dendron with a single biotin moiety 
installed at the periphery G1-P in 70% yield.  
Similarly, as shown in Scheme 3.6, the molecule G1-F was synthesized starting 
from the monomer 19, which was dialkylated with periphery units 13 to get the 
dendron 23 in a single step. Notice the difference in yields with the two steps required 
to get dendron 22. Then, by clicking the biotin azide 18 to the propargyl moiety present 
 
Scheme 3.5. Synthesis of G1-P and installment of the ligand at the periphery. 
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in the biaryl repeat unit of 23, we got the G1 dendron with a single biotin moiety 
installed at the focal point G1-F. 
3.3.1.2 Synthesis of Final G2 Dendrons 
Before the next steps towards the targeted G2 dendrons, the hydroxymethyl 
moieties of G1 dendrons 22 and 23 were transformed into the corresponding 
bromomethyl fragments 24 and 25 respectively, which are shown in Figure 3.3. These 
substitutions were accomplished using phosphorus tribromide in the same conditions 
that rendered the periphery amphiphiles 12 and 13 (Scheme 3.2). In the same way, the 
dendron obtained from dialkylation of the monomer 20 with two periphery units 13 is 
rendered into its bromomethyl derivative 26. 
 
Scheme 3.6. Syntesis of G1-F. 
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The syntheses of the targeted G2 dendrons were achieved using a similar set of 
synthetic strategies than for G1-P and G1-F, as shown in Scheme 3.7. To achieve the 
syntheses of these dendrons, the previously described amphiphilic G1 dendron 26 was 
treated with the biaryl monomer 20, where the mono-alkylated product 27 was 
separated from a statistical mixture in 24% yield. In this case, although the isolation of 
the mono-substituted product from the di-substituted byproduct was the bottle neck of 
the entire synthesis, the byproduct can be used as a control dendron for the 
disassembly and release experiments. Also using a brominated dendron 24, which is 
more difficult to obtain than 26, to mono-substitute 20 produces a di-substituted 
byproduct that does not have any further use in our designed synthesis. Mono-
substituting 20 with brominated dendron 25, which takes the same number of synthetic 
steps than 26, also generates a byproduct that has no further use in our synthetic 
design. 
Molecule 27 was then treated with the bromomethyl dendron 25 or 24 to obtain 
the G2 dendrons 28 or 29, containing the propargyl moiety at the middle layer or the 
periphery of the dendron respectively. Copper-catalyzed Huisgen reaction of 28 and 29 
with the azide-functionalized ligand 18 afforded the dendrons with a single biotin 
 
Figure 3.3. Brominated G1 dendrons. 
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moiety installed at the middle layer G2-M, and a single biotin moiety installed at the 
periphery G2-P, respectively (Scheme 3.7). 
In a similar fashion than with dendron G1-F, to get a single biotin unit installed at 
the focal point of a G2 dendron, G2-F, we started from the monomer 19, which was di-
alkylated with the brominated G1 dendron 26 to get the G2 dendron 30, bearing a 
propargyl fragment at the focal point in a single step. Then, by clicking the biotin azide 
 
Scheme 3.7. Synthesis of G2-M and G2-P. 
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18 to the propargyl moiety present in 26, we got the G2 dendron with a single biotin 
moiety installed at the focal point G2-F. This synthesis is shown in Scheme 3.8. 
3.3.2 Self-Assembly and Determination of CACs of Dendrons 
The self-assembly properties of the target dendrons G1-F, G1-P, G2-F, G2-M, and 
G2-P in water were studied before trying to understand their disassembly. For this 
purpose, Nile red was used as the hydrophobic spectroscopic probe. After 
encapsulation, the CACs of the dendrons were determined using the fluorescence 
intensity of Nile red (λem= 615 nm), as shown in Figure 3.4. Since Nile red is a 
hydrophobic small molecule it is not water soluble and precipitates if it is exposed 
directly to an aqueous environment, and hence its emission spectrum cannot be 
detected (λex= 550 nm). However, once the dye is encapsulated its emission spectrum 
 
Scheme 3.8. Synthesis of G2-F. 
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can be easily acquired. Then, Nile red is dispersed in the aqueous solution once it is 
encapsulated in the hydrophobic pockets of the dendritic containers. 
Initially, when the dendron concentration is high, the intensity of the emission 
spectrum of the dye is high. However, when the concentration of the dendron in 
solution decreases the intensity of the emission of Nile red also decreases. Given the 
same amount of dye, when the dendron concentration goes down drastically, less 
dendron hold less dye molecules, and the non-encapsulated small molecules precipitate 
out of the solution. Finally, when the dendron reaches the CAC the emission intensity of 
Nile red decreases to a value that remains more or less stable, indicating that most of 
the hydrophobic pockets in the aggregate have been lost and only those hydrophobic 
moieties in the disassembled dendrons can hold a few molecules of dye. Such 
fluorescence intensity is close to cero, since the container properties of the assembly 
have been lost. 
 
Figure 3.4. CAC plots based on nile red fluorescence for dendron assemblies a) G1-F, 
b) G1-P, c) G2-F, d) G2-M, e) G2-P. 
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Then, for each dendron encapsulating Nile red, the fluorescence intensities at 
615 nm were recorded every time that the dendron concentration was reduced. The 
intensity values were plotted against the concentration of dendron to get a CAC curve, 
which should be sigmoidal ideally. From the curve, the point where the best fitted 
horizontal and vertical lines merge was taken as the CAC. Table 3.1 shows the CACs and 
the corresponding dendrons. 
From Figure 3.4 is evident that the dendrons have CACs with close values, since 
the CAC curves look very similar, and as it is reflected in Table 3.1. As anticipated, the 
CACs of final G1 and G2 dendrons were determined to be in the low micromolar range. 
3.3.3 Disassembly of the Dendritic Aggregates 
With the installment of a single ligand at different layers of a dendron, and after 
knowing the lowest concentration at which they assemble into nanostructures, we 
investigated the response of the different dendritic aggregates in presence of the 
complementary protein extravidin and in presence of non-complementary proteins with 
diverse pI values and molecular weights, viz. α-chymotrypsin (Chy, pI = 8.1-8.6), pepsin 
(Pep, pI = 2.9), and myoglobin (Myo, pI = 7.2). 
Prior to analyzing the interaction between the dendritic assemblies and the 
proteins, we analyzed the size of the assemblies in aqueous phase using dynamic light 
Table 3.1. Critical aggregation concentrations 
Dendron G1-F G1-P G2-F G2-M G2-P 
CAC (µM) 11.65 8.02 7.25 7.08 7.01 
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scattering (DLS), with G1 dendron concentrations of 12.5 µM and G2 dendron 
concentrations of 10 µM; both concentrations are above the respective CACs. The sizes 
of the assemblies were found to be in a few tens of nanometers, ranging from ~30 nm 
to ~200 nm, 44 nm for G1-F, 220 nm for G1-P, 29 nm for G2-F, 92 nm for G2-M, and 51 
nm for G2-P. These initial aggregate sizes are represented as red lines in Figure 3.5. The 
reason for the variations in size with the subtle change in the position of the ligand is 
not clear. However, note that the replacement of a hydrophilic PEG chain in a G1 or G2 
dendron by a less hydrophilic pendant biotin decreases the PEG density on the assembly 
surface, decreasing hydrophilicity and increasing the chance of non-specific interactions 
with non-complementary proteins. Such decrease in PEG density seemed to be more 
relevant in G1, where substituting one of the three PEG chains in a dendron molecule 
could mean a reduction of up to 33% in hydrophilicity, while in a G2 it could mean a 
 
Figure 3.5. DLS-size change of dendritic assemblies in aqueous phase upon interaction 
with different proteins. a) G1-F, b) G1-P, c) G2-F, d) G2-M, e) G2-P. 
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reduction of up to 14%. It is possible that these differences confer changes in the way 
the assemblies pack together in solution, which results in size variations among the 
biotin functionalized dendrimeric assemblies. 
It is interesting however that the size of all these assemblies reduced to about 
~13 nm in presence of extravidin at 2 µM. A particular difference in disassembly among 
the biotin-functionalized dendrons was observed in the case of the G2-P that 
disassembled into smaller aggregates of around ~7-8 nm in presence of extravidin, as 
seen in Figure 3.5e. G1-P also presented some deviations, showing larger aggregates 
around ~28 nm. However, these larger aggregates could also be formed by further 
aggregation of smaller assemblies. 
The decrease in the size of the assemblies was observed only in presence of the 
complementary protein, extravidin. In the presence of the non-complementary 
proteins, no disassembly was observed, although a tendency of the biotin functionalized 
dendrimeric assemblies to increase size, forming larger aggregates was noticed for G1-F 
and G1-P, as shown in Figure 3.5a,b. This aggregate enlargement did not occur when 
control dendrons G1 at a concentration of 12.5 µM, and G2 at a concentration of 10 µM, 
 
Figure 3.6. DLS-size unchanged of control dendritic assemblies in aqueous phase upon 
interaction with different proteins. a) G1 dendron, b) G2 dendron, c) proteins. 
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both with PEG replacing the ligand moiety, were exposed to the same proteins. Figure 
3.6a,b shows such control dendrons. This suggested that biotin functionalization of 
dendrons was the reason for such aggregate enlargement. Figure 3.6c shows what could 
be the size of the proteins at a concentration of 20 µM, since the same proteins at 2 µM 
were undetected by DLS. 
Although DLS, in volume percentage, shows disassembly for the biotin-
 
Figure 3.7. DLS distributions by volume, intensity, and number of the disassembly 
experiments 
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functionalized dendritic aggregates when they are exposed to extravidin, the same data 
also shows that not all the aggregates suffer disassembly. This is shown in Figure 3.5 as a 
small and broad peak around 100 nm for all the dendritic aggregates when they are 
exposed to extravidin (red lines). To have a better appreciation of what particles with 
different size remain in solution after exposure to extravidin, we must refer to the 
percentage of intensity curves in DLS as shown in Figure 3.7. 
Briefly, DLS measures Brownian motion and relates this to the size of the 
particles. It gives information about the size of the particles in three different 
distributions: (i) the number distribution or number percentage, depending on the 
number of particles of each size. (ii) The volume distribution, which shows the volume 
occupied by the detected particles according to the volume of a sphere ((4/3)  r3), 
which means that by volume distribution a particle of 50 nm (area of the peak) is 1000 
times larger than a particle of 5 nm (1:1000 ratio). (iii) The intensity distribution, which 
makes the area of the peak at 50 nm 1000000 times larger than the area for the 5 nm 
particle (1:1000000), which is due to large particles scattering much more light than 
small particles according to Rayleigh’s approximation (I ~ d6; where I is the intensity of 
light scattered and d is the diameter of the particle). 
Then, from Figure 3.7 it is certain that non-specific proteins do not trigger 
disassembly of our dendritic aggregates since the size of the assemblies is not reduced; 
on the contrary, aggregation that helps increasing the size of the particles could be 
happening. On the other hand, when the dendritic aggregates were exposed to 
extravidin, it is clear how the distribution by number shows the formation of particles of 
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size around 10 nm in every case, similar to the distribution by volume. However, from 
the intensity distribution it is clear that after exposure to extravidin, there are still some 
large particles that either did not suffer disassembly or aggregated from smaller 
particulates. 
3.3.4 Release of Encapsulated Guest Molecules 
Next, we investigated the host capabilities of the dendrons in the presence and 
absence of complementary and non-complementary proteins. Specifically, we were 
interested in assessing the effect of incorporating the ligand moieties at different 
locations within the dendrons upon the disassembly-induced guest release from the 
dendron host. To investigate these differences, Nile red was encapsulated in the 
micelle-like nanoassemblies and its release was triggered as a consequence of binding 
induced disassembly upon exposure to extravidin. Nile red is a hydrophobic molecule 
that exhibits reduced fluorescence in water, unless it is sequestered in a hydrophobic 
pocket. Therefore, the reduction in fluorescence is a good indicator of the binding 
induced disassembly event. 
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As shown in Figures 3.8a and 3.8b, small differences in placement of the ligand in 
the dendron produced rather different responses. First, percentage of dye released was 
assessed after exposing 25 µM solutions of the dendrons to increasing concentrations of 
extravidin. We noticed that G1-P and G2-P responded to increasing concentrations of 
extravidin more than other dendrons studied. To further evaluate this behavior, we 
monitored the release profiles over time for all the dendritic assemblies upon exposing 
these assemblies to 14 µM of extravidin as shown in Figure 3.8b. During the first hour, 
the release in the G2-P assembly was as high as 65%, while the release of the G1-P 
assembly was around 22% increasing to 40% after 3 hours. Interestingly, the release 
from the G1-P assembly ultimately reached about 77%, which is comparable with the 
 
Figure 3.8. Fluorescence based percentage of release upon interaction of dendrons 
with a) increasing concentration of extravidin, b) 14 µM of extravidin, c) buffer 
solution, d) (control dendrons exposed to) extravidin. 
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81% observed for G2-P. In comparison, similar exposures to extravidin resulted in 35%, 
25%, and 13% for G1-F, G2-F, and G2-M respectively. Interestingly, the release in G2-M 
is comparable to the release percentages observed due to non-specific interactions. 
As a control experiment, the release of the Nile red from the dendritic 
assemblies was also monitored in the absence of any protein, as shown in Figure 3.8c. 
No discernible release (<10%) was seen in these dendritic assemblies. Similarly, Figure 
3.8d shows that control dendrons lacking the biotin ligand also did not exhibit 
appreciable dye release in the presence of extravidin. These results show that the 
release profiles observed in Figure 3.8a and 3.8b are indeed due to the ligand-protein 
binding. Moreover, it is clear that among the second generation dendrons, G2-P 
assembly is the only one releasing efficiently the hydrophobic guests following to 
extravidin binding. 
 102 
To test the selectivity in the systems towards the target protein further, the 
biotin-functionalized dendrons were exposed to increasing concentrations of non-
complementary proteins, Chy, Pep, and Myo monitoring the change in Nile red 
fluorescence (Figure 3.9a-c). No significant change in the emission intensity was 
observed for any of the dendrons in the presence of Chy and Pep. However, while Myo 
did not exhibit any change in the fluorescence intensity in the G1-P, G2-M and G2-P 
based assemblies, there was a significant change in fluorescence in the G1-F and G2-F 
based assemblies, as it was further tested exposing the assemblies to constant 
concentrations of non-complementary proteins and it is shown in section 3.5.2. 
 
Figure 3.9. Exposure of dendritic assemblies to increasing concentrations of a) Chy, b) 
Pep, c) Myo, and d) absorption based percentage of release upon interaction of 
dendrons with 14 µM of Myo. 
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Interestingly, these latter dendrons also exhibited much smaller release in response to 
extravidin, as it was previously shown in Figure 3.9b. It is noteworthy that Myo is a 
metalloprotein and therefore the co-factors in metalloproteins could be simply 
quenching the fluorescence of the dye molecule without the need for releasing the 
contents from the amphiphilic assembly. In fact, such a phenomenon has been 
previously observed with polymer-surfactant co-assemblies.33 
To test this possibility, we investigated the change in absorption spectrum for 
Nile red in the presence of Myo. If it is simply a quenching phenomenon, no change 
should be present in the absorption spectrum since all dye molecules are still confined 
in the amphiphilic assembly without being released. Indeed, we noted that there was no 
change in the absorption spectrum over time, suggesting that the observed 
phenomenon is due to excited state quenching of the fluorescent dye molecules, as 
shown in Figure 3.9d. 
3.3.4.1 A Particular Case of Quenching of the Cargo 
In this part, we were interested in gaining insights into the observed 
fluorescence reduction in the presence of Myo, especially for G1-F and G2-F. There are 
two limiting mechanisms by which such quenching could occur: (i) inherently different 
encapsulation stabilities among the dendritic assemblies, causing the dye to leak out of 
G1-F and G2-F and bind to the hydrophobic pockets in the protein, where the proximity 
between the metalloprotein cofactor and the dye molecule causes fluorescence 
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quenching; or (ii) the possible non-specific interactions between assemblies formed by 
G1-F, and G2-F with Myo favour quenching of the cargo.  
To test the possibility (i), we used a recently reported polymeric nanogel that has 
been well-established to have crosslink-density dependent encapsulation stabilities.58,59 
Nile red-encapsulated nanogels with 0%, 20%, and 50% crosslink densities were exposed 
to Myo. If this mechanism was operative, there should be a crosslink density dependent 
emission dependent quenching. In all cases, we found that the extent of quenching was 
quite independent of the crosslink density (Figure 3.10). The quenching however was 
found to increase with increasing concentration of the Myo, as observed with G1-F and 
G2-F assemblies. These results are taken to suggest that Myo itself is not capable of 
binding the Nile red molecule, because the 0% crosslinked nanogel assembly has been 
found to be quite leaky. This rules out mechanism (i) and makes mechanism (ii) the most 
likely possibility. 
 
 
Figure 3.10. Encapsulation stability and quenching. a) Quenching of Nile red (NR) 
fluorescence encapsulated in nanogels (NG, 1 mg/mL) at different crosslink densities 
and concentrations of Myo, b) quenching after a single exposure to Myo (5.5 mg/mL). 
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Within the realm of quenching, it is also important to know whether the 
quenching is due to dynamic collisions or non-specific binding (a static quenching 
event). Since dynamic and static quenching differ in their temperature dependence, we 
exposed the assemblies G1-F and G2-F encapsulating Nile red, to increasing 
concentrations of Myo at two different temperatures. The number of collisions between 
the dendritic assemblies and the protein was expected to increase at a higher 
temperature in the case of dynamic quenching, leading to an increase in quenching.60 
On the other hand, in the case of static quenching, the weak dendritic assembly–protein 
complex would dissociate at a higher temperature, leading to a decrease in quenching.61 
Figure 3.11 shows the Stern–Volmer plots for G1-F and G2-F respectively at 25 °C and 38 
°C. The fact that the quenching increases with temperature supports the weakly bound 
complex hypothesis. Thus, it is interesting to note that G1-F and G2-F exhibit higher 
non-specific interaction and at the same time do not exhibit significant release of the 
guest molecules in response to the target extravidin. On the other hand, the dendrons 
G1-P and G2-P that exhibited the highest release in response to extravidin did not 
exhibit any non-specific quenching with Myo. 
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This evidence of a weakly bound complex between G1-F or G2-F and Myo, 
supports the idea that, eventhough PEG is coating these nanoassemblies, thetering of 
biotin to the focal point of the dendrons is generating assemblies where the PEG shell is 
not efficiently preventing non-specific interactions. 
Additionally, the release of nile red observed by absorption from G1-F assembly, 
shown in Figure 3.9d, reached up to 20% which is high for mere non-specific 
interactions. Thus, it could be explained as due to the formation of a weak complex 
assembly-quencher, since formation of a ground-state complex that generates static 
quenching can result in different extintion coefficients for those fluorophores 
encapsulated but distant from the quencher metalloprotein, and for those closer to the 
metalloprotein. This results in perturbation of the fluorophore absorption spectrum and 
hence, in a false release profile that supports the static quenching in the system. 
The idea of having two populations of fluorophores encapsulated in the same 
assembly, one of them not accesible to the quencher, is in turn supported by the 
downward curvature towards the x-axis displayed in the Stern–Volmer plots in Figure 
 
Figure 3.11. Quenching of cargo. a) Stern-Volmer plot for G1-F + NR at 25 oC and 38 oC 
vs increasing concentration of Myo, d) Stern-Volmer plot for G2-F + NR at 25 oC and 38 
oC vs increasing concentration of Myo. 
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3.11, a phenomenon seen in proteins having some triptophan residues on the surface 
and some buried.61 
3.3.5 Making Sense of Disassembly and Release 
These latter data and those from the previous sections indicate that if the 
release of hydrophobic guests is triggered by the specific extravidin-biotin interaction, 
the selective binding with the complementary protein can occur more easily when a 
biotin ligand is grafted at the periphery than when it is grafted at the middle layer or at 
the focal point of the dendron, and that somehow this makes the release of 
hydrophobic guests faster for G2-P than for the other constructs, as observed in Figure 
3.8a,b. If disassembly is controlled by the same interaction, since the biotin-extravidin 
binding is considered irreversible, when extravidin binds to a dendron in the assembly a 
reduction in the size of assembly will occur after some time, while the system 
reorganizes and equilibrates in smaller size assemblies as it was observed by DLS (Figure 
3.5). Thus, although all systems reorganized into smaller size assemblies, the release 
was higher for the dendron systems with a ligand located at the periphery. The reason 
for this disparity was not entirely clear to us. 
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Based on the release kinetics, which was also faster for the dendritic systems 
with ligand at the periphery, we hypothesized that in these cases the assembly 
reorganization was drastic enough to produce a higher release. On the other hand, in 
the cases with a ligand at the middle layer and focal point the assemblies rearranged 
slower into smaller size structures, allowing for the encapsulated hydrophobic small 
molecules to still be accommodated in hydrophobic pockets. In fact, Figure 3.8b shows 
that even after 6 hours of G2-M (25 µM) exposure to a constant concentration of 
extravidin (14 µM), the release was as low as 13%. At this point, the interesting question 
of why is the release from G2-P so high compared to the release from G2-M and G2-F 
remain still open. 
Nevertheless, based on our data and analysis at a molecular level, we propose a 
hypothesis involving the approach of a tetrameric extravidin to the biotin ligand 
surrounded by a different PEG nano-environment in the different locations, as 
represented in Figure 3.12. When biotin is grafted at the middle layer (Figure 3.12b) or 
 
Figure 3.12. Pictoric representation of protein approaching a G2 dendron with biotin 
grafted at a) the periphery, b) the middle layer, and c) the focal point. 
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at the focal point (Figure 3.12c) it is surrounded by an environment rich in PEG. This 
makes the specific binding with extravidin, which implies deep penetration of the ligand 
inside one of the four binding pockets of tetrameric extravidin, very difficult compared 
to G2-P (Figure 3.12a). We have employed molecular dynamics (MD) simulations, 
carried out by our collaborators,43 to gain additional insights in the understanding of 
why the different positioning of a biotin ligand within the dendron scaffold has such a 
strong effect on the final properties. 
First, it was important to understand how these molecules fold in solution. In 
fact, it is known that similar dendritic structures can undergo strong folding in 
solution,62,63 so that if the biotin ligand is backfolded and surrounded by PEG in the 
experimental conditions the specific binding with extravidin will be unlikely. 
The entire simulation work was carried out with the AMBER 12 suite of 
programs.64 Molecular models were created with three different functionalization points 
for biotin, to understand how the individual dendrons arrange in solution. G2-P, G2-M 
and G2-F dendron models were created and parameterized according to similar studies 
on dendrons interacting with proteins.65,66,67 Starting configurations of the dendrons 
were then immerged in a simulation box (Figure 3.13a) containing explicit water 
molecules. All systems underwent 200 ns of MD in periodic boundary conditions at 25 °C 
(298 K) of temperature and 1 atm of pressure. During this time, all dendrons reached 
the equilibrium with good stability. The root mean square displacement (RMSD) and the 
radius of gyration (Rg) data extracted from the MD simulations were used to assess the 
system’s equilibration. 
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The size of G2 in water predicted by MD simulation does not change substantially 
depending on the tethering position of biotin, i.e. the radius of gyration (Rg) in the three 
cases is 9.4-10 Å (Figure 3.13a). In general, the dendrons tend to compact the 
hydrophobic decyl chains at the core, and to surround them with hydrophilic PEG. On 
the other hand, in terms of distribution of the biotin ligand the situation is different. The 
plots in Figure 3.13b report the radial distribution function(RDF) g(r) of the biotin ligand 
calculated with respect to the dendrons center and expressed as a function of the 
dendron radius (Rg) for the cases where biotin is grafted at the periphery (G2-P: red), 
the middle layer (G2-M: blue), or at the focal point (G2-F: black). In general, the g(r) 
values give indication on the relative probability to find the biotin ligand at a certain 
distance from the dendron center, being the position of the g(r) maximum peak the 
most probable one.  
The biotin density, going from the center to the surface, is calculated at each 
simulation step, and the reported g(r) data are averaged in time over the equilibrated 
phase MD trajectories (the last 100 ns). Thus, high and sharp peaks in g(r) identify high 
 
Figure 3.13. MD simulation of G2 dendrons in water. a) Dendron folded in solution 
assuming a globular shape; b) RDF plots for the biotin in the G2 dendrons. 
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biotin density regions, but they also indicate high localization, confinement and 
backfolding (namely, atoms that cannot move are counted at each step in the same 
region of space). 
On the contrary, flexible and fluctuating groups will have low and broad g(r) 
peaks. Figure 3.13b shows that at the equilibrium biotin distribution is very different for 
G2-P, G2-M and G2-F. In particular, the biotin g(r) maximum peak for G2-P (red curve) 
corresponds well with its Rg indicating that, on average, the ligand availability on the 
surface is very good. On the contrary, the maximum peaks of black and blue g(r) curves 
at a distance r~0.5 Rg suggest that biotin is considerably more backfolded in the case of 
G2-F and G2-M. These data give indication on how much the biotin ligand is available at 
the surface of the dendron, and thus also on the probability to have a specific binding 
with extravidin. 
The experimental biotin-avidin energy of binding is known to be -20.4 kcal mol-
1,68,69,70 however the dendron-extravidin affinity will be worse for G2-F and G2-M 
dendrons since biotin is backfolded for them, unlike in G2-P. From the experimental 
biotin-avidin affinity and the biotin availability at the dendrons surface, it was possible to 
calculate the relative probability for the dendron-avidin specific binding (statistical 
weight). So, if we set the probability of having extravidin specifically bound to the biotin 
moiety in G2-P to 1, then the probability of having extravidin bound to the biotin moiety 
in G2-F and G2-M is reduced to ~0.1 due to reduced ligand availability. This means that 
the probability of extravidin specific binding to biotin ligands at the surface of G2-P 
aggregates is ten times higher than in the case of G2-F and G2-M. 
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3.3.5.1 Multivalent Binding of Extravidin 
Given the differences of ligand availability for the dendrons, our results suggest 
that when extravidin gets in contact with a biotin at the surface of a G2-P aggregate, the 
formation of a specific binding will be an energetically favored event. In addition, it is 
worth noting that extravidin is a protein tetramer possessing four binding sites for 
biotin. Thus, after a first specific binding occurs between extravidin and one biotin at the 
G2-P aggregate surface, the protein can find also other biotin ligands available in the 
neighborhood to establish more specific bindings in a cooperative way. This will be an 
energetically favored thus highly probable event,71,72 according to the so-called 
multivalent effect, and to the fact that extravidin is energetically favored to bind four 
biotins at the same time. 
The consequences of this behavior can be important. In fact, this tendency of 
extravidin to bind more biotin ligands at the same time, when available, can in principle 
speed up the disassembly process. Conceptually, since extravidin will tend to preserve its 
structure much more than the dendron aggregate, in case of cooperative binding to 
multiple ligands, it is reasonable to think that the dendrons from the aggregate will 
adapt over extravidin, rather than the unlikely opposite option: protein collapsing over 
the G2-P surface. This is consistent with a picture where G2-P aggregates are 
progressively degraded. 
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3.3.5.2. Proposed Mechanisms for Disassembly and Release 
One key factor allowing for multivalent binding is biotin availability. Namely, 
biotin ligands must be accessible at the aggregate surface and free to complete specific 
interactions with extravidin. In fact, as we already discussed on Figure 3.13, the chance 
of having multivalent specific binding between the dendrons and extravidin will be 
extremely sensitive to biotin availability at the surface of the aggregates. As our results 
suggested, biotin availability is high for G2-P and low for G2-M and G2-F (Figure 3.13). 
 
Figure 3.14. Proposed mechanism for disassembly and release from biaryl amphiphilic 
dendrons. a) In G2-P biotin is highly available for extravidin - exfoliation-like 
disassembly; b) in G2-M and G2-F biotin is less available for extravidin. 
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Thus, at the G2-P aggregates surface extravidin will find many accessible binding spots 
for completing specific interactions. Moreover, after a first specific binding is 
established, the same extravidin protein will be then energetically favored to bind more 
biotins from other G2-P dendrons. On the other hand, since the probability to have 
specific binding for G2-M and G2-F is reduced, even if a first specific interaction occurs 
between extravidin and one biotin ligand, it is reasonable to hypothesize that the chance 
of having multivalent extravidin binding at the surface of G2-M and G2-F aggregates will 
be lower. 
In light of our overall results, we propose two different possible mechanisms for 
self-assembly schematized in Figure 3.14. (i) For the G2-P case, multivalent binding of 
extravidin leads to the rapid disassembly of the dendron aggregates in solution, in an 
exfoliation-like manner as in Figure 3.14a. (ii) For G2-M and G2-F, the aggregates would 
disassemble more slowly due to the destabilization induced by extravidin binding, as in 
Figure 3.14b. In principle, the first proposed mechanism would result in the rapid 
production of smaller aggregates limited by extravidin size, and in a higher level of 
hydrophobic guest release. Here, the velocity of the process and the small size of the 
aggregates would not allow for the structural rearrangement necessary to retain the 
guest molecules. The second proposed mechanism would most likely produce larger size 
aggregates and thus, lower levels of release. 
To summarize this section, the high level of biotin availability of G2-P is 
compatible with its fast disassembly and hydrophobic guests in presence of extravidin, 
as shown by our DLS and fluorescence experiments. At the same time our data 
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demonstrates that G2-M and G2-F aggregates also disassemble in presence of extravidin 
(Figure 3.5), but more slowly. In addition, the final size of the disassembled aggregates is 
larger than that of G2-P (~14 vs ~7 nm), and no appreciable guest release is present 
during the disassembly of the G2-M and G2-F aggregates (Figure 3.8a,b). 
3.4 Summary 
Our research reveals that ligand placement on a supramolecular scaffold for 
binding induced disassembly greatly impacts disassembly and release of encapsulated 
guest molecules, as we have shown from the high release difference observed, for 
example, between G2-P and G2-M. The best place to attach a ligand, looking for a 
protein triggered release from a dendritic micelle-like nanostructure, is the periphery. 
MD simulations show backfolding of the ligand when attached to middle layer and focal 
point and a better availability for protein binding when the ligand is attached at the 
periphery. Incorporation of the biotin ligand in the dendrons gives the dendritic 
assemblies selectivity towards the target protein extravidin, regardless of the ligand 
position. Nonetheless, ligand positioning in the dendrons gives the assemblies sensitivity 
towards release upon binding of a target protein. In addition, multivalent binding of the 
same extravidin protein to other G2-P dendrons via specific biotin-extravidin interaction 
is an energetically favored event. These evidences allowed us to hypothesize two 
different mechanisms of disassembly induced by extravidin binding that depend on the 
ligand location in the scaffold. A fast one for G2-P based on high biotin availability at the 
aggregate surface, multivalent interactions and aggregates exfoliation. This mechanism 
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leads to fast formation of small disassembled aggregates and to a high release of 
hydrophobic guests. A second mechanism for G2-M and G2-P portraits a slower 
disassembly, based on extravidin binding induced aggregate destabilization, and the 
formation of larger and more ordered aggregates in solution that are still capable of 
retaining the guest molecules in their interior. 
Substitution of a PEG unit in the dendron for a pendant biotin increased non-
specific interactions of the assemblies with proteins, which was seen as the formation of 
larger aggregates in solution. This became more evident when the density of PEG chains 
on the hydrophilic face was low, as it is in a G1 dendron compared to a G2. This, in turn, 
facilitates the formation of a weak complex assembly-protein that was evidenced when 
a metalloprotein acted as a quencher, generating static quenching of the encapsulated 
fluorophore molecules. The research reported here gives a picture of how 
supramolecular disassembly and release might be largely affected by choosing a specific 
location for a trigger, rather than a random placement based on molecular architecture. 
Also, we have shown how controlled variations in PEG density could affect interactions 
of nanoparticles with proteins. 
3.5 Experimental Section 
3.5.1 Synthetic Procedures and Characterization of Compounds 
All chemicals and solvents were purchased from commercial sources and were 
used as such, unless otherwise mentioned. 1H NMR spectra were recorded on a 400 
MHz Bruker NMR spectrometer using the residual proton resonance of the solvent as 
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the internal standard. Chemical shifts are reported in parts per million (ppm). When 
peak multiplicities are given, the following abbreviations are used: s, singlet; bs, broad 
singlet; d, doublet; t, triplet; m, multiplet. 13C NMR spectra were proton decoupled and 
recorded on a 100 MHz Bruker spectrometer using the carbon signal of the deuterated 
solvent as the internal standard. Fluorescence spectra were recorded using a JASCO FP-
6500 spectrofluorimeter. FAB-MS spectra were measured on a JEOL JMS700. MALDI-
TOF spectra were measured on a Bruker OmnifleX. IR spectra were measured on a 
Bruker Alpha-P FT-IR. 
3.5.1.1 General Procedure for the Synthesis of Dendritic Compounds 
To a solution of the biaryl monomer AB2 (1.0 equiv.) and the appropriate 
bromobenzyl compound (1.0-3.0 equiv.) in anhydrous acetone, was added K2CO3 (3 
equiv.) and 18-crown-6 (0.1 equiv.). The reaction mixture was refluxed under argon 
atmosphere for 12-24 h (12 h for G1 and 24 h for G2). The progress of the reaction was 
monitored by TLC. After completion of the reaction, acetone was evaporated and the 
crude reaction mixture was partitioned between ethyl acetate and water. The aqueous 
layer was extracted three times with ethyl acetate and the combined organic layer was 
dried over Na2SO4. Afterwards, the solution was filtered and evaporated to dryness. The 
crude product was purified by silica gel column chromatography, CombiFlash. 
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3.5.1.2 General Procedures for Incorporation of Biotin-azide to the Dendron using 
“Click” Chemistry 
Procedure A: To a solution of dendritic acetylene compound (1.0 equiv.), and 
biotin-azide 18 (2 equiv.) in THF, was added the same volume of aqueous CuSO4.5H2O 
(0.2 equiv.) and sodium ascorbate (0.2 equiv.) in such a way that the final solution 
THF/H2O was in a ratio 1:1. The reaction was heated at 50 
oC for 24 h to 60 h, depending 
on dendron generation. After completion of the reaction, NH4Cl solution was added to 
the reaction mass and then, extracted with ethyl acetate three times. The organic layers 
were collected and dried over anhydrous Na2SO4, filtered, concentrated, and the 
product purified by silica gel column chromatography, CombiFlash. 
Procedure B: A mixture of the dendritic acetylene compound (1.0 equiv.), biotin 
azide 18 (3.0 equiv.), CuSO4.5H2O (1.0 equiv.) and sodium ascorbate (1.0 equiv.) in 
DMSO solvent was heated at 50 oC for 24-32 h (24h for G1 and 32h for G2). The progress 
of the reaction was monitored by TLC. After completion of the reaction, the reaction 
mixture was portioned between dichloromethane and saturated aqueous NH4Cl 
solution. The aqueous layer was extracted twice with dichloromethane and the 
combined organic layer was dried over anhydrous Na2SO4 and evaporated to dryness. 
The crude product was isolated by silica gel column chromatography, CombiFlash. 
3.5.1.3 Synthesis of compound 3 (DA-1-7) 
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To a solution of 3,5-dihydroxybromobenzene (23 g, 121.6 mmol) in anhydrous 
THF (500 mL) in an ice bath was added Hunig’s base (74.2 mL, 425.8 mmol); the mixture 
was stirred at room temperature and under argon atmosphere for 15 min. At ice-bath 
temperature, methoxymethyl chloride (MOM-Cl) (32.3 mL, 425.8 mmol) was added 
slowly. The reaction mixture was allowed to stir overnight at room temperature. Then, it 
was poured into water to quench the remaining chloride and then, most of the THF was 
evaporated. The remaining aqueous solution was extracted three times with ethyl 
acetate. The combined organic layers were evaporated and subjected to silica gel 
column chromatography to yield 33 g (98%) of compound 3. For the characterization 
details of this compound please see reference 37. 
3.5.1.4 Synthesis of compound 4 (DA-1-19) 
 
The ethyl ester of 3,5-dihydroxy-5-bromobenzoic acid (30 g, 114.9 mmol) was 
mixed with 1-bromodecane (24.0 mL, 114 mmol), K2CO3 (47.6 g, 344.7 mmol) and 18-
crown-6 (3.0 g, 11.5 mmol) in anhydrous acetone (500 mL) in Ar environment and 
refluxed overnight. Upon evaporation of the solvent, the mixture was dissolved in water 
and extracted three times with ethyl acetate. The combined extracts were dried over 
anhydrous Na2SO4. The crude product obtained upon evaporation of solvent was 
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purified by silica gel column chromatography to yield 15.2 g (33%) of compound 4. For 
the characterization details of this compound please see reference 73.73 
3.5.1.5 Synthesis of compound 5 (DA-1-30) 
 
To a solution of compound 3 (10 g, 36.1 mmol) in anhydrous THF (100 mL) was 
added n-BuLi (43.3 mL of a 2.5 M in hexane solution, 108.3 mmol) under argon 
atmosphere at -78 oC and stirred for 30 min. At the same temperature, SnBu3Cl (29.4 
mL, 108.3 mmol) was added and stirred from -78 to 25 oC, and then for 12 h. The 
reaction mixture was quenched with saturated aqueous NH4Cl solution, the acetone was 
evaporated, and the remaining aqueous solution extracted three times with ethyl 
acetate. The organic layers were collected on anhydrous Na2SO4. The solvent was 
evaporated to afford the crude reaction mixture, which was purified by silica gel column 
chromatography to yield 14 g (75%) of product 5 as viscous oil. For the characterization 
details of this compound please see reference 37. 
3.5.1.6 Synthesis of compound 6 (DA-1-24) 
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To a solution of mono-alkylated 4 (12 g, 30.0 mmol) in anhydrous 
dichloromethane (150 mL) was added triethylamine (12.0 mL 90.0 mmol) and cooled to 
0 oC. Then, acetylchloride (6.4 mL, 90.0 mmol) was added dropwise and stirred at room 
temperature for 12 h. The reaction mixture was quenched with water and extracted 
three times with dichloromethane. The organic layers were collected on anhydrous 
Na2SO4. The solvent was evaporated to afford the crude reaction mixture, which was 
purified by silica gel column chromatography to afford 12.5 g (91%) of product 6 as 
viscous oil. For the characterization details of this compound please see reference 37. 
3.5.1.7 Synthesis of compound 7 (DA-1-46) 
 
The aryl stannane 5 (7 g, 14.3 mmol) and the bromo-ester 6 (6.35 g, 14.3 mmol) 
were dissolved in deoxygenated DMF (20 mL) under argon atmosphere. To this solution, 
2.5 mol% of Pd(PPh3)2Cl2 (0.25 g, 0.35 mmol) was added and the reaction mixture 
heated at 120-130 oC for 24 h. After cooling the reaction mixture to room temperature, 
the mixture was passed through a celite pad and washed with ethyl acetate. Finally the 
filtrate was washed with water and the organic layer was evaporated to dryness. The 
crude product was purified by silica gel chromatography to afford 4.4 g of biaryl coupled 
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compound (55% yield). For the characterization details of this compound please see 
reference 37. 
Then, to a solution of the previous biaryl coupled compound (5 g, 8.9 mmol) in 
anhydrous THF (25 mL), was added LiAlH4 (0.85 g, 22.3 mmol) in portions at 0 
oC under 
argon atmosphere, stirring at room temperature for 12 h. The reaction mixture was 
quenched with ethyl acetate and then acidified using dilute HCl (1 N) solution. The 
resultant mixture was extracted three times with ethyl acetate and the combined 
organic extracts were dried over anhydrous Na2SO4. Upon evaporation of solvent, the 
crude was purified by silica gel chromatography to afford 3.3 g of compound 7 (85% 
yield). For the characterization details of this compound please see reference 37. 
3.5.1.8 Synthesis of compound 9 (DA-1-10) 
 
The mixture of 3,5-dihydroxybenzyl alcohol (10 g, 71.4 mmol), 1-bromodecane 
(13.4 mL, 64.2 mmol), K2CO3 (19.6 g, 142.8 mmol), sodium iodide (10.6 g, 71.4 mmol) 
and 18-crown-6 (1.8 g, 7.14 mmol) in anhydrous acetone (50 mL) was refluxed for 12 h. 
Upon evaporation of the solvent, the mixture was dissolved in water and extracted 
three times with ethyl acetate. The combined extracts were dried over anhydrous 
Na2SO4. The crude product obtained upon evaporation of solvent was purified by silica 
gel column chromatography to yield 8.2 g (41%) of compound 9. For the 
characterization details of this compound please see reference 73. 
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3.5.1.9 Synthesis of compound 10 (DA-1-16) 
 
The mixture of compound 9 (2.8 g, 9.9 mmol), propargyl bromide (3.32 g mL 
from a 80% sln. in toluene, 29.8 mmol), K2CO3 (4.1 g, 29.8 mmol), and 18-crown-6 (0.26 
g, 1.0 mmol) in anhydrous acetone (20 mL) was refluxed for 12 h. Upon evaporation of 
the solvent, the mixture was dissolved in water and extracted three times with ethyl 
acetate. The combined extracts were dried over anhydrous Na2SO4. The crude product 
obtained upon evaporation of solvent was purified by silica gel column chromatography 
to yield 3.0 g (95%) of compound 10. For the characterization details of this compound 
please see reference 37. 
3.5.1.10 Synthesis of compound 11 (DA-1-12) 
 
The mixture of compound 9 (5.1 g, 18.3 mmol), PEG-Ts (6.7 g, 16.5 mmol), K2CO3 
(6.8 g, 49.4 mmol), and 18-crown-6 (0.4 g, 1.6 mmol) in anhydrous acetone (20 mL) was 
refluxed for 12 h. Upon evaporation of the solvent, the mixture was dissolved in water 
and extracted three times with ethyl acetate. The combined extracts were dried over 
anhydrous Na2SO4. The crude product obtained upon evaporation of solvent was 
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purified by silica gel column chromatography to yield 6.8 g (80%) of compound 11. For 
the characterization details of this compound please see reference 73. 
3.5.1.11 Synthesis of compound 12 (DA-1-104) 
 
To a stirring solution of 10 (1.8 g, 5.65 mmol) in dichloromethane (20 mL) was 
added PBr3 (1 mL, 11.31 mmol) under argon atmosphere at room temperature. The 
reaction was monitored using TLC. After complete disappearance of the starting 
material the remaining PBr3 was quenched by slow addition of a saturated NaHCO3 
solution. The resulting mixture was extracted with dichloromethane (3x50 mL). The 
combined organic layer was dried over anhydrous Na2SO4 and concentrated using 
vacuum. The crude compound was purified on silicagel column chromatography 
CombiFlash (1:4 Ethyl acetate, Hexanes) to afford 12 (1.65 g, 76%). 1H NMR (CDCl3-
400MHz)  6.57 (t, J = 1.9 Hz, 2H, a,b), 6.49 (t, J = 2.2 Hz, 1H, c), 4.67 (d, J = 2.3, 2H, d), 
4.41 (s, 2H, f), 3.92 (t, J = 6.5 Hz, 2H, e), 2.53 (t, J = 2.3 Hz, 1H, g), 1.79-1.72 (m, 2H, h), 
1.48-1.21 (m, 14 H, i), 0.87 (t, J = 6.8 Hz, 3H, j). 13C NMR (CDCl3-100MHz)  162.4, 160.5, 
158.8, 139.8, 108.6, 107.7, 101.9, 78.4, 75.9, 68.32, 56.0, 33.7, 32.0, 29.7, 29.5, 29.5, 
29.3, 26.1, 22.8, 14.3. 
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3.5.1.12 Synthesis of compound 13 (DA-1-35) 
 
To a stirring solution of 11 (6.4 g, 12.4 mmol) in dichloromethane (20 mL) was 
added PBr3 (16.1 mL from a 1M sln, 16.1 mmol) under argon atmosphere at room 
temperature. The reaction was monitored using TLC. After complete disappearance of 
the starting material the remaining PBr3 was quenched by slow addition of a saturated 
NaHCO3 solution. The resulting mixture was extracted with dichloromethane (3x50 mL). 
The combined organic layer was dried over anhydrous Na2SO4 and concentrated using 
vacuum. The crude compound was purified on silicagel column chromatography 
CombiFlash (1:4 Ethyl acetate, Hexanes) to afford 32 (5.0 g, 70%). For the 
characterization details of this compound please see reference 73. 
3.5.1.13 Synthesis of compound 15 (DA-1-111) 
 
To a solution of 2-(2-amino-ethoxy)-ethanol (10.0 mL, 100.0 mmol) in 
dichloromethane (50 mL) and an Ar atmosphere was added di-tert-butyl dicarbonate 
(32.8 g, 151.0 mmol) at ice bath temperature and stirred overnight. Water was added to 
the reaction mixture and extracted three times with dichloromethane. The combined 
organic extracts were dried over anhydrous Na2SO4. Afterwards, the solvent was 
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evaporated to dryness. The crude product 15 was taken for the next step without 
further purification. 
3.5.1.14 Synthesis of compound 16 (DA-1-112) 
 
To the solution of crude compound 15 (31.6 g, 100 mmol) in anhydrous toluene 
(100 mL) was added triethyl amine (13.3 mL, 100.0 mmol) and cooled to ice bath 
temperature. Then, methane sulfonyl chloride (7.7 mL, 100.0 mmol) was added 
dropwise at the same temperature. After 20 minutes stirring at room temperature (RT), 
tetrabutylammonium iodide (37 g, 100.2 mmol). An aqueous solution of sodium azide 
(40 g, 615.4 mmol) was added. Then, the reaction mass was heated at 70 oC for 6h. After 
cooling the reaction mixture to RT, water was added and extracted twice with ethyl 
acetate and then dried over anhydrous Na2SO4. After the evaporation of solvent, the 
crude product was purified by silica gel column chromatography to yield 18.0 g (78%) of 
compound 16. For the characterization details of this compound please see reference 
37. 
3.5.1.15 Synthesis of compound 17 (DA-1-128) 
 
To a solution of compound 16 (2 g, 8.2 mmol) in dichloromethane (40 mL) was 
added trifluoroacetic acid (0.80 mL, 10.4 mmol) at 0 oC. After stirring at RT for 8 hours, 
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the solvent was evaporated and dried under vacuum to obtain the Boc-deprotected 
compound 17 that was used as such for the next step. 
3.5.1.16 Synthesis of compound 18 (DA-1-129) 
 
Biotin (1.0 g, 4.1 mmol) was dissolved in DMF (25 mL) and heated to 50-60 oC for 
45 minutes, and then allowed to cool to RT. To this solution was added 
carbonyldiimidazole (0.97 g, 6.0 mmol) previously dissolved in DMF (10 mL) and stirred 
at RT for 3 h. Then, the previous solution was added to a solution of compound 17 (1.1 
g, 8.7 mmol) previously dissolved in DMF (5 mL) and stirred overnight at in Ar 
atmosphere. The solvent was removed under vacuum. The remaining solid was washed 
with water and then, with cold acetone under negative pressure in a fritted funnel. After 
a long drying the product was recover in 0.7 g (46%) of the product 18 as a white solid. 
For the characterization details of this compound please see reference 37. 
3.5.1.17 Synthesis of compound 19 (DA-1-66) 
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To the propargylated product of the biaryl compound 7 (0.7 g, 1.3 mmol) 
dissolved in a mixture of methanol (20 mL), 1,4-dioxane (2 mL), and water (1 mL), 1.4 g 
of Dowex resin was added stirring under Ar atmosphere. The reaction mass was refluxed 
for 4 h. Then, it was filtered and the remaining solid was dissolved in water and 
extracted with ethyl acetate. The organic fractions were dried over Na2SO4. The solvent 
was evaporated and the product purified by silica gel chromatography getting 0.3 g of 
product 19 (58%). For the characterization details of this compound please see 
reference [1]. 
Compound 20 was obtained in exactly the same way as compound 19. The 
characterization details of this compound are in reference 37. 
3.5.1.18 Synthesis of compound 21 (DA-1-107) 
 
A mixture of compound 20 (0.25 g, 0.04 mmol), compound 12 (0.14 g, 0.04 
mmol), K2CO3 (0.08 g, 0.06 mmol) and 18-crown-6 (0.01 g, 0.004 mmol) in acetone (15 
mL) was refluxed for 12 h. Upon evaporation of the solvent, the mixture was dissolved 
in water and extracted three times with ethyl acetate. The combined extracts were 
dried over anhydrous Na2SO4. The crude product obtained upon evaporation of solvent 
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was purified by silica gel column chromatography to afford of compound 21 (0.079 g, 
25%). 1H NMR (Acetone d6-400MHz)  6.78-6.69 (m, 4 H, a,b), 6.51-6.50 (m, 3 H, c,d,e), 
6.40 (d, J = 2.36, 1H, f), 5.01 (s, 2H, g), 4.78 (d, J = 2.40 Hz, 2 H, h), 4.63 (m, 2 H, i), 4.04 
(t, J = 4.68 Hz, 2 H, j), 3.99 (t, J = 6.48 Hz, 2H, k), 3.91 (t, J = 6.28 Hz, 2 H, m), 3.65 (t, J = 
4.56 Hz, 2 H, n) 5.53-3.52 (m, 11 H, o), 3.44-3.42 (m, 2H, p), 3.26 (s, 3H, q), 3.05 (t, J = 
2.36, 1H, r), 2.84 (d, J = 12.8, 3H, u), 1.80-1.73 (m, 2H, v), 1.64-1.57 (m, 2H, w), 1.51-1.45 
(m, 2H, x), 1.42-1.19 (m, 26H, y), 0.92-0.83 (m, 6H, z); 13C NMR (Acetone d6-100MHz)  
161.4, 159.9, 159.9, 158.2, 158.1, 157.9, 157.8, 144.3, 141.2, 137.3, 119.6, 112.4, 112.3, 
109.9, 107.2, 106.8, 104.8, 104.6, 101.4, 79.7, 77.0, 72.6, 71.4, 71.4, 71.1, 71.1, 71.0, 
70.2, 70.1, 69.5, 69.2, 68.6, 64.8, 64.7, 58.7, 56.3, 32.6, 32.6, 30.3, 30.3, 30.3, 30.1, 30.1, 
26.8, 23.3, 23.3, 14.4, 14.3. 
3.5.1.19 Synthesis of compound 22 (DA-1-127) 
 
According to the general procedure for synthesis of dendritic compounds, the 
biaryl mono-G1-propargyl monomer 21 (0.13 g, 0.116 mmol) was reacted with the 
bromomethyl compound 13 (0.06 g, 0.127 mmol) to give compound 22 (0.12 g, 72%). 1H 
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NMR (Methanol d4-400MHz)  6.69-6.67 (m, 2H, a), 6.65-6.51 (m, 7H, b), 6.46 (t, J = 2.2 
Hz, 1H, f), 6.42 (t, J = 2.2 Hz, 1 H, f’), 4.99-4.97 (m, 4 H, g, g’), 4.69 (d, J = 2.36 Hz, 2 H, h), 
4.60 (s, 2H, i), 4.10-4.08 (m, 2H, j), 4.02-4.0 (m, 2H, j’), 3.94-3.79 (m, 10H, w, w’), 3.61-
3.39 (m, 38H, q), 2.91 (t, J = 2.40 Hz, 1H, r), 1.78-1.70 (m, 4H, v, v’), 1.59-1.12 (m, 44H, 
y), 0.92-0.82 (m, 9H, z); 13C NMR (Acetone d6-100MHz)  168.5, 167.4, 165.3, 159.4, 
159.1, 156.6, 154.8, 150.7, 144.2, 140.8, 136.1, 133.6, 125.5, 124.4, 110.9, 110.4, 107.3, 
106.3, 102.5, 100.5, 83.4, 83.0, 78.7, 77.1, 74.1, 71.6, 70.3, 70.2, 69.9, 67.7, 65.8, 58.0, 
55.5, 34.7, 31.7, 31.5, 30.1, 25.9, 23.0, 22.4, 20.8, 13.4, 12.3. MALDI-ToF m/z expected 
for C82H130O19: 1420.9; found 1442.6 for C82H130O19+Na
+. 
3.5.1.20 Synthesis of dendron G1-P (DA-1-164) 
 
According to the general procedure for click chemistry, the compound 22 (0.04 g, 
0.0028 mmol) was reacted with biotin azide 18 (0.02 g, 0.0056) to give G1-P dendron 
(0.03 g, 70%). 1H NMR (Methanol d4-400MHz) ; 8.22 (s, 1H, c), 6.81-6.72 (m, 3H, b), 6.70-
6.63 (m, 5H, a), 6.62-6.53 (m, 2H, d) 6.47-6.43 (m, 1H, e), 5.25-5.15 (m, 2H, g) 5.10-4.95 
(m, 4H, f, f’), 4.64 (s, 2H, i), 4.57 (t, J = 4.8 Hz, 2H, r), 4.52-4.40 (m, 1H, p), 4.29-4.22 (m, 
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1H, q), 4.13-4.11 (m, 3H, x), 4.04-4.03 (m, 2H, j’), 4.0-3.96 (4H, j), 3.93-3.87 (m, 3H, v’), 
3.86-3.82 (m, 2H, w’), 3.81-3.78 (m, 3H, w), 3.69-3.41 (m, 41H, t), 3.35-3.29 (m, 2H), 
3.27-3.26 (m, 6H), 3.13-3.08 (m, 1H), 2.98-2.82 (m, 2H), 2.72-2.62 (d, J = 12.4 Hz, 1H, m), 
2.17-2.14 (t, J = 7.2 Hz, 2H, k), 1.82-1.71 (m, 4H, v, v’), 1.67-1.52 (m, 6H, h), 1.51-1.18 (m, 
44H, y), 0.2-0.82 (m, 9H, z); 13C NMR (CDCl3-100MHz)  160.4, 160.0, 158.9, 157.4, 
157.2, 157.0, 142.0, 139.4, 135.9, 119.3, 112.1, 111.0, 106.1, 105.6, 104.4, 104.2, 102.1, 
100.8, 94.6, 77.2, 71.9, 70.8, 70.6, 70.5, 69.9, 69.7, 69.6, 68.8, 68.0, 67.4, 65.4, 59.0, 
55.9, 31.9, 30.9, 29.5, 29.4, 29.3, 29.1, 26.0, 25.9, 22.6, 14.1. MALDI-ToF m/z expected 
for C96H154N6O22S: 1777.34; found 1799.15 for C96H154N6O22S + Na
+, 1777.14 for 
C96H154N6O22S + H
+. 
3.5.1.21 Synthesis of compound 23 (DA-1-187) 
 
According to the general procedure for synthesis of dendritic compounds, the 
biaryl monomer 19 (0.088 g, 0.2 mmol) was reacted with the bromomethyl compound 
13 (0.30 g, 0.52 mmol) to give 0.20 g (yield: 70%) of compound 23. The characterization 
details of this compound are in reference 37. 
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3.5.1.22 Synthesis of dendron G1-F (DA-1-91) 
 
According to the general procedure for click chemistry, the compound 23 (0.07 g, 
0.05 mmol) was reacted with biotin azide 18 (0.02 g, 0.006 mmol) to give 0.04 g (83%) of 
G1-F dendron. The characterization details of this compound are in reference 37. 
3.5.1.23 Synthesis of compound 24 (DA-2-78) 
 
To a stirring solution of 22 (0.324 g, 0.228 mmol) in dichloromethane (10 mL) 
was added PBr3 (0.22 mL, 2.28 mmol) under argon atmosphere at room temperature. 
The reaction was monitored using TLC. After complete disappearance of the starting 
material, the remaining PBr3 was quenched by slow addition of saturated NaHCO3 
solution. The resulting mixture was extracted with dichloromethane (3x50 mL). The 
combined organic layer was dried over anhydrous Na2SO4 and concentrated using 
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vacuum. The crude compound was purified by column chromatography, CombiFlash 
(1:4 Ethyl acetate, Hexanes) to afford 24 (0.076 g, 22%). 1H NMR (Methanol d4-400MHz) 
 6.73-6.41 (m, 11 H, a), 4.95 (s, 4H, b), 4.67 (d, J = 2.4 Hz, 2H, c), 4.54 (s, 2H, d), 4.12-
4.06 (m, 2H, e), 4.05-3.97 (m, 2H, f), 3.96-3.40 (m, 32H, g), 2.91 (t, J = 2.3 Hz, 1H, h), 
1.81-1.70 (m, 4H, i), 1.62-1.11 (m, 42H, j), 0.95-0.82 (m, 9H, k); 13C NMR (Methanol d4-
100MHz)  160.4, 160.1, 158.9, 157.5, 157.0, 156.7, 139.8, 130.0, 106.0,105.6, 100.6, 
100.4, 75.5, 71.5, 70.4, 70.3, 70.2, 70.1, 70.0, 69.9, 69.4, 69.2, 67.7, 67.2, 57.7, 55.3, 
38.9, 31.7, 29.4, 29.3, 29.3, 29.1, 29.1, 25.9, 25.8, 22.4, 22.3, 18.7, 13.1, 13.1. MALDI-ToF 
m/z expected 1483.79 for C82H129BrO18; found 1483.51 for C82H129BrO18 + H
+. 
3.5.1.24 Synthesis of compound 25 (DA-2-2) 
 
To a stirring solution of a G1 23 (0.53 g, 0.373 mmol) in dichloromethane (20 mL) 
was added PBr3 (0.3 g, 1.12 mmol) under argon at room temperature. The reaction was 
monitored using TLC. After complete disappearance of the starting material the 
remaining PBr3 was quenched by slow addition of saturated NaHCO3 solution. The 
resulting mixture was extracted with dichloromethane (3x50 mL). The combined organic 
layer was dried over anhydrous Na2SO4, filtered and concentrated using vacuum. The 
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crude compound was purified by column chromatography using CombiFlash (1:4 Ethyl 
acetate, Hexanes) to afford 25 (0.432 g, 78%). 1H NMR (Methanol d4 – 400 MHz);  6.89 
(s, 1H, a), 6.76 (s, 1H, b), 6.58-6.53 (m, 7H, c), 6.42-6.40 (m, 2H, d), 4.96 (s, 4H, e), 4.57-
4.55 (m, 4H, f, g), 4.47 (s, 1H, i), 4.08-4.06 (m, 4H, h), 3.94-3.78 (m, 11 H, i, j), 3.74-3.54 
(m, 31 H, k), 3.53-3.46 (m, 5H, m), 2.91 (t, J = 2.3 Hz, 1H, n), 1.80-1.69 (m, 5H, p), 1.61-
1.16 (m, 53H, q), 0.95-0.84 (m, 9H, z). MALDI-ToF m/z expected 1483.79 for 
C82H129BrO18; found 1483.51 for C82H129BrO18 + H
+. 
Compound 26 was synthesized in the same fashion. 
3.5.1.25 Synthesis of compound 27 
 
According to the general procedure for synthesis of dendritic compounds, the 
biaryl monomer 20 (0.072 g, 0.115 mmol) was reacted with the bromomethyl dendritic 
compound 26 (0.192 g, 0.115 mmol) to give the mono alkylated product 27 (0.061 g, 
19%).1H NMR (CDCl3 – 400 MHz);  6.79-6.62 (m, 6H, a), 6.60-6.51 (m, 9H, b), 6.44-6.42 
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(m, 2H, c), 5.02 (s, 2H, d), 4.92 (s, 4H, e), 4.69 (s, 2H, f), 4.14-4.06 (m, 8H, g), 3.94-3.87 
(m, 12H, k, n), 3.78-3.44 (m, 70H, p), 3.35 (s, 6H, h), 3.33 (s, 3H, i), 3.31 (s, 3H, j), 1.79-
1.72 (m, 8H q), 1.69-1.58 (m, 4H, r), 1.46-1.38 (m, 4H, r), 1.37-1.15 (m, 48H, r), 0.91-0.79 
(m, 12H, w); 13C NMR (CDCl3-100MHz)  160.5, 160.1, 159.3, 159.1, 157.3, 157.2, 157.0, 
141.9, 139.5, 138.4, 135.6, 119.8, 119.2, 110.3, 109.3, 106.3, 105.8, 105.2, 104.4, 103.6, 
100.9, 72.0, 70.9, 70.7, 70.7, 70.6, 70.5, 69.8, 68.9, 68.2, 67.5, 65.9, 65.6, 59.1, 32.0, 
31.7, 29.7, 29.7, 29.5, 29.4, 29.3, 26.2, 26.1, 22.8, 15.4, 14.2. MALDI-ToF m/z expected 
for C124H202O33: 2221.91; found 2259.66 for C124H202O33 + K
+, 2243.69 for C124H202O33: + 
Na+, 2221.73 for C124H202O33 + H
+. 
3.5.1.26 Synthesis of compound 28 (DA-2-12) 
 
According to the general procedure for the synthesis of dendritic compounds, 
the dendron-mono-alkylated scaffold 27 (0.07 g, 0.031 mmol) was reacted with the 
bromo-dendron compound 25 (0.087, 0.059 mmol) to give compound 28 (0.091 g, 80%). 
1H NMR (Acetone d6 – 400 MHz);  6.92-6.86 (m, 2H, a), 6.78-6.59 (m, 21 H, a), 6.47-6.43 
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(m, 4H, a), 5.17-5.10 (m, 4H, b), 5.07-5.01 (m, 8H, c), 4.69 (d, J = 2.2 Hz, 2H, e), 4.67-4.63 
(m, 2H, f), 4.22-4.20 (m, 1 H), 4.15-4.04 (m, 13H, g), 4.02-3.91 (m, 14H, h), 3.84-3.77 (m, 
9H, i), 3.71-3.40 (m, 97H, g, i), 3.29-3.23 (m, 18H, j), 2.96(t, J = 2.2 Hz, 1H, k), 1.82-1.71 
(m, 8H, h), 1.65-1.57 (m, 6H, h), 1.52-1.42 (10H, h), 1.42-1.17 (m, 88H, h), 0.92-0.82 (m, 
21H, z); 13C NMR (Acetone d6-100MHz)  161.4, 161.2, 160.0, 159.9, 157.9, 157.7, 154.6, 
140.9, 140.8, 139.6, 119.3, 111.5, 111.3, 111.2, 106.8, 106.5, 105.8, 104.7, 101.4, 101.1, 
80.0, 77.1, 72.6, 71.4, 71.3, 71.2, 71.2, 71.0, 70.3, 70.1, 69.4, 69.3, 69.2,68.6, 68.4, 58.8, 
56.9, 32.7, 32.6, 26.9, 26.8, 23.3, 23.3, 14.4, 14.3. MALDI-ToF m/z expected for 
C206H330O51: 3623.79; found 3645.49 for C206H330O51 + Na
+. 
3.5.1.27 Synthesis of compound 29 
 
According to the general procedure for synthesis of dendritic compounds, the 
dendron-mono-alkylated scaffold 27 (0.103 g, 0.046 mmol) was reacted with the bromo-
dendron compound 24 (0.076 g, 0.051 mmol) to give compound 29 (0.12 g, 71%). 1H 
NMR (CDCl3 – 400 MHz);  6.73-6.41 (m, 27H, a), 5.11-4.9 (m, 12 H, b, f), 4.73-4.65 (m, 
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4H, c), 4.16-4.02 (m, 10H, d, e), 3.97-3.81 (m, 20H, g, h), 3.77-3.44 (m, 104H, g), 3.38-
3.32 (m, 18H, i), 2.52 (t, J = 2.2 Hz, 1H, k), 1.85-1.11 (m, 112H, g), 0.93-0.81 (m, 21H, j); 
13C NMR (CDCl3-100MHz)  160.5, 160.1, 159.2, 159.2, 159.1, 158.9, 157.4, 157.3, 157.1, 
157.1, 139.7, 139.4, 138.0, 136.3, 136.1, 119.9, 119.6, 110.3, 106.9, 106.3, 105.8, 105.3, 
105.2, 104.9, 104.9, 104.5, 101.2, 100.9, 72.0, 72.0, 70.9, 70.7, 70.7, 70.7, 70.6, 70.6, 
70.5, 70.5, 69.8, 68.9, 68.2, 67.5, 65.4, 59.1, 59.1, 56.0, 32.0, 29.8, 29.7, 29.7, 29.5, 29.4, 
29.4, 29.2, 26.2, 26.1, 22.8, 14.2. 
3.5.1.28 Synthesis of dendron G2-M (DA-2-90) 
 
According to general procedure for click chemistry, compound 28 (0.017 g, 0.005 
mmol) was treated with biotin-azide 18 (0.005 g, 0.014 mmol) to give G2-M dendron 
(0.0074 g, 40%). 1H NMR (Methanol d4 – 400 MHz);  7.71 (s, 1H, z), 6.82-6.41 (m, 27H, 
a), 5.65-5.58 (m, 4H, b, c), 4.68-4.51 (m, 4H, x, y, d), 4.40-4.32 (m, 5H, k), 4.31-4.23 (m, 
5H, f), 4.18-3.97 (m, 9H, e), 3.89-3.72 (m, 15H, n, r), 3.69-3.63 (m, 12 H, k), 3.62-3.56 (m, 
48 H, g, k, m, u, ), 3.55-3.48 (m, 35H, g, m, v), 3.32-3.25 (m, 3H, n, w), 2.86-2.72 (m, 4H,), 
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2.41-2.30 (m, 8H, q), 2.12-1.95 (m, 16H, i, m), 1.85-1.62 (m, 33H, i, r), 1.60-1.48 (m, 17H, 
i, h), 1.45-1.20 (m, 80H, i, p), 1.01-0.85 (m, 21H, j). 13C NMR (Acetone d6-100 MHz)  
160.6, 160.3, 159.1, 157.2, 157.1, 157.0, 156.5, 144.0, 143.5, 140.0, 138.7, 136.5, 136.3, 
119.4, 110.5, 106.0, 105.7, 105.1, 104.5, 104.0, 100.8, 100.7, 100.3, 70.3, 70.3, 70.2, 
70.0, 69.6, 69.5, 69.3, 68.8, 68.7, 68.5, 68.4, 67.7, 67.5, 57.9, 35.2, 31.8, 31.8, 29.6, 29.4, 
29.2, 29.2, 28.7, 28.5, 28.4, 26.1, 26.0, 25.4, 22.5, 22.5, 13.6, 13.6, 13.5. MALDI-ToF m/z 
expected for C220H354N6O54S: 3980.24; found 4023.08 for C220H354N6O54S + 2Na
+. 
3.5.1.29 Synthesis of dendron G2-P (DA-2-89) 
 
According to the general procedure for click chemistry, compound 29 (0.022 g, 
0.006 mmol) was treated with biotin-azide 18 (0.006 g, 0.018 mmol) to give (0.013 g, 
17%) G2-P dendron. 1H NMR (CDCl3 – 400 MHz);  7.78 (s, 1H, z), 6.82-6.40 (m, 27H, a), 
6.24-6.22 (m, 1H, x), 5.57-5.56 (m, 1H, y), 5.32-5.17 (m, 2H, w), 5.11-4.89 (m, 12H, c), 
4.75-4.66 (m, 2H, d), 4.60-4.37 (m, 4H, u, v), 4.36-4.21 (m, 2H, t), 4.19-3.32 (m, 155H, e, 
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f, i), 3.26-3.02 (m, 4H, r, s, q), 2.89-2.51 (m, 4H, r, q, k), 2.25-2.15 (m, 2H, h, k), 2.10-1.95 
(m, 2H, g), 1.87-1.57 (m, 26H, j, l), 1.55-1.11 (m, 88H, i), 0.95-0.77 (m, 21H, ). 13C NMR 
(Acetone d6-100 MHz)  160.9, 160.6, 159.8, 157.9, 157.6, 157.7, 156.5, 144.0, 143.5, 
140.2, 138.8, 136.5, 136.3, 119.5, 110.6, 106.2, 105.9, 105.3, 104.7, 104.3, 100.9, 100.8, 
100.4, 70.3, 70.2, 70.0, 69.6, 69.5, 69.3, 68.8, 68.7, 68.5, 68.4, 67.7, 67.5, 57.9, 35.3, 
31.9, 31.8, 29.7, 29.5, 29.3, 29.2, 28.7, 28.5, 28.4, 26.1, 26.0, 25.4, 22.6, 22.5, 13.7, 13.6. 
MALDI-ToF m/z expected for C220H354N6O54S: 3980.24; found 4025.46 for C220H354N6O54S 
+ 2Na+. 
3.5.1.30 Synthesis of compound 30 
 
According to the general procedure for synthesis of dendritic compounds, the 
monomer 19 (0.03 g, 0.07 mmol) was reacted with the bromo-dendron compound 26 
(0.30 g, 0.18 mmol) to give compound 30 (0.20 g, 70%). The characterization details of 
this compound are in reference 37. 
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3.5.1.31 Synthesis of dendron G2-F 
 
According to the general procedure for click chemistry, compound 30 (0.050 g, 
0.014 mmol) was treated with biotin-azide 18 (0.007 g, 0.020 mmol) to give (0.025 g, 
46%) G2-F dendron. The characterization details of this compound are in reference 37. 
3.5.2 Encapsulation, Disassembly, and Release Protocols 
3.5.2.1 Encapsulation of Nile red 
To encapsulate nile red in a dendron aggregate 2 mL 50 µM solutions of each 
dendron were prepared and stirred at 5 oC for 12 hours. Small amounts of Nile red were 
mixed with the dendron solutions and these heterogeneous mixtures sonicated for 4 
hours. The solutions were stirred at room temperature until temperature equilibration 
and then stirred at 5 oC for 16 hours. Then, the samples were diluted to 25 μM and 
stirred at 5 oC for 12 hours more. After that, each sample was filtered through a syringe 
filter (0.22 μm). The 25 μM dendron solutions were thus ready for CAC measurement 
and dye release. 
 141 
3.5.2.2 Determination of CACs 
The CACs of the dendrons in aqueous solutions were determined using the 
fluorescence intensity of nile red (λem= 615 nm), as shown in Figure 3.4. 1 mL of 25 μM 
dendron solution as prepared above was transferred to a cuvette where its 
concentration was varied by replacing a measured volume of this solution with the same 
volume of water. An emission spectrum (λex= 550 nm) was recorded for each 
concentration of the dendron and a decreasing fluorescence intensity was obtained 
from each spectrum. When the concentration of the dendron was below the CAC the 
change in fluorescence intensity became smaller each time. The intensity values were 
plotted against the concentration of dendron to get a curve (ideally sigmoidal). From the 
curve, the point where the best fitted horizontal and vertical lines merge was taken as 
the CAC. 
3.5.2.3 Dye release upon exposure to an increasing concentration of protein 
500 µL solution of dendron 25 µM encapsulating Nile red was exposed to protein 
2 µM (extravidin, α-chymotrypsin, pepsin, myoglobin) by adding 2 µL of protein solution 
from a stock 500 µM. After mixing well, the emission spectrum of Nile red was recorded 
(λem= 615 nm, λex= 550 nm). Consecutive additions of 2 µL of protein 500 µM were made 
every two minutes, recording fluorescence after each time until completing 14 µM of 
protein in the 500 µL of dendron solution. Temperature was maintained at 25 oC. A 
control experiment to test stability of encapsulation over time was made by exposing 
the assemblies only to the buffer solution (HEPES 25 mM, pH 7.4) as shown in Figure 
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3.8c. A control experiment exposing 25 µM solutions of analog dendrimers G1 and G2, 
with PEG instead of ligand, to increasing concentration of extravidin was made to test 
the non-specificity of the assemblies lacking biotin towards the protein, as shown in 
Figure 3.8d. 
3.5.2.4 DLS Measurements to monitor disassembly 
The size of the dendrimeric assemblies and their change in size, when exposed to 
proteins, was measured by dynamic light scattering. For that, 12 µM solutions of the 
dendrons were prepared in water. Initial size of the assemblies was measured in 1 mL 
solution. Then, the assemblies were exposed to 2 µM protein and after mixing well, DLS 
was measured. The results for disassembly in presence of extravidin, interactions with 
α-chymotrypsin, pepsin, myoglobin, and control dendrons (PEG instead of ligand) are 
shown in Figure 3.5 and Figure 3.7. The proteins’ sizes are shown in Figure 3.6. All 
measurements were made in a Malvern Zeta-sizer. 
3.5.2.5 Dye release upon a single exposure to 14 µM of protein 
500 µL of dendron solution encapsulating Nile red was exposed to protein 14 µM 
(extravidin, α-chymotrypsin, pepsin, myoglobin) by adding 14 µL of protein solution 
from a stock 500 µM. After mixing well, the emission spectrum of Nile red was recorded 
(λem= 615 nm, λex= 550 nm) every 15 minutes during the first hour, and then every hour 
during six hours. Release profiles over time for α-chymotrypsin, pepsin, and myoglobin 
are shown in Figure 3.15. Temperature was maintained at 25 oC. 
 143 
 
3.5.2.6 Encapsulation stability test based on crosslink density: 
Three different solutions of nanogels with 0%, 20%, and 50% crosslink densities 
encapsulating Nile red were prepared in a concentration of 1 mg/mL. The initial 
fluorescence was measured. Then, 1 mL of these solutions was exposed to 0.5 mg/mL 
myoglobin and the fluorescence recorded for 50 min. The concentration of myoglobin 
was increased to 1.0 mg/mL, 1.5 mg/mL, and 2.0 mg/mL measuring fluorescence for 
each change in myoglobin concentration for a few minutes. The final plots of time vs 
quenching percentage are shown in Figure S4a. When the nanogels were exposed to a 
high concentration of myoglobin, the change in quenching percentage was also high, 
Figure 3.10. 
3.5.2.7 Stern-Volmer Plots for G1-F and G2-F 
Two samples of dendron solution 25 µM in 500 µL encapsulating Nile red, at 
temperatures of 25 and 38 oC, were exposed to increasing concentrations of myoglobin. 
The value of the initial fluorescence of the dendrons (F0) divided by the fluorescence of 
Figure 3.15. Release profile of 25 µM dendron assemblies when exposed to 14 µM 
solution of a) α-chymotrypsin, b) pepsin, and c) myoglobin. 
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the same dendrons in presence of the myoglobin (F), in increasing concentration Vs the 
metalloprotein concentration was plotted in Figure 3.11. 
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CHAPTER 4 
 
SYNTHESIS OF A CROSSLINKABLE DENDRON FOR INTRACELLULAR TARGETING OF 
PROTEINS 
4.1 Introduction 
As discussed in Chapter 1, dendrimers possess high stability and the ability to 
form unimolecular micelles in aqueous solutions. On the other hand, as stated in 
Chapter 3, self-assembling dendrons can only form nanoassemblies in concentrations 
above their CAC, which inherently is a disadvantage if a self-assembling system is to be 
used as a drug delivery vehicle.1 
In the previous Chapter, we discussed the synthesis and structural advantages of 
dendrons, their characteristics, and their potential as scaffolds in drug delivery and 
sensing. As a matter of fact, we used biaryl amphiphilic self-assembling dendrons to 
study the stimulus-responsive disassembling properties of a supramolecular 
nanoassembly in the presence of a complementary protein, taking advantage of the CAC 
of the dendrons. The architecture of these dendrons was also used to discriminate the 
ligand location on the molecular structure that better led to a release of guest 
molecules upon protein binding.  
A molecular system that requires being above a CAC to form nanoassemblies 
with some degree of stability, inevitably involves equilibrium between the 
nanoassembly stage and the molecular stage, as shown in Figure 4.1. During such 
equilibrium, the non-covalently encapsulated guest molecules are prone to leak out of 
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the assembly and into the media. In a biological system, this leakage can result in the 
carrier unloading the drug before it reaches the target site. Then, the leaked cargo could 
diffuse into normal tissue causing unwanted side effects.2 Also, a dendritic self-
assembling system would have to overcome the dilution factor that implies translating 
from in vitro to in vivo conditions without going too close to or below its CAC. 
A solution to overcome this stability problem involves the incorporation of 
crosslinkers into the system, which can be adjusted to make the dendritic system 
responsive to environmental changes, such as a reducing environment.3,4 Crosslinking is 
a feature usually found in nanogels, although in a dendron, the crosslinkable units can 
be incorporated exactly in the desired locations due to the possibility of controlled 
functionalization during synthesis. Once the stability issue is corrected, a system could 
go through biological barriers, such as cell membranes, without losing cargo. Then, if the 
system is decorated with the right targeting moieties such as a ligand,5 it could reach the 
complementary protein in the cell. 
Decoration of nanoparticles with ligands has tremendous implications in drug 
delivery and sensing due to the specificity that ligands confer to a system.6 In the 
 
Figure 4.1. Inherent equilibrium of self-assembling dendrons. 
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particular case of dendrons, as shown in the previous Chapter, protein binding through 
a ligand is the stimulus that triggers disassembly and release.5,7,8 Targeting mechanisms 
for a delivery vehicle in cancer chemotherapy could be classified in two categories, 
passive and active targeting. Passive targeting is based on the propensity of 
nanoparticles of 10-200 nm in size to accumulate selectively in the tumor tissue. This is 
possible due to the increased permeability of the tumor vasculature and ineffective 
lymphatic drainage, also known as the enhanced permeation and retention (EPR) 
effect.9 Active targeting is accomplished by decorating the nanoparticle with ligands that 
exhibit high affinity for receptors, which are usually overexpressed on the surface of 
cancer cells or as binding sites in overexpressed proteins inside the cell.10 
Here, we present a dendritic system designed to overcome encapsulation and 
stability problems resulting from an inherent CAC dependent equilibrium, with the 
potential capability to respond to different stimuli, as shown in Figure 4.2. 
 
Figure 4.2. Schematic of crosslinked dendritic aggregates. 
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4.2 Approach and Molecular Design 
Biaryl dendrons are facially amphiphilic in each layer of the design, the focal 
point and the periphery. This is accomplished by incorporating hydrophilic and 
hydrophobic side chains at opposite sides of the aryl moieties, which are oriented at 
opposite faces when the dendrons are in aqueous solution, due to the inherent twist of 
the biaryl.11 It has been shown in a recent work from our lab that dendrons can be 
crosslinked at the core of the assembly by using UV light, if the proper crosslinking 
moieties are incorporated in the hydrophobic face of the dendron, i.e. photodimerizable 
coumarin.12 In the same work, it was shown how the system could encapsulate 
hydrophobic guest molecules prior to crosslinking and preserve the crosslinking 
capacity. However, the responsiveness of the crosslink in that design was not applicable 
towards a biologically relevant stimulus, since light can only penetrate a few millimeters 
in organic tissue. To fully exploit the capability of dendrons to be adapted as crosslink 
nanoassemblies and stable nanocarriers, it is important to make the supramolecular 
aggregate responsive to biologically relevant stimuli by introducing, in this case, a redox 
responsive crosslinkable moiety and a ligand for protein targeting.  
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We targeted a single dendritic design, initially with the potential to be 
conjugated to any ligand able to perform a nucleophilic attack. The structure of the 
targeted dendron is shown in Figure 4.3. Pentaethyleneglycol monomethylether (PEG) 
was chosen as the hydrophilic moiety for the reasons mentioned in the previous 
chapter. Briefly, PEG confers water solubility and biocompatibility when it is installed as 
the outer shell in a nanoparticle.  
Crosslinking in nanoparticles 
could be performed either at the 
surface or at the core.3 Our dendron 
has the crosslinking units as the 
hydrophobic moieties of the 
molecule, which means the 
hydrophobic chains will collapse 
towards the core of the self-
assembly where they will crosslink 
upon a redox stimulus. For that, an 
alkyl chain with a pyridyl disulfide as a terminal group functions as both the crosslinking 
unit and the hydrophobic moiety. However, due to the reactivity of the pyridyl disulfide 
functionality, the hydrophobic fragments must be attached to the dendron in the last 
step of the synthesis via an orthogonal reaction. For this, the pyridyl disulfide bearing 
alkyl chain has an azide as the other terminal group. If the dendron backbone is 
functionalized with terminal alkyne functionalities, azide-alkyne click chemistry can be 
 
Figure 4.3. Targeted G1 dendron. 
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performed to attach the crosslinkable hydrophobic moieties to the dendron in the last 
step of the synthesis. 
It has been found that for this type of dendrons the gain in CAC from a G1 to a 
G2 is already small,13 while the gain from G0 to G1 is significant (mM to µM) this is a 
reason to limit the synthetic efforts to the synthesis of only a G1 type of crosslinkable 
dendrons. Also, the simplest crosslinkable dendron will have 3 of such functionalities, 
which corresponds to a G1 dendron with the redox responsive units at the hydrophobic 
face. A G2 dendron would have 7 of these functional groups, although after crosslinking, 
the formation of new covalent bonds between G1 dendrons in the assembly will render 
a crosslinked aggregate, not different from the crosslinked aggregate formed by a G2 
dendron. Then, it is worthwhile to synthesize only a G1 dendron, which, in the end, after 
crosslink, does not present a meaningful difference with a G2.  
A system that responds to a reducing environment is attractive from the drug 
delivery perspective, due to the high reducing environment in the cells.3 Although 
glutathione, the most abundant reducing agent in most cells, has an intracellular 
concentration of approximately 3 mM, its concentration in the blood is around 10 µM.14 
Such difference in concentration is more than two orders of magnitude higher for the 
intracellular environment, which makes glutathione a highly desirable stimulus to 
target. 
Given the possibility the aggregate remains preserved after it has been 
internalized by the cell and de-crosslinked by glutathione, it would be interesting to 
explore the possibility of triggering intracellular disassembly of the dendron self-
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assembly. For that, once more, we take advantage of the control over the 
functionalization in the synthesis of a dendron to introduce a ligand as a second 
responsive functionality to target an overexpressed protein, which is to be found within 
a cancer cell. 
Such target could be 
dihydrofolate reductase (DHFR), which is 
an enzyme that has a critical role in 
regulating the amount of 
tetrahydrofolate by reducing dihydrofolic 
acid to tetrahydrofolic acid in the cell.15 
Tetrahydrofolate, as well as its 
derivatives, is essential in the synthesis of purine and thymidylate, which in turn, are 
important for cell proliferation and cell growth.16,17 DHFR plays a central role in the 
synthesis of nucleic acid precursors, which makes it a target for anticancer drugs, along 
with the fact that folate is needed in rapidly dividing cells to make thymine.18 The 
deficiency of this enzyme causes deficiency in folate, which has been linked to health 
problems such as anemia. The overexpression of DHFR is a requirement for the rapid 
cell division shown by cancer cells. The highest concentrations of DHFR have been found 
in brain cancer cells.19 
Methotrexate (MTX), a folic acid derivative, is a ligand that has been found to 
bind efficiently to DHFR (nanomolar range).20,21,22 However, its poor solubility makes it 
difficult to functionalize, a requirement for its synthetic transformation.23 For that, we 
 
Figure 4.4. Targeted ligand. 
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functionalized this ligand with two hydrophilic fragments of amino-diethylene glycol in 
an attempt to increase the ligand solubility in different solvents. The targeted ligand is 
shown in Figure 4.4. 
The functionalization of the dendron with the ligand can be accomplished at the 
benzylic position by simply transforming the benzylic hydroxyl into an excellent leaving 
group, trifluoromethanesulfonate (triflate, -OTf). Then, a hydroxyl from the ligand will 
attack the benzylic position displacing the triflate and forming the ligand-functionalized 
dendron. The reason to attach the ligand at the benzylic position of the focal point is 
related to the HLB of the dendron. Since the pyridildisulfide components are highly 
hydrophobic, a dendron in which a PEG chain has been replaced by a linker and ligand 
that are not as hydrophilic could simply precipitate out of solution. A way to overcome 
this problem, since we don’t want the ligand buried in the hydrophobic core, is to 
endow the ligand with a hydrophilic linker and then attach it to a position that does not 
involve substituting PEG in the molecule, i.e. the benzylic hydroxyl.  
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Scheme 4.1. Synthesis of the target G1 dendron. 
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4.3 Results and Discussion 
4.3.1. Synthetic Strategy 
In this synthesis, we target a dendron initially incorporating PEG chains as the 
hydrophilic components and propargyl functionalities in the positions, where we want 
the hydrophobic chains to be attached by click chemistry at a later step. Accordingly, 
and as shown in Scheme 4.1, we started with the synthesis by mono-protecting one 
phenolic hydroxyl in the ester of 4-bromo-3,5-dihydroxybromobenzoic acid 1 with tert-
butyldimethylsilyl chloride (TBS-Cl), in presence of the base imidazole, to get the aryl 
scaffold 2. The remaining phenolic hydroxyl was then acetylated by reacting it with 
acetyl chloride using triethylamine as the base. From this reaction we obtained the 
bottom aromatic ring 3, which is protected by two different protective groups in such a 
way that it is possible to selectively deprotect the phenolic hydroxyls to make them 
react individually.  
Once we got the bromoaryl 3, its reaction with the arylstannane 4 (compound 5 
in Chapter 3) under Stille coupling conditions, generated the biaryl protected AB2 
monomer 5. Then, the acetyl group protecting one phenolic hydroxyl was hydrolyzed 
with lithium aluminum hydride (LiAlH4) to deprotect the hydroxyl; simultaneously, the 
ester functionality was reduced to a methyl alcohol getting the mono-deprotected biaryl 
6. The now available phenolic hydroxyl was O-monoalkylated using propargyl bromide in 
the presence of potassium carbonate and 18-crown-6 to get the alkyne bearing biaryl 7. 
The selective deprotection of the remaining phenolic hydroxyl in the bottom aromatic 
ring, using tetrabutylammonium fluoride (TBAF), led to the biaryl 8, which was O-
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alkylated with PEG by reacting with PEG-Ts in the O-monoalkylation conditions already 
described. From the previous step, we got the MOM diprotected AB2 compound 9. 
Compound 9, which bears a PEG chain and a propargyl unit as well as the 
benzylic alcohol, was reacted with Dowex resin to deprotect the phenolic hydroxyls in 
the top ring to yield the AB2 monomer 10. Utilizing a bromomethyl periphery unit 11 
(compound 12 in Chapter 3) to O-alkylate the remaining phenolic hydroxyls, we got the 
G1 dendron 12 with the required three alkyne functionalities for click chemistry. Finally, 
the alkyne-azide click chemistry was possible between 12 and the hydrophobic molecule 
13, which is functionalized with an azide on one end and with a pyridyldisulfide group 
(PDS) on the other end, to get the targeted crosslinkable G1 dendron 14 (Scheme 4.1). 
However, before performing this previous reaction, the pyridyldisulfide moiety in 
13 had not been reported to be stable under the click chemistry conditions used in the 
reaction with the dendron 12, as seen in Scheme 4.1, requiring certain synthetic efforts 
to achieve. For that reason, we run a test reaction to observe the behavior of the 
pyridyldisulfide moiety under the conditions of alkyne-azide click chemistry, as shown in 
Scheme 4.2. Briefly, 3-hydroxybenzyl alcohol 15 was O-alkylated with a propargyl 
substituent to get the product 16, which was set up to react with 13 in the click 
 
Scheme 4.2. Test reaction for 13 under click chemistry conditions. 
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chemistry conditions overnight. The desired product triazol-pyridyldisulfide 17 was 
obtained in acceptable yield and purified without major inconvenience. 
The synthesis of the azide 13 is shown in Scheme 4.3 and was started from the 
commercially available 6-mercaptohexanol 18, which was functionalized and at the 
same time protected with 2,2’-dipyridyl disulfide 19, in acidic conditions,24 to get 6-(2-
dithiopyridyl)hexanol 20. The terminal hydroxyl in 20 was functionalized into the 
mesylate 21 by reaction with mesyl chloride (MsCl). The mesyl group is a good leaving 
group and was substituted by an azide group to give the hydrophobic azide 
incorporating a crosslinkable moiety 13. 
 
Scheme 4.4. Modification of the ligand MTX. 
 
Scheme 4.3. Synthesis of the hydrophobic crosslinkable moiety. 
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The modifications made to the ligand MTX are shown in Scheme 4.4. After 
attempting to solubilize MTX in solvents such as N,N-dimethylformamide (DMF), 
dimethylsulfoxyde (DMSO), methanol (MeOH) and mixtures of the solvents, 
MeOH/DMF, NMP/DMF, only N-methyl-2-pyrrolidone (NMP) was suitable to accomplish 
the reaction.23 For that, the carboxylic acid groups of MTX 22 were reacted in an amide 
coupling with the amino group of 2-(2-aminoethoxy)ethanol aided by the coupling agent 
HATU and Hünig’s base (N,N-diisopropylethylamine, DIPEA)25 to get the more soluble 
modified ligand 23. 
As mentioned before, to try to incorporate the ligand 23 to the structure of the 
dendron with the least possible variation in the HLB of the dendron, we decided to 
conjugate the ligand to the benzylic position of the dendron. For that, dendron 12 was 
reacted with triflyl chloride (TfCl) to afford 24,26 as shown in Scheme 4.5. Then, the 
 
Scheme 4.5. Attaching the ligand to a G1 dendron at the benzylic position. 
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ligand 23 substituted the benzylic position of the dendron aided by DBU, yielding 
dendron 25, which was clicked with the hydrophobic moieties 13 to afford the final 
target 26. 
4.3.2 Self-Assembly and Crosslink 
The self-assembly properties of dendron 14 in water were studied using DLS, 
with a dendron concentration of 25 µM, which is above the typical CAC found for these 
dendrons (2-11 µM). The size of the assemblies formed by this dendron is around 142 
nm. The size of the initial aggregate is represented in Figure 4.5 as the curves in red 
color. The size discrimination by number of particles is consistent with the 
discriminations in volume and intensity, showing that the distribution of the 
nanoparticulates oscillates around a single size of dendritic assembly. 
To crosslink the assembly, we used a known reducing agent, dithiothreitol (DTT). 
In this experiment, DTT plays the same role that glutathione (GSH) would play in the 
intracellular environment, reducing the disulfide bonds and cleaving the 
pyridothione,27,28 which is a good leaving group (Scheme 4.6). The remaining 
 
Figure 4.5. Size of the dendritic aggregates, before and after crosslink. a) distribution by 
number shows only one size of assembly, b) distribution by volume is consistent with 
the number %, c) distribution by intensity is also in the distribution range of number %. 
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functionality, a thiol group, is attached to the backbone of the dendron by means of a 
triazol ring. The reactivity of the thiol groups to form disulfide bonds is the basis for the 
crosslinking reaction here. 
The size of the crosslinked dendritic self-assembly distributes around 143 nm, 
which is 9 nm smaller than the size of the aggregate before crosslinking. The shrinking 
size of the nanoparticles is evidence that crosslink of the assembly indeed happened. 
More evidence that the nanoparticle could have crosslinked is the formation of the 
product from the reaction between DTT and the PDS moieties of the dendron, 
pyridothione. Pyridothione is a water soluble molecule that absorbs at 343 nm, making 
it possible to quantify its presence in the dendron solution upon reaction with DTT. 
Using UV-Vis spectroscopy, to monitor pyridothione absorbance, it was possible to 
quantify the degree of reaction of the PDS functionalities of the dendron as up to 63%, 
relative to the percentage of cleavage achieved when the dendron is exposed to a great 
excess of DTT during 48 hours, as shown in Figure 4.6. 
 
Scheme 4.6. Crosslinking reaction of the dendron. 
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To be able to quantify the PDS groups cleavage when the dendron and DTT were 
in solution in a molar ratio 1:3, which is equivalent to a ratio PDS:DTT 1:1 for the three 
PDS units per G1 dendron, the sample was exposed to an excess of DTT in such a way 
that the ratio PDS:DTT was increased to 1:20. After 48 hours of this reaction, the 
absorbance detected was taken as a relative 100% of the PDS reacted. Since the 
pyridothione molar absorptivity is known ( = 8.08 x 103 M-1cm-1 at 343 nm),27 we can 
use it to calculate, theoretically, the 100% of 75 µM PDS that reacted (dendron at 25 µM 
x 3 PDS groups per dendron) simply by using the Beer-Lambert law. From that, it was 
found that only 74% of the PDS units were cleaved when the DTT excess was 20:1 
respect the PDS groups. Based on this calculation, the percentage of crosslinking shown 
in Figure 4.6 is close to 50% for the ratio PDS to DTT 1:1. 
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Figure 4.6. Cleavage of pyridothione tracked by UV-Vis spectroscopy. 
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Next, to test if the equilibrium dendron-aggregate has been shifted towards the 
aggregate stage, the dendron self-assembly was exposed to a solution of 
water:methanol 50% and the change in size was observed through DLS. In general, 
methanol is a solvent in which these dendrons are solubilized, hence any aggregate 
would be expected to promptly dissociate in presence of this solvent. As shown in 
Figure 4.7, the size of the self-assembly increased from 142 to 332 nm for the non-
crosslinked self-assembly, an increase in more than twice the initial size of the assembly 
that indicates swelling of the aggregate and a disruption in the non-covalent forces that 
held the assembly together. However, when the crosslinked dendritic assembly was 
exposed to the same conditions, water:methanol 1:1, the size increased only from 142 
to 182 nm. The large difference in size between crosslinked dendritic assembly and G1 
dendron in 50% methanol is also evidence of the crosslinking taken place and being 
effective in holding together the self-assembly.  
 
Figure 4.7. DLS measurements of the stability of the assemblies in 50% methanol. a) 
distribution by number, b) distribution by volume, c) distribution by intensity. 
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The dendritic aggregates were also studied by transmission electron microscopy 
(TEM) before and after exposure to DTT. The TEM images of G1 and G1 crosslinked are 
shown in Figure 4.8. Before crosslinking, the images show more spherical shapes for the 
aggregates; after crosslinking, the shapes of the nanoparticulates became more oval in 
general. However, the size does not seem to change when going from non-crosslinked 
to crosslinked, as it was observed by DLS although the size does seem to be slightly 
larger in the images than what was observed by DLS. 
 
Figure 4.8. TEM images of non-crosslinked dendritic aggregates. Panels (a) and (b); 
and crosslinked aggregates, panels (c) and (d).The panels come from different 
samples. 
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4.4 Summary 
In summary, the functionalization of a dendron structure with hydrophobic 
moieties containing PDS can be easily performed at a later step of the synthesis through 
a reaction such as alkyne-azide click chemistry, which is orthogonal to the reactive 
functional groups in both the dendron and hydrophobic moiety. 
We found that assemblies of PEG-PDS dendrons can be formed in aqueous 
solution. However, due to a higher inherent hydrophobicity, these dendrons cannot be 
deprived of any PEG chain for the attachment of a ligand on the hydrophilic face of the 
dendron. For that matter, the attachment of a ligand at the benzylic position of the 
backbone of the dendron was successfully achieved via a triflate leaving group. On the 
other hand, the solubility and hydrophilicity of the ligand MTX was accomplished by 
functionalization with a short aminodiethylene glycol chain. 
Crosslinking of the PDS functionalities in the dendritic aggregates, compared to 
the non-crosslinked samples, gave the nanoparticulates more stability when they were 
exposed to a mixture 1:1 of water and methanol. Although only half of the PDS 
functionalities reacted, that was enough to confer the nanostructures more stability, 
potentially locking the inherent equilibrium of these amphiphilic dendrons in the self-
assembly stage and preventing the leakage of encapsulated guest molecules. 
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4.5 Experimental Section 
4.5.1 Synthetic Procedures and Characterization of Compounds 
All chemicals and solvents were purchased from commercial sources and were 
used as such, unless otherwise mentioned. 1H NMR spectra were recorded on a 400 
MHz Bruker NMR spectrometer using the residual proton resonance of the solvent as 
the internal standard. Chemical shifts are reported in parts per million (ppm). When 
peak multiplicities are given, the following abbreviations are used: s, singlet; bs, broad 
singlet; d, doublet; t, triplet; m, multiplet. 13C NMR spectra were proton decoupled and 
recorded on a 100 MHz Bruker spectrometer using the carbon signal of the deuterated 
solvent as the internal standard. Fluorescence spectra were recorded using a JASCO FP-
6500 spectrofluorimeter. FAB-MS spectra were measured on a JEOL JMS700. MALDI-
TOF spectra were measured on a Bruker OmnifleX. IR spectra were measured on a 
Bruker Alpha-P FT-IR. 
4.5.1.1 General Procedure for the Alkylation of Phenolic Hydroxyls 
The phenolic hydroxyl group (1.0 equiv.) was solubilized in anhydrous acetone 
along with the benzyl bromide (1.0 equiv. for mono-alkylation and 2.20 equiv. for 
dialkylation). The base K2CO3 (2.0-3.0 equiv.), and 18-crown-6 (0.05-0.1 equiv.) were 
added. The reaction mixture was refluxed under argon atmosphere for 12-48 hours. The 
progress of the reaction was monitored by TLC. After completion of the reaction, the 
solvent was evaporated and the crude reaction mixture mixed with water and extracted 
with dichloromethane or ethyl acetate three times. The combined organic layer was 
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dried over anhydrous Na2SO4 and evaporated to dryness. The crude product was 
purified by column chromatography using silica gel as stationary phase. 
4.5.1.2 General Procedures for “Click” Chemistry 
To a solution of dendritic triacetylene compound (1.0 equiv.), and PDS-azide 13 
(4 equiv.) in THF, was added the same volume of aqueous CuSO4.5H2O (1.0 equiv.) and 
sodium ascorbate (2.0 equiv.) in such a way that the final solution THF/H2O was in a 
ratio 1:1. The reaction stirred at room temperature. After completion of the reaction, 
NH4Cl solution was added to the reaction mass and then, extracted with ethyl acetate 
three times. The organic layers were collected and dried over anhydrous Na2SO4, 
filtered, concentrated, and the product purified by silica gel column chromatography. 
4.5.1.3 Synthesis of compound 2 (DA-2-171) 
 
The aromatic ester 1 (21 g, 80 mmol) was dissolved in 450 mL of 
dichloromethanealong with the imidazole (5.50 g, 80 mmol). The temperature of the 
solution was reduced with an ice bath. The acetyl chloride was dissolved separately in 
60 mL of dichloromethane and then added dropwise to the ester and base solution, 
stirring and under Ar atmosphere in the ice bath for 1 hour. After 12 hours stirring the 
reaction mass was washed two times with saturated NaHCO3 solution. The organic layer 
was dried on Na2SO4, filtered, concentrated and purified by silica gel column 
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chromatography to get the product 2 (13.21 g, 44%). 1H NMR (CDCl3-400MHz)  7.31 (s, 
1H, a), 7.12 (s, 1H, b), 5.67 (bs, 1H, c), 4.35 (q, J = 7.1 Hz, 2H, d), 1.38 (t, J = 7.1 Hz, 3H, e), 
1.05 (s, 9H, f), 0.28 (s, 6H, g). 
4.5.1.4 Synthesis of compound 3 (DA-2-189) 
 
The monoprotected ester 2 (11.4 g, 30.37 mmol) was dissolved in 125 mL of 
dichoromethane, after adding triethylamine (6.14 g, 60.75 mmol) the temperature of 
dropped by means of an ice bath and the acetyl chloride (4.8 g, 60.75 mmol) was added. 
The reaction was left stirring under Ar atmosphere for 18 h. Then, it washed two times 
with saturated NaHCO3 solution. The aqueous layers were collected and extracted with 
125 mL of dichloromethane, once. The organic layers were dried on Na2SO4, filtered, 
concentrated and purified by silica gel column chromatography to get the product 3 
(10.95 g, 87%). 1H NMR (CDCl3-400MHz)  7.42 (d, J = 1.8 Hz, 1H, a), 7.40 (d, J = 1.9 Hz, 
1H, b), 4.35 (q, J = 7.1 Hz, 2H, d), 2.36 (s, 1H, c), 1.38 (t, J = 7.1 Hz, 3H, e), 1.05 (s, 9H, f), 
0.29 (s, 6H, g). 13C NMR (CDCl3-100MHz)  168.3, 165.1, 154.1, 149.5, 130.5, 117.8, 
117.0, 61.4, 25.6, 20.8, 18.3, 14.2, 4.3. FAB-MS for C17H25BrO5Si: m/z (r.i.) 417 (M
+, 39), 
375 (40), 361 (83), 359 (80), 331 (28), 319 (25). 
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4.5.1.5 Synthesis of compound 5 (DA-3-43) 
 
The solvent was degasified by bubbling Ar through it for 1 hour. The reagents 3 
(6.91 g, 16.56 mmol) and 4 (7.32 g, 15.02 mmol) were placed in a 100 mL round-bottom-
flask (RBF) that was also purged with Ar for 15 min. 50 mL of DMF were transferred with 
a syringe to the RBF with the reagents. The solution was heat to 110 oC. Then, the 
catalyst, bis(triphenylphosphine)palladium(II) dichloride (0.43 g, 0.61 mmol), was quickly 
added. The reaction was heat at 110-120 oC and stirred with Ar atmosphere for 24 
hours. Then, the DMF was evaporated and the remaining mass was washed with 150 mL 
of ethyl acetate and filtered. The organic solution was washed with water (2 x 100 mL) 
and brine. The organic layer was dried on Na2SO4, filtered, concentrated and purified by 
silica gel column chromatography in CombiFlash to get the stille coupling product 5 
(52.15 g, 27%). 1H NMR (CDCl3-400MHz)  7.45 (d, J = 1.6 Hz, 1H, a), 7.42 (d, J = 1.5 Hz, 
1H, b), 6.70 (t, J = 2.3 Hz, 1H, c), 6.61 (d, J = 2.3 Hz, 2H, h), 5.13 (s, 4H, i), 4.37 (q, J = 7.1 
Hz, 2H, d), 3.46 (s, 6H, j), 2.04 (s, 3H, k), 1.39 (t, J = 7.1 Hz, 3H, e), 0.75 (s, 9H, f), 0.04 (s, 
6H, g). FAB-MS for C27H38O9Si: m/z (r.i.) 535 (M
+, 50), 503 (35), 477 (100), 447 (50), 373 
(40), 345 (18). 
 174 
4.5.1.6 Synthesis of compound 6 (DA-3-13) 
 
Compound 5 (2.12 g, 3.97 mmol) was solubilized in 35mL of anhydrous. Stirring, 
under Ar atmosphere, and with an ice bath, the reducing agent LiAlH4 (0.75 g, 19.85 
mmol) was added in portions. After complete addition, the reaction was allowed to 
reach room temperature. After 24 hours stirring the reaction mass was quenched by 
adding 50 mL of ethyl acetate at 0 oC and stirring for a 10 min. The solvent was 
evaporated to again, add ethyl acetate and water, extracting the aqueous solution three 
times with ethyl acetate. The organic layers were collected and dried over Na2SO4. The 
solvent was evaporated and the product purified through column chromatography to 
get 6 (0.86 g, 48%). 1H NMR (CDCl3-400MHz)  6.74 (t, J = 2.3 Hz, 1H, c), 6.67 (d, J = 2.3 
Hz, 2H, h), 6.63 (m, 1H, a), 6.49 (m, 1H, b), 5.16 (s, 4H, i), 4.61 (s, 2H, d), 3.46 (s, 6H, j), 
0.74 (s, 9H, f), 0.07 (s, 1H, e), -0.01 (s, 6H, g). FAB-MS for C23H34O7Si: m/z (r.i.) 451 (M
+, 
44), 433 (42), 393 (52), 331 (23). 
4.5.1.7 Synthesis of compound 7 (DA-3-32) 
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Compound 6 (0.73 g, 1.62 mmol), propargyl bromide (0.39 g, 3.23 mmol), K2CO3 
(0.45 g, 3.23 mmol), and 18-crown-6 (0.09 g, 0.32 mmol) were refluxed in 15 mL of 
acetone, as described in the general procedure for alkylations getting the product 7 
after purification by chromatography (0.20 g, 25%). 1H NMR (CDCl3-400MHz)  6.77 (d, J 
= 1.2 Hz, 1H, a), 6.68 (m, 1H, c), 6,67 (d, J = 2.0 Hz, 2H, h), 6.58 (m, 1H, b), 5.15 (s, 4H, i), 
4.67 (d, J = 5.4 Hz, 2H, d), 4.61 (d, J = 2.4 Hz, 2H, n), 3.46 (s, 6H, j), 2.45 (t, J = 2.4 Hz, 1H, 
k), 1.67 (t, J = 5.87 Hz, 1H, e), 0.75 (s, 9H, f), 0.02 (s, 6H, g). 
4.5.1.8 Synthesis of compound 8 (DA-3-35) 
 
Compound 7 (0.2 g, 0.41 mmol) was dissolved in anhydrous THF, to which TBAF 
(0.43 g, 1.63 mmol) was added. The reaction was left stirring and in Ar environment at 
room temperature for 12 hours. THF was evaporated with air flow at room 
temperature. Then, 20 mL of NH4Cl solution were added. The aqueous solution was 
extracted with ethyl acetate. The organic layers were collected and dried over Na2SO4. 
The solvent was evaporated and the product 8 was purified through column 
chromatography (0.15 g, 94%). 1H NMR (CDCl3-400MHz)  6.78 (t, J = 2.3 Hz, 1H, c), 6.71 
(d, J = 1.2 Hz, 1H, b), 6.70 (d, J = 2.3 Hz, 2H, h), 6.68 (m, 1H, a), 5.17 (s, 4H, i), 4.68 (s, 2H, 
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d), 4.64 (d, J = 2.4 Hz, 2H, n), 3.48 (s, 6H, j), 2.46 (t, J = 2.4 Hz, 1H, k), 1.71 (bs, 1H, e). 
FAB-MS for C20H22O7: m/z (r.i) 374(M+, 100), 329(53), 297(72), 267(50), 69(85). 
4.5.1.9 Synthesis of compound 9 (DA-3-37) 
 
According to the procedure for alkylation of phenolic hydroxyls, the biaryl 8 (0.14 
g, 0.38 mmol) was mixed with the tosylate of pentaethylene glycol monomethyl ether 
PEG-Ts (0.16 g, 0.38 mmol), K2CO3 (0.16 g, 1.15 mmol), and 18-crown-6 (0.02 g, 0.08 
mmol) in anhydrous acetone and refluxed, stirring and under Ar atmosphere. After 
purification, 9 was obtained (0.16 g, 68%). 1H NMR (CDCl3-400MHz)  6.78 (s, 1H, b), 
6.74 (s, 1H, a), 6.73 (d, J = 2.3 Hz, 2H, h), 6.68 (t, J = 2.3 Hz, 1H, c), 5.16 (s, 4H, i), 4.70 (s, 
2H, d), 4.62 (d, J = 2.4 Hz, 2H, n), 4.08 (m, 2H, f), 3.71 (m, 2H, g), 3.61 (m, 11H, r), 3.53 
(m, 5H, r), 3.48 (s, 6H, j), 3.37 (s, 3H, p), 0.07 (s, 1H, e). 13C NMR (CDCl3-100MHz)  157.5, 
157.1, 155.6, 154.0, 142.1, 141.0, 135.5, 130.0, 119.6, 112.8, 111.7, 105.3, 104.9, 104.5, 
103.7, 94.7, 78.8, 75.4, 71.9, 70.8, 70.7, 70.6, 70.5, 70.5, 69.6, 68.9, 68.8, 65.3, 59.0, 
56.4, 56.0. 
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4.5.1.10 Synthesis of compound 10 (DA-3-39) 
 
Compound 9 (0.16 g, 2.61 mmol) was dissolved in 10 mL of methanol, 1 mL of 
1,4-dioxane, and 0.5 mL of water. Dowex resin was added (0.48 g) and the reaction was 
set to reflux, stirring and under Ar atmosphere. The mixture reacted for 4 hours. Upon 
completion of the reaction the solvents were evaporated and the remaining mass 
washed with acetone and filtered. The acetone was evaporated and 10 mL of water 
added to remaining mass, to extract with ethyl acetate (3 x 10 mL). The organic layers 
were dried over Na2SO4. The organic solution was filtrated and concentrated. After 
purification, product 10 was got (0.12 g, 90%). ESI-MS m/z calculated for C27H36O10 + H
+: 
520.57; found: 1061.0 for (2(C27H36O10) + Na)
+, 543.2 for (C27H36O10 + Na)
+. Additional 
characterization details for compound 10 are found in reference 29.29 
4.5.1.11 Synthesis of compound 12 (DA-3-40) 
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According to the procedure for the alkylation of phenolic hydroxyls, compound 
10 (0.12 g, 0.24 mmol), compound 11 (0.25 g, 0.52 mmol), K2CO3 (0.16 g, 1.18 mmol), 
and 18-crown-6 (0.03 g, 0.12 mmol) were mixed in anhydrous acetone and refluxed, 
stirring under Ar atmosphere. After purification, compound 12 was obtained (0.19 g, 
62%). 1H NMR (CDCl3-400MHz)  6.78 (s, 1H, b), 6.76 (s, 1H, a), 6.64 (d, J = 2.1 Hz, 2H, c), 
6.63 (d, J = 2.0 Hz, 2H, d), 6.60 (d, J = 2.3 Hz, 2H, i), 6.55 (d, J = 2.3 Hz, 1H, z), 6.49 (t, J = 
2.2 Hz, 2H, x), 4.97 (s, 4H, e), 4.70 (s, 2H, g), 4.66 (d, J = 2.4 Hz, 4H, w), 4.57 (d, J = 2.3 Hz, 
2H, f), 4.12-410 (m, 4H, h), 4.06-4.04 (m, 2H, i), 3.85-382 (m, 4H, j), 3.72-3.70 (m, 5H, k), 
3.68-3.56 (m, 37H, k), 3.55-3.51 (m, 13H, k), 3.37 (s, 6H, u), 3.36 (s, 3H, y), 2.52 (d, J = 2.4 
Hz, 2H, v), 2.47 (d, J = 2.3 Hz, 1H, n). 13C NMR (CDCl3-100MHz)  160.1, 159.0, 158.8, 
157.1, 155.6, 142.2, 139.7, 135.6, 120.0, 110.3, 106.7, 106.2, 105.5, 105.0, 101.3, 101.2, 
78.9, 78.4, 77.2, 75.8, 75.6, 71.9, 71.9, 70.8, 70.6, 70.6, 70.5, 70.5, 70.5, 69.6, 67.5, 65.3, 
59.0, 59.0, 56.4, 56.0, 53.4. ESI-MS m/z calculated for C69H96O24 + H
+: 1311.0; found: 
1311.0 for (C27H36O10 + H)
+. 
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4.5.1.12 Synthesis of compound 14 (DA-3-41) 
 
According to the procedure for click chemistry, compound 12 (185 mg, 0.145 
mmol), compound 13 (124 mg, 0.463 mmol), CuSO4.5H2O (33 mg, 0.13 mmol), and 
sodium ascorbate (52 mg, 0.261 mmol) were mixed in 2 mL of THF and 2 mL of water. 
After purification of the reaction the product 14 was obtained (51 mg, 22%). 1H NMR 
(CDCl3-400MHz)  8.44 (d, J = 4.7 Hz, 2H, x), 8.41 (d, J = 3.8 Hz, 1H, w), 7.70-7.58 (m, 7H, 
a, z), 7.19 (s, 1H, y), 7.08-7.03 (m, 3H, a), 6.77 (d, J = 5.8 Hz, 2H, a), 6.67-6.49 (m, 10H, a), 
5.15 (s, 4H, b), 5.09 (s, 2H, c), 4.94 (s, 4H, d), 4.69 (s, 2H, e), 4.31 (t, J = 7.2 Hz, 4H, f), 
4.18-4.04 (m, 8H, f, h), 3.83-3.81 (m, 4H, g), 3.70-3.48 (m, 57H, f, g), 3.36 (s, 6H, i), 3.34 
(s, 3H, j), 2.76 (t, J = 7.2 Hz, 4H, k), 2.69 (t, J = 7.2 Hz, 2H, n), 1.91-1.84 (m, 6H, p), 1.76-
1.56 (m, 12H, p), 1.45-0.89 (m, 19H, p). MALDI-ToF m/z expected for C102H144N12O24S6: 
2114.69; found 2152.66 for C102H144N12O24S6 + K
+, 2136.69 for C102H144N12O24S6 + Na
+, 
2114.73 for C102H144N12O24S6 + H
+. 
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4.5.1.13 Synthesis of compound 20 (DA-3-2) 
 
The compounds 6-mercaptoetanol 18 (1 g, 7.45 mmol) and 2-aldrithiol 19 (2.46 
g, 11.17 mmol) were dissolved in methanol (10 mL). Stirring, and under Ar atmosphere 
250 µL of glacial acetic acid were added. The reaction was left 18 hours. The solvent was 
evaporated and NaHCO3 solution was added, to be extracted with dichoromethane. 
After purification by column chromatography CombiFlash, the product 20 was obtained 
(1.53 g, 85%). 1H NMR (CDCl3-400MHz)  8.46 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H, a), 7.74 (dt, J 
= 8.1, 1.0 Hz, 1H, d), 7.66 (ddd, J = 8.1, 7.4, 1.8 Hz, 1H, c), 7.09 (m, 1H, b), 3.62 (t, J = 6.5 
Hz, 2H, e), 2.79 (t, J = 7.2 Hz, 2H, f), 1.71 (dd, J = 7.2, 7.1 Hz, 2H, g), 1.54 (dd, J = 5.0, 6.7 
Hz, 2H, h), 1.38 (m, 4H, i, j). 13C NMR (CDCl3-100MHz)  160.5, 149.3, 137.3, 120.6, 
119.8, 62.8, 38.9, 32.5, 28.8, 28.2, 25.3. . ESI-MS m/z calculated for C11H17NOS2 + H
+: 
244.39; found: 266.07 for (C11H17NOS2 + Na)
+, 244.09 for (C11H17NOS2 + H)
+. 
4.5.1.14 Synthesis of compound 21 (DA-3-4) 
 
Compound 20 (4.67g, 19.20 mmol) and triethylamine (3.88 g, 38.39 mol) were 
solubilized in 120 mL of anhydrous THF. Under Ar atmosphere and stirring, the mesyl 
chloride (4.40 g, 38.39 mmol) was added. The reaction was left overnight, the THF was 
evaporated without heating the flask, water was added to the remaining mass, and then 
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extracted with dichloromethane. The organic layers were dried on Na2SO4, filtrated, 
concentrated, and purified through column chromatography to get product 21 (5.51 g, 
90%). 1H NMR (CDCl3-400MHz)  8.47 (ddd, J = 4.9, 1.7, 0.9 Hz, 1H, a), 7.74 (s, 1H, d), 
7.72 (s, 1H, c), 7.67 (ddd, J = 7.7, 1.8 Hz, 1H, b), 4.20 (t, J = 6.5 Hz, 2H, f), 3.00 (s, 3H, k), 
2.80 (t, J = 7.3 Hz, 2H, e), 1.77-168 (m, 4H, g, h), 1.46-1.38 (m, 4H, i, j). 13C NMR (CDCl3-
100MHz)  160.4, 149.3, 137.3, 121.0, 119.9, 69.8, 38.7, 37.4, 29.0, 28.6, 27.8, 25.0. ESI-
MS m/z calculated for C12H19NO3S3 + H
+: 322.48; found: 344.05 for (C12H19NO3S3 + Na)
+, 
322.06 for (C12H19NO3S3 + H)
+.  
4.5.1.15 Synthesis of compound 13 (DA-3-6) 
 
Compound 21 (6.11 g, 19.00 mmol) was solubilized in 30 mL of anhydrous DMF 
mixing it with NaN3 (1.85 g, 28.50 mmol). Stirring and under Ar atmosphere the reaction 
was left for 24 h. Then, more NaN3 was added and left reacting 6 more hours. 
Afterwards, 250 mL of water were added to next extract with diethyl ether (3 x 100 mL). 
The organic layers were dried on Na2SO4, filtered and purified by column 
chromatography to get the product 13 (4.38 g, 86%). 1H NMR (CDCl3-400MHz)  8.46 
(ddd, J = 4.9, 1.7, 0.8 Hz, 1H, a), 7.72 (dt, J = 8.1, 0.9 Hz, 1H, d), 7.65 (m, 1H, c), 7.30 
(ddd, J = 7.3, 4.9, 1.1 Hz, 1H, b), 3.24 (t, J = 6.9 Hz, 2H, f), 2.80 (m, 2H, e), 1.71 (dt, J = 
14.7, 7.2 Hz, 2H, g), 1.58 (dt, J = 14.24, 7.0 Hz, 2H, h), 1.45-1.36 (m, 4H, i, j). 13C NMR 
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(CDCl3-100MHz)  160.5, 149.4, 137.1, 120.6, 119.7, 51.3, 38.8, 28.7, 28.7, 27.9, 26.3. 
FAB-MS m/z calculated for C11H16N4S2 + H
+: 269.2. 
4.5.1.16 Synthesis of compound 23 (DA-3-132) 
 
MTX Compound 22 (0.050 g, 0.11 mmol) was mixed with the 2-(2-
aminoethoxy)ethanol (0.058 g, 0.55 mmol) in NMP (2 mL). Followed by the addition of 
DIPEA (0.071 g, 0.55 mmol). HATU (0.188 g, 0.495 mmol) was previously dissolved in 
NMP (2 mL) and this solution was poured into the MTX solution. Stirring and under Ar 
atmosphere, the reaction was left to complete for 5 days at room temperature. Diethyl 
ether was added to the reaction mass to precipitate a brown oil, which was washed 
once more with diethyl ether. The solution was separated from the oil, which was 
washed two more times with dichloromethane. The organic solution was separated 
from the oil. Then, the oil was mixed with acetone and sonicated. The product 25 (0.017 
g, 25%) precipitated as a yellow solid that was vacuum filtered and dried. 1H NMR 
(DMSO-d6-400MHz)  8.55 (d, J = 5.1, Hz, 1H, a), 7.73 (d, J = 9.0 Hz, 2H, b), 6.82 (d, J = 
8.9 Hz, 2H, c), 6.61 (s, 2H, y), 4.78 (s, 2H, d), 4.59 (s, 2H, z), 4.31 (dd, J = 13.6, 8.4 Hz, 1H, 
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e), 3.60-3.35 (m, 16H, h), 3.21 (s, 3H, w), 217-2.11 (m, 2H, g), 2.10-2.08 (m, 2H, f). ESI-
MS m/z calculated for C28H40N10O7 + H
+: 329.68; found: 329.32 for (C28H40N10O7 + H)
+. 
4.5.1.17 Synthesis of compound 24 (DA-3-134) 
 
To a stirring mixture of dendron 12 (20 mg, 0.015 mmol) and DMAP (7.5 mg, 
0.061 mmol) in anhydrous dichloromethane (1.2 mL), was added Tf-Cl (7.7 mg, 0.046 
mmol) inside the previous solution. After 48 h the reaction was stopped, more 
dichloromethane (10 mL) and brine (10 mL) were added. It was extracted three times 
with dichloromethane. The organic extracts were dried over anhydrous Na2SO4. The 
solution was purified by flash chromatography to get the pure product 24 (7.47 mg, 
34%). 19F NMR (CDCl3-300MHz)  -78.26 (3F). 
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4.5.1.18 Synthesis of compound 25 (DA-3-136) 
 
The dendron 24 (7.47 mg, 5.18 µmol) was dissolved in dichloromethane (1 mL), 
in a vial. The ligand 23 (3.26 mg, 5.18 µmol) was added followed by a drop of DBU (10 
mg, 77.7 µmol). Stirring, the reaction was left in the capped vial. After 65 hours, water 
was added (2 mL), and then, extracted three times with dichloromethane. Then, the 
aqueous solution was saturated with NaCl to be extracted three more times with 
dichloromethane. The organic layers were dried over anhydrous Na2SO4. After 
purification by flash chromatography, the product 25 was obtained (3 mg, 30%). 1H NMR 
(DMSO-d6-400MHz)  8.56 (d, J = 5.1 Hz, 1H, a) 7.73 (d, J = 8.9 Hz, 2H, b), 6.83-6.49 (m, 
11H, c), 4.98 (s, 4H, d), 4.77 (s, 2H, e), 4.68-466 (m, 6H, f, g), 4.59-4.57 (m, 4H, h), 4.34-
4.29 (m, 2H, i), 4.12-4.04 (m, 9H, j, k), 3.73 (m, 6H, j, k), 3.58-3.35 (m, 80H, j, k), 3.22-
3.21 (m, 16H, n, p, j), 2.60-2.45 (m, 3H, x). MALDI-ToF m/z expected for C97H134N10O30: 
1920.15; found 1943.70 for C97H134N10O30 + Na
+. 
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4.5.1.19 Synthesis of compound 26 (DA-3-138) 
 
According to the procedure for click chemistry, compounds 25 (3 mg, 1.56 µmol) 
and compound 13 (2.52 mg, 9.37 µmol) were mixed in presence of CuSO4.5H2O (0.58 
mg, 2.34 µmol) and sodium ascorbate (0.58 mg, 2.34 V) to get the target dendron 26 
(1.0 mg, 23%). 1H NMR (DMSO-d6-400MHz)  8.55 (s, 1H, a), 8.43-8.41 (m, 3H, b), 7.82-
7.61 (m, 9H, c), 7.22-7.19 (m, 4H, c), 6.86 (s, 1H, c), 6.71 (s, 1H, c), 6.67 (s, 2H, c), 6.61 (s, 
2H, c), 6.57 (m, 2H), 6.53 (m, 3H, c), 5.10 (s, 4H, d), 5.06 (s, 2H, e), 4.94 (s, 4H, f), 4.78 (s, 
2H, g), 4.50 (d, , J = 5.6 Hz, 2H, h), 4.31 (t, J = 5.6 Hz, 4H, h), 4.33-4.30 (m, 3H, i), 4.06-
3.90 (m, 5H, i, h), 3.71 (m, 5H, h), 3.57-3.35 (m, 65H, h), 3.20-3.18 (m, 11H, k), 2.80 (t, J = 
7.1 Hz, 4H, n), 2.74 (t, 7.2 Hz, 2H, p), 1.78-1.03 (m, 34H, h, q). 
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4.5.2 Determination of Size of Self-Assembly and Crosslinked Nanoparticulates 
4.5.2.1 Preparation of G1 Dendron Aggregates and DLS Measurements 
The samples of dendrons were prepared in solutions of 25 µM and sonicated for 
2 hours or until the solution looked clear. Next, the samples were stirred for 2 hours at 
room temperature before the DLS measurements were taken. The samples were not 
micro-filtered unless DLS revealed aggregate sizes higher than 1000 nm in diameter. 
4.5.2.2 Preparation of Crosslinked Aggregates 
A sample of dendron 25 µM in solution was taken a UV-Vis spectrum at 343nm 
and then, since this dendron concentration makes a PDS concentration of 75 µM, the 
sample was exposed to 75 µM of DTT by adding the corresponding microliters from a 
DTT stock solution 2 mM. After exposure to the crosllinking agent, the UV-Vis spectrum 
of the sample was taken. The absorbance at 343 nm was measured after 28 hours to 
verify cleavage of pyridothione groups. 
With the objective of cleaving all the PDS functionalities in the dendron, a 
second sample with the same concentration of dendron as before was exposed to an 
excess concentration of DTT in such a way that the ratio PDS:DTT was at least 1:20. UV-
Vis spectra were taken before and after exposure to DTT to check the highest 
absorbance for the sample.  
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4.5.2.3 DLS Measurements for Crosslinked Aggregates and Exposure to Organic 
Solvent 
The samples from the crosslinking procedure were analyzed by DLS to make sure 
that the particulate size remains mono-dispersed. Micro-filtered was not necessary 
unless there were particulates with sizes larger than 1000 nm. However, the samples 
were micro-filtered before exposure to methanol. For that, 500 µL of the crosslinked 
dendron sample at 25 µM were diluted to 12.5 µM by adding 500 µL of methanol. The 
samples were allowed to equilibrate before DLS measurements. 
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CHAPTER 5 
 
SUMMARY AND FUTURE DIRECTIONS 
5.1 Introduction 
This thesis focused mainly on the importance of ligand availability for 
supramolecular interactions between macromolecules, such as proteins and small 
molecules or between proteins and synthetic macromolecules, such as dendrons. Using 
the knowledge on protein-ligand interactions that has been reported up to date, we 
chemically modified a few ligands with the aim of, upon binding to a specific protein, 
incorporating in our systems some of the characteristics shown by those proteins such 
as hydrophilic surface, globular shape, deep binding pockets, strong non-covalent 
interactions, etc. 
An interesting and innovative system for screening of small molecules against a 
target protein was described in Chapter 2. There, we used the binding pocket of hCA1 to 
hinder, upon binding of a probe bearing an enzyme cleavable bond, the action of an 
enzyme on the probe. Such action would cleave and activate an otherwise silent 
fluorophore. The probe is displaced out of the protein binding pocket and made 
available for the enzyme, only in the presence of a small molecule (competitor) with 
affinity for the binding site.1 This concept could be used in the screening of small 
molecules looking for “hits”, and also to find relative binding constants for protein-
ligand systems that are difficult to deal with using traditional methods.2 
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In Chapter 3, we took advantage of the ligand-protein interaction and great 
binding affinity of the system biotin-extravidin, to study the best location to install a 
hydrophilic ligand on a dendron. Given the self-assembly property of our biotin-
modified dendrons in aqueous solution, we encapsulated a fluorescent probe and 
studied dendron-disassembly and release efficiency upon protein binding. We found 
that installing a ligand at the periphery of these dendrons makes the ligand more 
available for the protein in solution, which gives better release profiles than when the 
ligand is tethered to the other locations. 
Based on the knowledge gained from studying these supramolecular systems, in 
Chapter 4 we proposed the synthesis of a dendron modified with a particular ligand for 
targeting the intracellular enzyme DHFR, and endowed the dendron with redox-
sensitive crosslinkable functionalities with the objective of de-crosslink in the 
intracellular reducing environment, and disassembly in the intracellular milieu upon 
protein binding. 
Based on the research described in this thesis, there are some modifications that 
would be as interesting as pertinent to accomplish and that could give a deeper insight 
into the systems introduced by our group. 
5.2 Supramolecular Displacement Conditions for Analytical Applications 
As shown in Chapter 2, the length of the probe linker influenced the availability 
of the ligand for the enzyme. However, the shallowness or deepness of the binding 
pocket will have similar impact on such availability. To better understand this, and in 
 192 
order to propose a better and more general probe design aimed to target a wider range 
of binding sites, it would be useful to study a few more systems. 
An interesting target protein for this study is the protein β-lactoglobulin, which 
has a binding pocket that could bind either retinol at the rim of the binding site or a 
fatty acid at the bottom of the site.3 Results suggesting that bound retinol is more 
exposed to the environment make a retinol-based probe an interesting molecule to test. 
As shown in Figure 5.1, a retinol-based probe has a long linker that leaves the enzyme 
cleavable bond more exposed to the solvent than in the probes for hCA1, as shown by 
our preliminary results (Figure 5.2). Despite the good binding affinity of retinoic acid to 
β-lactoglobulin (39 nM),4 a probe synthesized with a linker between retinoic acid and 4-
methylumbelliferone was not effectively protected by β-lactoglobulin from PLE 
cleavage. In our preliminary results, as shown in Figure 5.2, 125 µM of β-lactoglobulin 
was not enough to hinder esterase action on the probe linker. Compare to the 20 µM of 
hCA1 needed in Chapter 2 to protect Probe A, which means that further experiments 
 
Figure 5.1. Retinoic acid- and fatty acids- based probe for β-lactoglobulin 
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are required to find the proper conditions to hinder enzymatic action on the β-
lactoglobulin-probe complex. 
However, palmitic acid has been found to coil in the β-lactoglobulin binding 
site.3,4 Hence, a probe based on the fatty acid could present a better inhibition profile 
than a retinol-based probe. Additionally, given the high propensity of hydrophobic small 
molecules to bind this target protein, it would be interesting to compare a hexanoic acid 
based probe to the previous two probes in terms of linker length and hindrance 
provided by β-lactoglobulin.5 
From a different perspective, but complementary to the interest of testing 
probes for a protein with a shallow binding site described above, it would be relevant to 
test this supramolecular displacement and activation of a silent fluorescence probe 
method against a disease relevant protein. To address this point, a good target would be 
the factor-inhibiting hypoxia-inducible factor (FIH), which is known to have a binding 
pocket 15 Å wide and to inhibit the hypoxic responses in the cell.6 Also, the screening 
 
Figure 5.2. Finding β-lactoglobulin (B-LG) concentration for esterase (PLE) activity 
inhibition. Probe at 5 µM, PLE at 50 nM. 
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assays for FIH are scarce, and the preparation of the reagents requires high levels of 
expertise.7 A probe design could consist simply of 8-hydroxyquinoline as the ligand and 
4-methylumbelliferone as the reporter, both linked through an ester bond. There is a set 
of ligands known to bind FIH, mostly quinoline derivatives such as clioquinol, which are 
commercially accessible ligands that would help the method to be easily transferred to 
HTS.8 This would be an excellent fire-proof test for our screening method. 
5.3 Using Supramolecular Dendron Exchange to Improve Ligand Diversity 
It was demonstrated recently that the dynamics of dendron exchange between 
dendritic aggregates involves only assemblies formed by G1 dendrons.9 This means that 
if we were to synthesize dendrons with the objective of exchanging them in solution to 
form aggregates with both dendrons, our synthetic efforts should be focused only on G1 
dendrons. Given the synthetic challenge that implies functionalizing biaryl amphiphilic 
dendrons and the risk of precipitation involved in replacing more than one PEG chain in 
a G1 dendron, as mentioned in Chapter 3 and Chapter 4, the dynamic exchange could be 
used to achieve aggregates with two different kinds of ligands, avoiding design and 
synthetic problems.10 
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In Chapter 4, we showed a dendron design that incorporates a single ligand and 
potentially, could target an intracellular protein. The dendron was endowed with 
crosslinkable functionalities that also work as hydrophobic moieties. These 
functionalities could be de-crosslinked as response to a reducing environment, which is 
found in the intracellular media. However, a crosslinked dendritic aggregate would have 
more chance of reaching the intracellular milieu if it could go easily through the cell 
membrane.11 
It would be relevant to endow a system with three different responsive features 
towards three different targets (i) an overexpressed protein receptor in the cell 
membrane, (ii) a reducing intracellular environment, and (iii) an overexpressed protein 
in the intracellular milieu. Figure 5.3 depicts the characteristics of a dendritic couple that 
 
Figure 5.3. Dendron exchange to increase ligand diversity in a dendritic aggregate. 
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merge their properties into a single assembly. Then, the action of a reducing agent such 
as DTT could lock those properties in the crosslinked nanoparticulate. 
The dendron design in Chapter 4 already incorporates a redox responsive feature 
and a ligand for intracellular targeting, methotrexate (MTX). Since MTX shares structural 
features with folic acid, the incorporation of the latter into the dendron structure could 
be achieve utilizing similar conditions.12 The final structure of the dendrons will only 
differ in the ligand moieties. 
5.4 Summary 
In this final chapter a short summary for the previous chapters has been 
presented, highlighting the main features and properties of the systems described in 
this thesis. As a complement to that research, general ideas about molecular designs 
have been presented with the potential to take further what has been done and shown 
in Chapter 2 and Chapter 4. 
We expect that the whole set of designs and ideas explored and proposed here, 
will help to improve the future molecular designs, and to understand better 
supramolecular systems involving proteins, dendrons, polymers, and small molecules. 
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